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ABSTRACT 
Several aspects of the phosphoinositide signal 
transduction system were examined 1n transformed and 
tumourigenic HeLa x fibroblast human somatic cell hybrids. The 
advantage of this cell system is that both transformed and 
tumourigenic cell lines can be derived from the one 
heterokaryon and, therefore, any noted differences between the 
pairs of cells is highly likely to be associated with the 
expression of the tumourigenic phenotype in vivo. 
The incorporation of inositol into the total 
phosphoinositide pools in serum-stimulated hybrids was examined 
and was found to be equivalent in transformed and tumourigenic 
cells. Therefore, it was inferred that the rate of breakdown of 
the phosphoinositides did not differ between the transformed 
and tumourigenic hybrids. A comparison of the normal and 
tumourigenic cell lines representing the hybrid parents, also 
indicated no difference in the turnover rate of the 
phosphoinositide pools. However, the absolute size of the 
steady state pools differed markedly between the parental lines. 
Thorough examination of the steady state levels of 
the phosphoinositides in the transformed and tumourigenic 
hybrids indicated that there was no difference ln the pool 
sizes within two of the hybrid pairs but that one hybrid pair 
and the parental lines did display a statistically significan t 
difference in the size of their pools, with the levels in the 
non-tumoutigenic cells exceeding those in their tumourigenic 
counterparts. However, when results were expressed per unit 
area of membrane rather than per cell, it was found that in 
each case the tumourigenic cells had slightly higher steady 
state levels of phosphoinositides than their non-tumourigenic 
partners. Nevertheless, the variation was not significant by 
statistical analysis. 
It was found that the ratio of phosphatidylinositol 
(4,S)bisphosphate to phosphatidylinositol did not differ 
between the transformed and tumourigenic cell hybrids, 
supporting the contention that the findings concerning total 
pool sizes mirror that proportion of the phosphoinositide pool 
directly relevant to signal transduction. However, more direct 
evidence, that there was no change in phosphatidylinositol(4,5)-
bisphosphate hydrolysis between the cell types, was obtained by 
monitoring the steady state levels of the inositol phosphates 
in the hybrid pairs. It was found that there was no consistent 
difference in the levels of any of the inositol phosphates, 
with the levels of the proposed second messenger 
inositol(l,4,S)trisphosphate being similar in the transformed 
and tumourigenic cells. Therefore, it was concluded that the 
expression of the tumourigenic phenotype in this cell system is 
not associated with an alteration in phosphoinositide 
metabolism under standard tissue culture conditions. 
To examine the possibility that variations between 
the hybrid pairs occur in the phosphoinositide pathway at 
stages subsequent to lipid hydrolysis, the properties of 
protein kinase c were investigated in the membrane and 
cytosolic fractions from the different cell types. It was found 
that the tumourigenic hybrids and the HeLa parent had 
substantially less PKC activity associated with their membranes 
than did the non-tumourigenic cells. Total cellular activities 
were also decreased in the tumourigenic lines but not to the 
same extent as the membrane-associated activities, a finding 
which may have functional implications since it is the 
membrane-bound form of the enzyme which is involved in signal 
transduction. 
Moreover, an independent measure of the levels of 
protein kinase C in the different cell types, determined by 
examining the levels of phorbol diester binding in intact 
cells, further indicated that the tumourigenic cell lines had 
reduced amounts of the enzyme. Therefore, it was concluded that 
a reduction in the activity of protein kinase c, particularly 
that bound to the membrane, is associated with the expression 
of the tumourigenic phenotype. 
The implications of these findings were considered 
in relation to the involvement of a deregulation of signal 
transduction in the maintenance of the turnourigenic phenotype. 
TUMOURIGENICITY AND THE PHOSPHOINOSITIDE PATHWAY 
CONTENTS 
CHAPTER 1 
Introduction 
l.A Cell cycle 
l.B Early Events Associated with 
Growth Factor Binding 
l.B.l Ion Fluxes 
l.B.2 Intracellular pH (pHi) 
l.B.3 Protein Phosphorylation 
l.C Signal Transduction Mechanisms 
l.C.l c-AMP Signal Transduction System 
l.C.2 The Phosphoinositide Signal Transduction 
System 
l.C.2.1 Receptor Mediated cleavage of 
Phosphatidylinosito1(4,5)bisphosphate 
l.C.2.1.1 calcium Dependence of Phospholipase C 
l.C.2.1.2 Substrate Specificity of Phospho l ipase c 
l.C.2.2 Role for Inositol(l,4,5)trisphosphate 
in Raising Intracellular Free calcium 
l.C.2.3 Metabolism of Ins(l,4,5)P3 and Other 
Inositol Phosphates 
l.C.2.4 Diacylglycerol Activation of Prote i n 
Kinase C 
l.C.2.4.1 Properties of Protein Kinase C 
l.C.2.4.2 A Family of Protein kinase C Genes 
l.C.2.4.3 Biochemical and Physiological 
Activation of Protein Kinase C 
l.C.2.4.4 Activators and Inhibitors of Prote i n 
Kinase C 
1 
1 
4 
5 
7 
9 
11 
12 
15 
16 
17 
20 
21 
24 
30 
31 
32 
40 
45 
l.C.2.4.5 catalyt ic Activity and Target Proteins 
of Protein Kinase C 
l.C.2.4.6 Down-regulation and Negative Feedback 
l.C.2.4.7 Role of Protein Kinase c in Mediating 
Cell Growth 
l.C.2.4.8 Metabolism of Diacylglycerol 
l.C.2.5 Synergism Between the Two Arms of the 
Phosphoinositide Pathway and Their 
Interaction with Other Growth Signals 
in the Mitogenic Response 
l.D Cellular Growth Regulation 
l.D.l Positive Factors Regulating cell Growth 
l.D.1.1 Increased Availability of Growth 
Factors and the Altered Growth State 
l.D.1.2 Increased Number of Functional Receptors 
and the Altered Growth State 
l.D.1.3 De-regulation of Second Messengers 
and the Altered Growth State 
l.D.2 Negative Factors Regulating 
Cell Growth 
l.E Scope of Thesis 
CHAPTER 2 
General Methods 
CHAPTER 3 
Definition and Maintenance of the 
Cell System 
48 
52 
56 
58 
61 
66 
69 
71 
72 
74 
77 
84 
89 
89 
Examination of Phosphoinositide Metabolism 93 
3.A 
3.B 
3.B.l 
in the Transformed and Tumourigenic HeLa/ 
Fibroblast Somatic Cell Hybrids 
Introduction 
Materials and Methods 
Labelling Medium for [ 3H ]-inositol 
Incorporation Experi ments 
93 
96 
97 
3.B.2 
3.B.3 
3.B.4 
3.B.5 
3.B.6 
3.B.7 
3.B.8 
3.B.9 
3.C 
3.C.l 
3.C.2 
3.C.3 
3.C.4 
3.C.5 
3.C.6 
3.D 
CHAPTER 4 
4 .A 
4.B 
Decay Experiments 
Re-appraisal of Labelling Medium 
Kinetics of Incorporation of 
[3H]-inositol into Cellular Membranes 
Relative Size of the Total Exchangeable 
Inositol Lipid Steady State Pools 
Cell surface Area Measurements 
Thin Layer Chromatography of Inosi t ol 
Lipids 
High Performance Liquid Chromatograph of 
Inositol Phosphates 
Protein and Inorganic Phosphate 
Determinations 
Results and Discussion 
Decay Experiments 
Kinetics of Incorporation of [3H]-inositol 
into Cellular Membrane 
Relative Size of the Total Exchangeable 
Inositol Lipid Steady State Pools 
Relative Cell Surface Area of the 
Cell Pairs 
Relative Phosphoinositide Steady State 
Pool Sizes corrected for cell 
Surface Area 
The Relationship Between Total 
Phosphoinositide Levels and those 
Phosphoinositides Associated with 
Signal Transduction 
Ramification of Results 
98 
102 
102 
104 
104 
104 
106 
107 
109 
109 
113 
117 
120 
124 
130 
136 
Protein Kinase c Content, Activity and 140 
Subcellular Distribution in the 
Transformed and Tumourigenic Cell Hybrids 
Introduction 
Materials and Methods 
140 
144 
4.B.l 
4.B.2 
4.B.3 
4.C 
4.C.l 
4.C.1.1 
4.C.1.2 
4.C.1.3 
4.C.2 
4.C.3 
4.C.3.1 
4.C.3.2 
4.C.3.3 
4.D 
CHAPTER 5 
Conclusions 
Isolation of Protein Kinase C 
Determination of Prote i n Kinase c 
Activity 
Phorbol Ester Binding Studies 
Results and Discussion 
Protein Kinase c Activity in the 
Cytosol and Membrane of Tumourigenic 
and Non-turnourigenic Cells 
PKC Activity Profiles Generated from 
DE 52 Chromatography of Cytosolic and 
Membrane Fractions 
Quantitation of Protein Kinase C and 
Protein Kinase M Activity in the Membrane 
and cytosol of the Tumourigenic and 
Non-tumourigenic Lines 
Relative Protein Kinase C Activities in the 
Transformed and Tumourigenic Hybrids 
and Parental Lines 
The Effects of Divalent Metal Chelators 
on the Subcellular Distribution of 
Protein Kinase C 
Phorbol Diester Binding to Intact Cells 
Characteristics of Phorbol Diester Binding 
The Relative Number of Higher Affinity 
Binding Sites in the Transformed and 
Tumourigenic Hybrids and Parental Lines 
comparison of Relative Protein Kinase c 
Activity and Phorbol Diester Binding 
Ramification of Results 
LITERATURE CITED 
APPENDIX 
ABBREVIATIONS 
144 
146 
148 
150 
150 
150 
154 
158 
161 
166 
166 
174 
174 
178 
185 
191 
230 
231 
DIAGRAMS: 
t.l 
1.2 
1.3 
1.4 
1.5 
1.6 
1.7 
FIGURES: 
3.1 
3.2 
3.3 
3.4 
3.5 
3.6 
4.1 
4.2 
4.3 
4. 4 
The Cell Cycle 
Signal Transduction Systems 
Metabolism of Inositol(l,4,5)trisphosphate 
Domain Structure of Protein 
Model of Protein Kinase C Activation in 
Intact Cells 
Metabolism of Diacylglycerol 
Oncogenes and the Phosphoinositide 
Pathway 
Decay of the Phosphoinositides 
Kinetics of Incorporation of Inositol 
into the Phosphoinositides 
Kinetics of Incorporation of Palmitate 
into Cellular Membranes 
Effect of Cell Density on Inositol and 
Palmitate Incorporation into Cellular 
Membranes 
Effect of Serum concentration on cell 
Growth 
Separation and Quantitation of Inositol 
Trisphosphates 
Protein Kinase c Activity Profiles in 
Membrane and cytosol of the Cell Hybrids 
Effect of Chelators on Subcellular 
Distribution of Protein Kinase C 
Binding of Phorbol 12,13-dibutyrate in 
Intact Cells: Scatchard Analysis and 
Binding curves 
Relationship Between the concentration 
of Free Phorbol 12,13-dibutyrate and 
the Levels of Its Non-specific Binding 
to Intact Cells 
2 
14 
25 
34 
44 
59 
75 
111 
114 
122 
127 
129 
132 
151 
164 
169 
170 
TABLES: 
3.1 
3.2 
3.3 
4.lA 
4.lB 
4. 2 
4.3 
Relative Steady State Phosphoinositi de 
Levels per Cell 
Relative cell Size Measurements 
Relative Phosphoinositide Levels per 
Unit Membrane 
Protein Kinase C Activity 1n the 
Membrane and cytosol 
Realtive Protein Kinase C Activity 1n 
Non-tumourigenic and Tumourigenic 
Cells 
Phorbol Diester Binding to Intact Cells 
Relative Phorbol Diester Binding and 
Protein Kinase C Activity Levels in 
the Non-tumourigenic and Tumourigenic 
cells 
119 
123 
125 
155 
156 
173 
17 5 
1 
CHAPTER 1: 
INTRODUCTION 
One of the greatest challenges of cell biology 
involves determining the sequence of events which direct a cell 
to divide. It is only when this sequence is known that one can 
fully assess how cellular growth is regulated and therefore 
gain some clearer insight into how it can be de-regulated when 
a cell becomes malignant. 
l.A CELL CYCLE 
The majority of actively dividing higher animal and 
plant cells have four stages in their growth cycle (see diagram 
1.1). The S phase designates the period occupied by DNA 
replication. This is separated from the visible start of 
nuclear division (M phase) by a period during which most cell 
growth occurs, known as the G2 phase. Cell division is then 
separated from the next round of DNA replication in most cells 
by another temporal gap known as the G1 period (for reviews 
see Prescott (1987); Pardee, (1978)). 
Not all cells, however, have a detectable G1 
period. For example, it is missing from at least three 
mammalian tissue culture lines [Chinese hamster line DON, a 
mouse teratocarcinoma (cited in Prescott (1982)) and the 
hamster line V79-8 (Liskay and Prescott (1978)] and rapidly 
dividing cells in the erythropoietic series do, apparently, at 
some stage of differentiation, lack a G1 phase (Alpen and 
2 
Figure 1.1 The Cell Cycle 
Go 
Stages 
of the 
Growth 
cycle 
SW1 
SW2 
S = DNA replication. 
. G2 = Gap 2 during which most cell growth 
occurs. 
M = Cell division·. 
G1 = Gap 1 during which regulation of the cell cycle 
occurs. This is the stage where the decision to 
remain within the cell cycle is made. 
G0 = Quiescent state when the cells -have left the 
growth cycle. 
The length of each stage in the cell cycle is variable according 
to cell type. 
For SW1 and SW2 see section 1.D.1. 
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Johnston (1967)). In addition, the embryonic development of 
animals in general, begins with a series of cell divisions 
lacking a G1 (and sometimes even G2 ) period (Prescott 
(1987)), these periods appearing at the time of, or just 
before, the first signs of morphogenesis. This is important 
since the cycle in very early development could be considered 
to represent an archetypal cell cycle uncluttered by the 
intrinsic or extrinsic restraints that form the mechanisms that 
regulate cell reproduction (Prescott (1987)). Therefore, the 
key events which have evolved to regulate cell proliferation 
may be temporally confined within the G1 period. In support 
of this is the fact that it is during the G1 phase that cells 
can escape the growth cycle and enter a viable, 
non-proliferative or quiescent phase known as G (Pardee 
0 
1978). Arrest in the G1 phase and subsequent entry into G0 
is generated in cultured normal cells by such factors as serum 
deprivation (Holley (1975)), removal of essential nutrients 
(Ley and Tobey 1970)) or spatial constraints leading to contact 
inhibition (Lieberman and Glaser (1981)). 
The induction of quiescence by deprivation of growth 
factors is considered to be an important element in the 
regulation of cell proliferation in vivo (Holley (1975)). Much 
information has been collected over the last 20 years 
concerning the way in which a variety of polypeptide growth 
factors, such as epidermal growth factor (EGF), 
platelet-derived growth factor (PDGF) and insulin, acting 
outside the cell, transmit their growth messages to the cell 
interior. This occurs via interaction of factors with specific 
4 
receptor proteins on the cell surface (reviewed in Rozengur t 
and Collins (1983)). It seems reasonable, therefore, to suppose 
that growth factors and their receptors, represent 
externalization of part of the circuitry that operates to 
regulate G1 arrest and release, allowing specific regulation 
of cell proliferation from outside the cell. 
The molecular means by which the binding of growth 
factors to their receptors leads to the transition from the 
G
0 
to the G1 phase, the activation of the G1 s switch 
and ultimately, some hours later, to mitosis, remains largely 
unknown (Pardee (1987)). Some of the early events, occurring 
within seconds to minutes after growth factor binding, are well 
documented (Rozengurt (1986); Metcalf et al. (1985)) as are the 
mechanisms of DNA replication and cell division (Gefter 
(1975)). However, the means by which receptor occupancy leads 
to the generation of the early events has only recently been 
uncovered and the events linking these early changes to DNA 
replication remains obscure (Pardee (1987)). 
l.B EARLY EVENTS ASSOCIATED WITH GROWTH FACTOR BINDING 
Several biochemical changes which have been reported 
to occur within 5 minutes of growth factor binding, are common 
to a wide range of cells (for reviews see Rosengurt, (1986); 
/ · Metcalfe et al. (1985); Pouyssegur et al. (1982a)). These 
include:-
1. increased ion fluxes across the plasma membrane 
2. elevated intracellular pH 
3. altered phosphorylation of a number of cellular 
proteins 
5 
l.B.l ION FLUXES: 
One of the earliest responses elicited by addition 
of growth factors to quiescent cells, is an increase in the 
fluxes of Na+, K+ and H+ ions across the plasma membrane. 
(Rozengurt (1982); Leffert (1982)) It now appears clear that 
many of these initial ionic events are generated by activation 
of the Na+/H+ antiport (Moolenaar et al. (1982), (1983)) 
which results in an influx of Na+ ions into the cell, 
accompanied by an efflux of H+ ions. This results in a 
secondary stimulation of Na+/K+ ATPase pump activity which 
both increases intracellular K+ and restores the 
electro-chemical gradient for Na+ (Smith and Rozengurt 
(1978)). 
In addition to these monovalent fluxes, perhaps the 
earliest ionic event occurring after mitogenic stimulation (15 
sec in fibroblast) is a transient increase in intracellular 
free ca 2+, accompanied by an efflux of ca 2+ ·ions from the 
cell (Hesketh et al. (1985); Berridge et al. (1984); Owen and 
Villereal (1983)). The initial source of these ca 2+ ions 
appears to be from internal stores as the efflux, thought to be 
mediated through activation of a ca 2+ATPase, can occur even 
in the absence of external ca 2+ (Lopez-Rivas and Rozengurt 
(1983)). In addition, it appears that there is some maintenance 
of elevated [ca 2+]. due to a secondary influx from outside 
1 
the cell (Joseph et al. (1985)). 
Because of the ubiquitous nature of these K+, 
Na+, H+ and ca 2+ fluxes in response to stimulation, much 
work has centred on examining their potential role as causal 
6 
factors in initiating the mitogenic response. The importance of 
Na+ to many cells is illustrated by the observation that, if 
extracellular Na+ concentrations are reduced below a set 
level (:::::: 40mM), mitogens fail to stimulate DNA synthesis. 
(Leffert and Koch (1982)). However, it has been shown from 
studies which have artificially raised [Na+]i to levels 
equivalent to those seen after growth factors stimulation, that 
an increase in the activity of this ion per se is not a trigger 
for cell proliferation and it has been proposed that the 
importance of this ion lies with its role as a counter ion 
mediating H+ efflux (Pouyssegur et al. (1982)). The role of 
K+ ions is also debatable. Studies using ion channel blockers 
in fibroblasts have indicated that it was possible to prevent 
growth factor stimulated increases in [K+]. or even 
1 
decrease the G arrested [K+]. levels without affecting 
0 1 
the re-initiation of DNA synthesis (Pouyssegur et al. (1982)). 
However, other studies, again using fibroblasts, from a 
different species, indicated that a permissive [K+]. is 
1 
necessary for cell division to occur (Lopez-Rivas et al. 
(1982)). 
The rise in intracellular free ca2+ which, in the 
initial phase at least, appears to be generated independently 
of the monovalent fluxes (Owen and Villereal (1983)), has been 
established as a mandatory signal for the action of a number of 
growth factors (see Berridge (1987a)). Extracellular ca2+ is 
needed specifically for the G
0
---"7 G1 and G1~s transit in 
many normal cells (Kleine et al. (1986) Milner (1972)) and DNA 
--
replication is inhibited in lymphocytes by ca2+-channel 
7 
blockers and the intracellular ca2+ antagonist, TMB-8 (Grier 
and Mastro (1985)). Moreover, agents which raise [ca 2+]. 
1 
have been shown to be mitogenic in some cells systems. (Greene 
et al. (1976)). 
The maintenance of a permissive pH., as governed 
1 
by H+ ion movements also appears necessary for cell division 
(Chambard and Pouyssegur (1986)) as indicated in the next 
section. 
l.B.2 INTRACELLULAR pH (pHi): 
control of intracellular pH is complex (reviewed in 
Roos and Boron (1981)). In bicarbonate free medium, the major 
ion exchanger responsible for such control is the Na+/H+ 
antiport (for characterization of antiport, see Aronson (1985), 
Jean et al. (1985), Paris and Pouyssegur (1983), Moolenaar 
(1986)). In such medium, treatment of a variety of cells with 
their mitogens results in an intracellular alkalinization 
representing a rise in pHi of approx. 0.1-0.3 pH units. 
(Moolenar et al. (1983); Paris and Pouyssegur (1984); Mills et 
al. (1985)). However, even though there is a great deal of 
evidence to indicate that growth factors activate the 
+ + Na /H exchanger, (Vigne et al. (1985); Mills et al. 
(1985); Paris and Pouyssegur (1984); Vara and Rozengurt (1985); 
Moolenar et al. (1983)) this does not necessarily imply that 
the subsequent rise in pH. is essential for the mitogenic 
1 
response. 
Some of the earliest findings which suggested that 
pHi may play a vital role in mitogenesis, came from work 
I 
I 
I 
I 
I 
' 
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using unfertilized sea urchin eggs. It was shown that 
incubation of the eggs with weak bases, such as ammonia, cou ld 
not only raise pH., but also mimic many fertilization events ]. 
including increased protein synthesis, DNA synthesis, 
polyadenylation of m-RNA and increased K+ conductance 
(Whitaker et al. (1982); Mazia (1974)). In addition, studies 
using fibroblasts have indicated that the phosphorylation of 
ribosomal S6 protein, which is stimulated by growth 
factor-binding in a number of cells (Chambard and Pouyssegur 
(1986)), is prevented by conditions which acidify the cell 
interior (Pouyssegur et al. (1982a). Likewise, by using agents 
such as the diuretic, amiloride and its derivatives which are 
known to inhibit the exchanger, it has been shown that blocking 
Na+/H+ exchange can also inhibit ribosomal S6 
phosphoryiation (Pouyssegur et al. (1982a)). Moreover, 
stimulation of DNA synthesis in G arrested fibroblasts by 
0 
growth factors is inhibited by amiloride and its analogues in 
the same rank order as that for Na+/H+ exchanger inhibition 
(L'Allamain et al. (1984)) and mutants, derived from the 
fibroblast line CCL39, which lack Na+/H+ ·exchange activity, 
cannot re-initiate DNA synthesis at extracellular pH values o f 
7.2 or below (Pouyssegur et al. (1985)). 
Therefore, several lines of evidence indicate, with 
relative certainty, that in bicarbonate-free medium the 
activation of the Na+/H+ antiport and subsequent rise in 
pHi is essential for growth factor stimulated DNA 
replication. The only flaw in this conclusion, in terms of 
applying it in vivo, is that, within an organism, one of t h e 
9 
principal buffers in the fluids bathing cells is bicarbonate 
(cited in White et al. (1973)). In bicarbonate containing 
medium, growth factors fail to elevate pH. and concentrations 1 
of amiloride analogues which block more than 95% of exchanger 
activity in CCL39 cells do not prevent re-initiation of DNA 
synthesis (L'Allemain et al. (1984)). Moreover, mutants which 
lack an exchanger grow normally, irrespective of extracellular 
pH in bicarbonate buffered medium (Pouyssegur et al. (1984)). 
However, this does not completely discount the role of pH. in 1 
mitogenesis, since it has been shown using A431 cells that, in 
bicarbonate buffers, intracellular pH is 0.1 to 0.15 pH units 
higher than in bicarbonate-free solutions over the entire pH 
range tested (Cassel et al. (1985)). Moreover, another mutant 
cell line which can reinitiate DNA synthesis at lower 
extracellular pH levels than its parental line, maintains its 
intracellular pH at suitably elevated levels. (Pouyssegur et 
al. (1985)). 
It is reasonable therefore, to conclude that for a 
cell to ensure progression through the cell cycle, it must 
generate an intracellular pH above a certain value and perhaps 
the frequent observation that growth factors stimulate 
Na+/H+ antiport activity, is a way of assuring that this 
occurs. 
l.B.3 PROTEIN PHOSPHORYLATION: 
Increases in the phosphorylation of proteins on 
serine, threonine and tyrosine residues have been reported to 
occur during the growth response (Kazlauskas and Di corleto 
I 
I 
i 
I 
I 
I 
I 
' 
I 
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(1987)). However, it is difficult to make a universal statement 
about the alterations in protein phosphorylation seen in 
response to mitogen stimulation because different sets of 
proteins are phosphorylated in different cell types. Moreover, 
the phosphorylation patterns produced are usually the result of 
an interplay between several different Kinases, operating at 
different times and for different durations throughout the cell 
cycle. Nevertheless there are a number of proteins, or types of 
proteins, which are commonly phosphorylated by several 
different growth factor systems. For example, platelet-derived 
growth factor (PDGF), bombesin and epidermal growth factor 
(EGF) all stimulate the phosphorylation of ribosomal S6 protein 
(Chambard and Pouyssegur (1986); Lawen and Martini (1985); Vara 
and Rozengurt (1985)). Likewise, a number of the cytoskeletal 
proteins are phosphorylated in response to mitogen stimulation 
( Sato et al. ( 1985)) as are the membrane located channels and 
carriers such as the Na+/H+ antiport (Burns and Rozengurt 
(1983)). 
Because alterations in the phosphorylation state of 
a protein usually results in a modification of its biological 
activity, the increased phosphorylation patterns may represent 
a host of secondary cellular changes. Furthermore, because sets 
of proteins appear to be phosphorylated in co-ordination with 
one another, assessing the significance of individual protein 
phosphorylations is ambiguous. Nevertheless, by correlating the 
onset of these phosphorylation events with DNA replication, 
good circumstantial evidence has been provided that many of the 
noted changes in the phosphorylation state represent important 
11 
events in regulating the transition of the cell through certain 
parts of the growth cycle. For example, a study, using 
quiescent fibroblasts from a number of species (Kohno (1985)), 
showed that stimulation with a variety of growth factors led to 
a rapid and marked increase, in the phosphorylation of two 
proteins, which was half maximal at 5 minutes after exposure to 
mitogens and diminished gradually after 30 minutes. 
Mitogen-induced phosphorylation of these proteins was 
correlated to the extent of mitogen stimulated DNA synthesis 
and such increases were not observed in exponentially growing 
cells, suggesting that these phosphorylations could constitute 
an early event involved in the control of cellular G
0
~G1 
transition. Alternatively, a study in rat liver cells, (Kleine 
et al. (1986)), arrested in late G1 phase by incubating the 
cells in a calcium deficient medium, indicated that lowering of 
the calcium, even in the presence of serum, not only halted the 
cell transit through the cell cycle but also, strikingly 
decreased the phosphorylation of several trypsin-sensitive cell 
surface proteins. Accordingly, raising the ca2+ concentration 
stimulated the phosphorylation of certain sets of surface 
proteins within 5 minutes and led to the initiation of DNA 
replication within two hours. Therefore, maintenance of these 
phosphorylation states may be part of the mechanism which 
2+ triggers the ca dependent G1~s transition. 
l.C SIGNAL TRANSDUCTION MECHANISMS 
Once the initial events associated with mitogenesis 
have been identified, the next step is to determine how the 
12 
binding of growth factors to their receptors generates such 
events. Until relatively recently, little was known about the 
way external messages are transduced across the membrane. The 
first success in the search for the intracellular molecules 
which carry such messages (the so-called second messengers) 
came with the discovery that intracellular levels of 
adenosine-3',5'-cyclic monophosphate (c-AMP) were elevated 1n 
response to a wide variety of hormones and neurotransmitters. 
( see Robison et al. ( 1971) ) Since that time an additional 
second messenger system has been proposed which involves the 
hydrolysis of a class of membrane phospholipids known as the 
phosphoinositides (Michell (1975)). 
l.C.l c-AMP SIGNAL TRANSDUCTION SYSTEM: 
The mechanics of c-AMP generation are now reasonably 
well understood (reviewed in Birnbaumer et al. (1985)). Binding 
of an agonist to its receptor forms a transmembrane complex 
which acts via a guanine nucleotide binding protein (G protein) 
known .as Gs or N s to activate the enzyme adenyla te cyclase. 
Gs consists of three subunits, ex., ;9 and 4 . In the absence of 
an agonist, guanine diphosphate (GDP) is bound to the cL 
subunit. However the formation of an agonist-receptor complex 
allows exchange of GDP for guanine triphosphate (GTP) leading 
to the dissociation of cc_- from/--y -subunits. It is the free 
c<.-GTP which activates adenylate cyclase. Hydrolysis of the 
bound GTP inactivates the Cl-subunit thus terminating the 
signal. Activation of adenylate cyclase promotes the conversion 
of ATP to c-AMP and pyrophosphate with a subsequent increase in 
I 
I 
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[c-AMP] .. The c-AMP then interacts with c-AMP-dependent 
1 
protein kinase (protein kinase A), which in turn phosphorylates 
specific proteins on threonine and serine residues (see Diagram 
1.2). The identity of the target proteins for this kinase vary 
widely among different cell types and, because many of the 
target proteins are themselves enzymes, the initial signal can 
be readily and diversely amplified. control of this second 
messenger system occurs by removal of the c-AMP via 
phosphodiesteric cleavage or through diffusion from the cell 
(Hunt and Martin (1980)) or, at the level of the receptor, via 
another G protein, (G. or N. ). Receptor-mediated 
1 1 
dissociation of this protein leads to the release of an 
inactive a:..-subunit and af 1 subunit, the latter of which binds 
and inactivates the activeC(.-GTP from Gs. (Litosch and Fain 
(1986)). 
Although the c-AMP system most elegantly describes 
how the extracellular messages of a wide variety of hormones 
and neurotransmitters can be decoded into something usable 
within the cell (Robison et al. (1971)), it does not appear to 
be the means by which the majority of growth factors generate a 
mitogenic response. Elevation of [c-AMP]. fails to generate 
1 
the monovalent ion fluxes associated with mitogenesis 
(Rozengurt and Mendoza (1985)) and the activation of the 
adenylate cyclase cascade can occur without an accompanying 
· · [ 2 +] h . . f h t rise 1n ca . , c aracter1st1c o t e response o many 
1 
growth factors. Moreover, increases inc-AMP have not 
consistently been correlated with DNA synthesis and, if 
anything, have more often been associated with having a 
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negative effect on cell proliferation (Hunt and Martin (1980). 
Nevertheless, sustained elevations of c-AMP have been reported 
in response to the receptor binding of some growth factors 
(Rozengurt and Mendoza (1985)) and it is conceivable that this 
second messenger molecule, although not essential, may 
contribute to the mitogenic response in some cells. 
l.C.2 THE PHOSPHOINOSITIDE SIGNAL TRANSDUCTION SYSTEM: 
The hydrolysis of the phospholipid, 
phosphatidylinositol in response to agonist stimulation, was 
first reported as early as 1953 by Hokin and Hokin. Later 
Durell et al. (1969) suggested a role for this phospholipid in 
receptor function and, in 1975, Michell made the connection 
between phosphatidylinositol metabolism and hormone-stimulated 
changes in [ca 2+] .. Since then, there has been much 
1 
investigation of the phosphoinositides as signal transducers 
and a great deal of evidence has been collected in support of 
the idea that their hydrolysis, in particular that of the 
phosphorylated derivative of phosphatidylinositol, 
phosphatidylinositol(4,S)bisphosphate (PIP 2 ), leads to the 
generation, wit~in the cell, of second messengers which are 
capable of mediating the actions of a wide variety of external 
cell stimuli including hormones, neurotransmitters, light, 
antigens and some growth factors (reviewed in Berridge 1984, 
1987, Exton (1985), Michell (1982)). The first indication that 
this might be the pathway used by mitogens came from work using 
lymphocytes (Fisher and Mueller (1968)). Since then, growth 
factors such as PDGF (Berridge et al. (1984)) bombesin (Heslop 
I 
I 
I 
I 
I 
I 
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et al. (1986) and conconavalin A (Ku et al. (1981)) have been 
-- --
shown to operate through phosphoinositide hydrolysis. Although 
much of the information concerning this pathway has been gained 
by the study of hormone receptor based systems, the fundamental 
conclusions still apply to the mitogenic response. Because the 
operation of the phosphonositide pathway forms the basis of the 
experimental approach to this thesis, the information currently 
available concerning the operation of this pathway will be 
considered in some detail. 
1.c.2.1 Receptor Mediated Cleavage of Phosphatidyl-
inositol (4,5) bisphosphate 
The phosphoinositides are a small sub-class of 
membrane phospholipids, making up less than 8% of the total 
phospholipid pool (Hawthorne (1982)). They turn over at a 
higher rate than other phospholipids and, uniquely, the 
inositol head group of phosphatidylinositol (PI) can be 
successively phosphorylated to form phosphatidylinositol(4)-
phosphate (PIP) and phosphatidylinositol(4,S)bisphosphate 
(PIP 2 ) and subsequently dephosphorylated in what is known as 
the futile cycle (Berridge and Irvine (1984)). PIP 2 appears 
to be the major precursor used by the receptor mechanism to 
generate second messengers (Berridge and Irvine (1984)) 
although there are now suggestions that PIP may also be a 
target for hydrolysis (Downes and Michell (1982)). 
When calcium-mobilizing growth factors bind to their 
receptors, they activate a phosphoinositide-specific-
phospholipase c resulting in the phosphodiesteric cleavage of 
17 
PIP 2 . This yields two molecules, both of which have been 
ascribed a second messenger function. These are inositol 
(1,4,S)trisphosphate (Ins(l,4,5)P 3 ) which, being aqueous 
soluble, is released into the cytoplasm and 
1,2-sn-diacylglycerol (DAG) which remains within the membrane 
( Ber r id g e ( 19 8 7 ) ) ( see diagram 1 . 2 ) . 
Despite its widespread distribution, 
phosphoinositide specific-phospholipase c (PLC) has not yet 
been fully characterised. Purification studies have largely 
been confined to the cytosolic form which, surprisingly, 
appears to predominate in most tissues examined (Carter et al. 
(1986)). Several lines of evidence suggest that the activity 
ascribed to PLC is frequently derived from multiple forms of 
the enzyme (Carter et al. ( 1986), Wilson et al. ( 1984)). 
Recently, there have been a growing number of reports of PLC 
activity in purified plasma membranes (Downes and Michell 
( 1981), cock croft et al. ( 19 84)). However, it is not yet clear 
whether this reflects the ability of the cytosolic form to 
. 
translocate to the membrane or whether they are two distinct 
enzymes. Perhaps the two most biologically important 
characteristics of the enzyme's activity are its calcium 
dependence and substrate specificity. 
l.C.2.1.1 calcium Dependence of Phospholipase C 
Determination of calcium dependence is particularly 
important due to the proposed role of the enzyme in generating 
the events which lead to a rise in intracellular free calcium. 
If phosphoinositide hydrolysis is to be considered as a valid 
: 
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candidate for the original signal transduction mechanism, then 
it must be shown to precede the reported calcium rise and 1n 
the initial stages, at least, be independent of that rise. 
Studies examining phosphoinositide hydrolysis in intact cells 
in the presence or absence of extracellular calcium, or after 
artifically raising the cytosolic calcium with ionophores, 
generated mixed conclusions. (Sasaki and Hasegawa-Sasaki 
(1985); Moscat et al. (1986); Yano et al. (1985)). Studies, 
using purified PLC to investigate ca2+ sensitivity, were also 
in disagreement until a thorough study by Irvine et al. (1984) 
indicated that the in vitro assessment of ca 2+ dependence of 
PLC, depended largely on the assay conditions used. From this 
and other findings (Downes and Michell (1982); cockcroft et al. 
(1984)) it was concluded that in vivo PLC is normally inactive 
over the entire physiological [ca2+Ji range. 
How, then, does receptor occupation lead to 
activation of PLC? The Irvine study suggested that PLC could be 
induced to attack its substrate under in vivo ionic conditions 
by conversion of its substrate to a non-bilayer configuration 
and, from this, it was proposed that receptor occupation could 
led indirectly to PLC activation by generating perturbations in 
the membrane (Irvine et al. (1984)). However, an alternative 
explanation which is now gaining a great deal of experimental 
support, is that receptors are coupled directly to a membrane 
associated PLC via interaction with one or more distinct GTP 
~ binding proteins (designated G /N ~ G and N.) in a p p s l. 
manner analogous to that of the adenylate cyclase system (see 
diagram 1.2). 
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coupling between receptors and PLC was first 
demonstrated for the blowfly salivary gland where it was shown 
that 5-hydroxytryptamine could stimulate the enzyme in the 
presence of GTP (Litosch et al. (1985)). These initial findings 
have been confirmed in a variety of cell types and the 
accumulated support for the role of a GTP binding protein in 
regulating PLC has now been the subject of several reviews 
(Cockcroft (1987); Smith et al. (1986); Litosch and Fain 
(1986); Snyderman et al. (1986); Gilman (1987)). With this 
model for receptor mediated activation of PLC, the controversy 
2+ 
over the ca dependence of the phosphoinositide hydrolysis 
can now be reconciled. It has now been shown that a certain 
level of ca 2+ is, in fact, required for PLC activity. 
concentrations of calcium in the lOOnM range are essential for 
optimal activation of the enzyme by both GTP---Y-s (which 
dissociates the subunits of Gp) and agonists (Uhing et al. 
(1985)). However, since the [ca2+]. of unstimulated cells 
i 
is around 150nM (Moolenaar et al. (1984)), this requirement can 
be fulfilled without the need for a rise in cytosolic free 
calcium. In addition, in some cells, the subsequent rise in 
[ca2+]. to the micromolar range may further promote the 
i 
hydrolysis of the inositol lipids to maintain the initial rate 
of hydrolysis (Ciapa and Whitaker (1986)). It is likely that 
this positive feedback mechanism may prevail in those systems 
where stimulation of the response is biphasic, an initial 
component followed by a sustained component. It has also been 
shown, however, that high levels of ca 2+ can activate PLC 
directly, without operating via the G protein (Cockcroft p 
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(1986)), thereby explaining the ability of ionophores to 
mediate phosphoinositide hydrolysis. 
These observations are further confirmed by a recent 
study (Renard et al. (1987)) which, unlike previous work, 
monitored [ca 2+]. in intact cells in relation to 1 
agonist-stimulated PLC activity, using a fluourescent ca 2+ 
indicator (QUIN-2). It was shown that PLC activity is little 
2+ affected by [Ca Ji above 193nM but is partially dependent 
on ca2+ below these levels, lending strong support to the 
idea that PLC mediated phosphoinositide hydrolysis occurs at 
basal ca 2+ levels. 
l.C.2.1.2 Substrate Specificity of Phospholipase C: 
Like ca 2+ dependency, the substrate specificity of 
PLC is also important because of the proposed dual nature of 
the second messengers produced. Although hydrolysis of any of 
the phosphoinositides would yield DAG, only PIP 2 would 
produce the triply phosphorylated inositol trisphosphate, which 
acts to raise [ca 2+]. from internal stores (see Section l 
l.C.2.2). The assessment of substrate specificity using 
endogenous substrates is made difficult by the rapid 
interconversion, not only between the lipid precursors but also 
the inositol phosphates produced (Roth (1987)). Studies using 
purified enzyme from sheep seminal vesicles (Wilson et al. 
(1984)) have indicated that PLC can hydrolyse all the 
phosphoinositides, in order of preference PIP 2>PIP)PI and 
that the phospholipid composition of the membrane can 
selectively influence PI hydrolysis. However, several studies 
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using membrane associated PLC activities have indicated that P I 
is not a substrate for PLC under conditions similar to those 1n 
vivo (Irvine et al. (1984); Uhing et al. (1985)). In most cases 
PIP 2 appears to be the prime target for receptor mediated 
hydrolysis, although some studies indicate that the relative 
amounts of PIP and PIP 2 cleaved, depends largely on substrate 
availability (Downes and Michell (1981)) and perhaps, on the 
forms of PLC present. In addition it appears that not all 
membrane PIP2 is available for PLC attack (Muller et al. 
(1986)). 
There is growing evidence in platelets that PLC may 
be proteolytically activated in response to agonists (Low et 
al. (1984)). However, this phenomenon seems confined to the 
platelet enzyme which appears to show other unique 
characteristics (Manne and Kung (1987)) and obviously is not 
involved in the mitogenic response. 
l.C.2.2 Role for Inositol(l,4,S)trisphosphate in 
raising Intracellular free Calcium 
Inositol(l,4,S)trisphosphate is thought to function 
2+ 
as a second messenger by liberating ca from non-
mitochondrial intracellular stores, thereby mediating the rise 
in intracellular free calcium seen in response to agonist 
stimulation. This second messenger role for Ins(l,4,5)P 3 was 
first proposed by Berridge and Irvine (1984) and has since been 
supported by observations in a variety of cell systems (for 
review see Berridge (1986); Williamson et al. (1985)). 
Not only do kinetic studies indicate that the 
timecourse of Ins(l,4,5)P 3 formation matches the agonist 
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induced [ca 2+J. rise (Irvine et al. (1985)) but studies 
l --
using semi-permeablized cells have shown that direct 
application of Ins(l,4,5)P 3 leads to release of ca
2
+ from 
internal stores (Muto et al. (1986); Biden et al. (1984); 
Hirata et al. (1984); Wolf,B.A. et al (1985)). It now appears 
certain that the principle location of this Ins(l,4,5)P 3 
sensitive store is the endoplasmic reticulum (E.R.) (Muallem et 
al (1985); Prentki et al. (1985)) and there is good evidence 
that Ins(l,4,5)P 3 acts through a specific receptor (Spat et 
al. (1986)). Uptake of ca 2+ into the store is ATP dependent 
and is mediated by the electrogenic ca 2+-ATPase, which 
+ requires a compensatory flow of K out of the E.R. to 
maintain electroneutrality (Muallem et al. (1985)). Release of 
ca 2+ induced by Ins(l,4,5)P 3 also requires an opposite flow 
of the counter ion, K+, but is ATP independent and is thought 
to be mediated by activation of a channel rather than 
inhibition of the uptake system (Adunyah and Dean (1986); Smith 
et a 1 . ( 19 8 5 ) ) . Ca 1 c i um r e 1 ease i s ha 1 f maxi ma 1 between 
0.1-3.0jUM Ins(l,4,5)P 3 depending on the tissue examined (eg 
see Berridge (1987)) which is in the range estimated in 
stimulated cells (eg Wollheim and Biden (1986); Aub and Putney 
(1984)). 
Structure-activity studies reveal that the vicinal 
phosphates on the 4' and 5' positions of the inositol ring are 
essential for full calcium mobilizing ability and that the 
affinity of the molecule for its putative receptor is greatly 
enhanced by having a phosphate on the opposite side of the 
molecule with a preference for the one position (Burgess et al. 
... 
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( 19 8 4 ) ; I r v in e et a 1 . ( 19 8 6 ) ) . Although the receptor i s 
specific for Ins(l,4,5)P3 , at higher concentrations, 
glyceroinositol(4,5)P2 , Ins(2,4,5)P 3 and Ins(4,5)P 2 are 
also active in mobilizing ca 2+ (Putney et al. (1986)). No 
release occurs upon addition of inositol, Ins(l)P, Ins(2)P, 
rns(l:2)cyclic P or Ins(l,4)P2 (Putney et al. (1986); Burgess 
et al. (1984)). 
Several studies have indicated that not all of the 
ca 2+ stores within the E.R. are Ins(l,4,5)P 3-sensitive 
(Berridge and Irvine (1984); Muto et al. (1986) but see Prentki 
et al. ( 1985)) prompting the suggestion that, in some cells, 
those sections of the E.R. containing Ins(l,4,5)P 3-gated 
channels are compartmentalized to localize the response. 
Nevertheless, in most cells examined Ins(l,4,S)P 3 is capable 
of releasing more than 50% of stored calcium within seconds of 
formation which is sufficient to raise [ca2+]. to a level 1. 
where it can generate a physiological response (Brass and 
Laposata (1987); Biden et al. (1984)). 
It has been noted, however, that in many systems, 
including those involved in the proliferative response, the 
initial rise in intracellular free calcium, generated by the 
liberation from internal stores, is usually prolonged by the 
additional entry of extracellular calcium mediated by 
activation of channels located 1.n the plasma membrane (Putney 
(1978); Joseph et al. (1985)). There is some evidence to 
suggest that inositol(l,4,5)~ 3 may also mediate these 
transmembrane calcium fluxes. A study involving single channel 
recordings of Ins(l,4,5)P3-activated conductance in excised 
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patches of T-lymphocyte plasma membranes (Kuno and Gardner 
(1987)), has shown that not only could addition of 
Ins(l,4,5)P3 lead to channel activation but that the 
rns(l,4,S)P 3-activated channel appeared to be identical to 
the mitogen activated, voltage-insensitive, calcium permeable 
channel involved in T cell activation. It has not been verified 
in these reports, however, whether Ins(l,4,5)P3 is acting 
directly on the plasma membrane or through a metabolite. (See 
next Section.) 
l.C.2.3 Metabolism of Ins(l,4,5)P3 and Other 
Inositol Phosphates 
In accordance with its role as a second messenger, 
Ins(l,4,5)P 3 is rapidly metabolised (see diagram 1.3). Until 
recently, it was thought that the only mechanism by which it 
was inactivated was through the action of a series of 
phosphatases which successively dephosphorylate Ins(l,4,S)P 3 
to free inositol (Storey et al. (1984)). The first reaction 
involves removal of the 5-phosphate to give rns(l,4)P 2 
(Downes et al. (1982)), which, as mentioned earlier, is 
incapable of mobilizing ca 2+ from internal stores. 
Ins(l,4)P 2 is then dephosphorylated to either Ins(l)P or 
Ins(4)P and these subsequent mono-phosphates are then converted 
to free inositol which may be re-cycled back to 
phosphatidylinositol (Storey et al. (1984)). This pattern of 
Ins(l,4,5)P 3 degradation has been documented in many cell 
types and the specific phosphatases mediating these reactions 
have been characterized (reviewed in Majerus et al. (1988); 
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Downes (1986)). Lithium ions have been shown to inhibit 
inositol phosphate metabolism with the primary site of action 
being inositol(l)monophosphatase (Hallcher and Sherman (1980)) 
which converts Ins(l)P to inositol. This characteristic has 
been used experimentally as a method of sensitizing the 
measurement of agonist induced inositol phosphates by 
preventing breakdown, (Berridge et al. (1982)) and may explain 
how lithium exerts some of its effects in vivo (Sherman et al. 
(1986)). 
The first evidence that there was an alternative 
route for the metabolism of Ins(l,4,5)P 3 came from work by 
Irvine et al. (1984), in which inositol phosphates were 
separated by a newly developed high performance liquid 
chromatography (HPLC) technique rather than by stepwise elution 
from Dowex columns. It was shown that much of the inositol 
trisphosphate that accumulated in cholinergically stimulated 
parotid gland, was not Ins(l,4,5)P 3 but another isomer, 
rns(l,3,4)P 3 . The discovery of this isomer was useful in that 
it explained some of the anomalous inositol trisphosphate 
kinetics in relation to calcium mobilization, and Li+ 
sensitivity reported previously in the literature (Thomas et 
al. (1984); Rubin (1984); Burgess et al. (1985)). With HPLC 
separation it was shown that Ins(l,4,5)P 3 rose immediately 
after stimulation, peaked at 15 seconds then declined to 
baseline by 1 minute. Ins(l,3,4)P 3 production, on the other 
hand, did not occur before a 5 second lag and continuously rose 
over 15 minutes in most cells examined (Burgess et al. (1985), 
Irvine et al. (1985)). 
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Because neither the logical lipid precursor nor an 
isomerase could be found within cells, the origin of 
Ins(l,3,4)P 3 was a mystery until the discovery of yet another 
agonist-induced inositol phosphate, identified as 
inositol(l,3,4,S)tetrakisphosphate (Batty et al. (1985)). It 
now appears certain that this Ins(l,3,4,5)P4 is produced by 
the phosphorylation of the original messenger Ins(l,4,5)P 3 
(Hawkins et al. (1986); Stewart et al. (1986)) and then 
dephosphorylated to Ins(l,3,4)P3 (Downes et al. (1986). The 
Ins(l,3,4)P 3 may then be dephosphorylated to either 
Ins(3,4)P2 (Dillon et al._ (1987)) or Ins(l,3)P2 (Hansen et 
al. (1986)), the dephosphorylations being lithium-sensitive. In 
a recent report using angiotensin stimulated adrenal glomerular 
cells, it has been suggested that Ins(l,3,4)P 3 may also be 
re-phosphorylated to a novel tetrakisphosphate which lacks a 
phosphate in the 5 position (Balla et al. (1987)). This idea is 
particularly interesting due to the recent reports of the 
presence of inositol pentakisphosphate (InsP 5 ) and inositol 
hexakisphosphate (InsP 6 ) within mammalian cells (Vallejo et 
al. (1987)). 
Ins(l,3,4,5)P4 levels peak 20 seconds after 
stimulation (Hawkins et al. (1986)) and because of its rapid 
formation and hydrolysis, a second messenger role for this 
molecule has been sought. It has been shown in a number of cell 
types that, unlike Ins(l,4,5)P3 , Ins(l,3,4,5)P4 is 
incapable of mobilizing calcium from internal stores (Irvine 
and Moor (1986)). It was thought, instead, that it may mediate 
the subsequent entry of extracellular calcium, seen as a 
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secondary response in most cells after agonist stimulation. 
This idea was tested by Irvine and Moor (1986), by 
microinjection of submicromolar concentrations of 
Ins(l,3,4,5)P4 into sea urchin eggs. It was found that this 
caused a raising of the fertilization envelope (egg activation) 
and that this effect was dependent on both the presence of 
extracellular calcium and on the co-injection of a ca 2+ 
mobilizing compound such as Ins(2,4,5)P 3 . The provision that 
extracellular calcium be present indicated that 
Ins(l,3,4,5)P 4 is probably activating a calcium entry system 
located in the plasma membrane and, in fact, specific receptors 
for Ins(l,3,4,5)P4 have been reported on membranes of HL-60 
cells (Bradford and Irvine (1987)). The requirement for the 
co-injection of an agent capable of liberating ca 2+ from 
internal stores is more intriguing. It was suggested that 
perhaps this requirement was peculiar to the egg system but it 
has since been shown in lacrimal acinar cells that 
Ins(l,4,5)P3 and Ins(l,3,4,5)P4 act in concert (but not 
individually) to activate ca2+ - dependent K+ channels 
leading to an influx in ca 2+ (Morris et al. (1987)). This may 
suggest that [ca 2+]. must already be elevated for 
1 
Ins(l,3,4,5)P4 to be effective. Alternatively, as proposed by 
Putney (1986), it may be that the Ins(l,4,5)P 3 mobilizable 
intracellular calcium stores must be empty before 
extra-cellular calcium can be recruited. Whatever the mechanism 
(Irvine (1987)), the ability of Ins(l,3,4,5)P 4 to stimulate 
entry of ca 2+ into the cell is interesting, considering that 
the kinase which converts Ins(l,4,5)P 3 to Ins(l,3,4,5)P 4 is 
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calcium sensitive, being regulated by calmodulin (Biden et al. 
(1987)). Therefore, the initial liberation of ca 2+ from 
intracellular stores not only promotes the metabolism of the 
effector but produces a compound capable of prolonging the 
response in what appears to be a self-potentiating system. 
As yet, no second messenger function has been 
ascribed for Ins(l,3,4)P 3 and it has been proposed that the 
kinetics of its formation may argue against it playing an 
active part in a signal transduction event. Although it has 
been reported to mobilize intracellular calcium in several cell 
types, its potency in most cases is much lower than that of 
Ins(l,4,5)P3 (Irvine et al. (1986)) and it is generally 
considered that catabolism to Ins(l,3,4)P 3 is the means by 
which the calcium mobilization signal, initiated by 
Ins(l,4,5)P3 , is terminated. However, Ins(l;3,4)P3 may have 
some, as yet, unidentified signal transducing ability, either 
in its own right or as a potential precursor for the 
biologically active polyphosphates (IP5 and IP6 ). 
Yet another group of inositol phosphates which may 
be involved in signal transduction, are the cyclic inositol 
phosphates. It has been known for some time that the action of 
phosphoinositide-specific phospholipase Con 
phosphatidylinositol in vitro, leads to generation of Ins(l:2) 
cyclic-monophosphate (Dawson and Clarke (1972)) as well as the 
non-cyclic derivative (Ins(l)P) and it has now been shown that 
the cleavage of PIP 2 and PIP by purified PLC from seminal 
vesicles also generates cyclic compounds (Wilson et al. 
(1985)). Moreover, although the ability of cins(l,2:4,5)P 3 
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to mobilize intracellular calcium varies with the tissue 
examined it has been found to be as potent as Ins(l,4,5)P3 1n 
some cell types (Wilson et al. (1985a)). 
Until recently it was not clear whether cyclic 
inositol phosphates were produced in stimulated cells because 
these compounds did not survive the acidity of the extraction 
conditions employed. However, it has now been shown that cyclic 
inositol phosphates are generated in response to agonist 
stimulation in a number of cell types (see Majerus et al. 
(1986)). It seems likely that the cyclic phosphates will be 
degraded, albeit more slowly, by the same phosphatases which 
degrade Ins(l,4,S)P 3 with the ring being opened only after 
dephosphorylation to crns(l:2)P (Majerus et al. (1986)). The 
enzyme capable of cleaving this compound has been isolated and 
characterized (Ross and Majerus (1986)). In addition, isolation 
of two isozyrnes of phospholipase c from lymphocytes has 
indicated that, with phosphatidylinositol as a substrate, 
distinct ratios of Ins(l)P to cins(l:2)P are formed with the 
different enzymes, suggesting a potential mechanism, operating 
at the level of the receptor, whereby the relative amounts of 
the cyclic inositol phosphates can be regulated 1n response to 
agonist stimulation (Carter et al. (1986)). 
l.C.2.4 Diacylglycerol Activation of Protein Kinase c 
The principle means by which diacylglycerol (DAG) is 
thought to act as a second messenger within the cell is through 
its ability to directly activate the enzyme, protein kinase C 
(Takai et al. (1979)). It now appears, however, that the 
I 
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metabolism of DAG, like that of Ins(l,4,5)P3 , may also 
generate further biological regulators. (See Section l.C.2.4.8) 
l.C.2.4.1 Properties of Protein Kinase C: 
Protein kinase c (PKC) was originally described in 
1977 as a proteolytically activated proenzyme (Inoue et al. 
(1977)). However, it has since been found that it may be 
reversibly activated by association with membrane phospholipids 
in the presence of physiological ca 2+ concentrations and DAG, 
(Takai et al. (1979); Kishimoto et al. (1980)) leading to the 
name ca
2+-activated and phospholipid-dependent protein 
kinase. The enzyme is ubiquitously distributed in tissues and 
organs and it has been purified to homogeneity from many 
sources. (For reviews see Kikkawa and Nishizuka (1986); 
Schwantke et al. (1985); Nishizuka (1984)). PKC is composed 1n 
all cases of a single polypeptide chain with no sub-unit 
structure. Neither calmodulin nor any antibody against 
calmodulin affects the enzyme activity (Kikkawa and Nishizuka 
(1986)). Magnesium is essential for catalytic activity, the 
optimal range being about 5-lOmM and the optimum pH range for 
activity (as assessed in Tris acetate buffer) is 7.5-8.0 
(Kikkawa and Nishizuka (1986)). 
It has been reported that both the kinetics and 
catalytic activity, of PKC, are almost indistinguishable 
between the various isolates (Kikkawa and Nishizuka (1986)). 
However, the molecular weight of the enzyme varies with the 
technique used and the tissue examined (range 77-84 OOOM as r 
judged by SDS-PAGE). This tissue specific variation was also 
.... 
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noted ror other physical properties such as pH optimum and 
Stokes radius (see Schwantke et al. (1985)), but until 
. --
recently, it was only speculated that these differences might 
reflect distinct molecular species. However, with the 
application of molecular biology technology to the study of 
PKC, it has been found that there are at least four different 
forms of the enzyme produced by cells. (For reviews see Parker 
and Ullrich ( 1987); carpenter et al. ( 1987)) 
l.C.2.4.2 A Family of Protein Kinase c Genes: 
Because several reports of the existence of multiple 
cDNA species of PKC appeared in the literature within months of 
one another, initially there were problems with conflicting 
nomenclature (Coussens et al. (1986) and Ohno et al. (1987): 
for resolution, see Kubo et al. (1987)). However, the 
nomenclature used by coussens et al. (1986) appears to be the 
one that has now been universally adopted (Carpenter et al. 
(1987)). In that study, it was shown that three highly related 
but non-identical PKC sequences could be isolated from both 
bovine and human brain cDNA libraries, and that the 
corresponding human genes, designated a_, /3 and I'"'( were localized 
on to separate chromosomes. At the same time Knopf et al. 
(1986) had isolated three distinct cDNA clones from rat brain. 
However, it was later shown that two of these clones, now 
termed ft I and f3 II, were derived f ram alternative splicing of 
the one gene. Ohno et al. (1987), who originally showed the 
presence of the two splicing alternatives, have recently 
identified the presence of cDNA clones encoding the four types 
of PKC (_g:., j!> I, /3 II ,1 ) in rabbit brain, and work by the same 
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group has demonstrated the presence of both I and II in a 
human splenic cDNA library ( Kubo et al. ( 1987)). From this, it 
was concluded that the presence of all four types of PKC is a 
common feature of all mammalian cells. In addition, Northern 
and southern hybridization analysis suggests the potential for 
even greater genetic complexity within the PKC gene family 
(Coussens et al. (1986)). 
The first sequence-structure analysis was performed 
on bovine PKC CL by Parker et al. ( 1986). The cDNA selected for 
analysis was translated into a 76 kDa product with a two-domain 
structure which could be functionally divided into a catalytic 
(carboxy terminal) and regulatory (amino terminal) domain (see 
diagram 1.4). As mentioned earlier, limited proteolysis of PKC 
leads to the generation of an active fragment that is •no longer 
subject to ca 2+, phospholipid and DAG dependence (protein 
kinase M) (Kishimoto et al. (1983)). 
Using antipeptide antisera, the upper limit of this 
catalytically active fragment has been defined to the 
c-terminal 380 residues. Within this c-terminal domain, is a 
Gly x Gly ·x x Gly sequence (where Xis any other amino acid) 
which, alongside lysine 368, forms part of the predicted 
nucleotide (ATP) binding site. In addition, there are several 
other characteristic stretches, all of which remain highly 
conserved in all the serine, threonine and tyrosine specific 
protein kinases. 
Towards the amino terminus of the regulatory domain, 
there is a region that is characterised by a tandem repeat, 
each repeat unit containing six cysteine residues. such 
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cysteine-rich duplication sequences are found in a number of 
polypeptides, although for the most part, the functional 
significance of this protein architecture is not clear. It has 
some similarities to a number of DNA binding proteins where 
such structures have been proposed to form cysteine (zinc) 
"fingers" and divalent metal ion co-ordination complexes (Berg 
(1986)). There is no direct evidence that PKC is a DNA binding 
protein but PKC activity and immunoreactivity has been reported 
in the nuclei of brain cells (Wood et al. (1986)) and B 
lymphocytes (Cambier et al. (1987)). 
After the cysteine repeats there is a stretch of 
approximately 200 amino acids preceding the catalytic domain. 
Within this sequence lies the only potential calcium binding 
site that comes close to the "E-F hand" structure 
characteristic of calmodulin and calmodulin-related 
ca 2+-binding proteins. Although PKC is inhibited by the 
calmodulin inhibitors, the phenothiazines, there is no direct 
evidence that this is the ca 2+ binding site and the location 
of the ca 2+-binding site(s) within PKC is difficult to 
predict from the primary sequence. There is direct evidence 
that the diacylglycerol and phospholipid binding sites are 
located within this regulatory domain but there is no single 
hydrophobic stretch which might form a suitable site for 
interaction with membranes. There are predicted amphipathic 
helices that, as in phospholipase A2 , could provide a site 
for interaction with the membrane (Maraganore (1987)) but a 
detailed understanding of the phospholipid/diacylglycerol/ PKC 
interaction will ultimately require the resolution of its 
tertiary structure. 
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A recent study by House and Kemp (1987) has 
indicated that the regulatory domain of PKC also contains an 
amino acid sequence between residues 19 and 36 that resembles a 
substrate phosphorylation site in its distribution of basic 
residue recognition determinants. This sequence is not a site 
of autophosphorylation (Huang et al. (1986)) but has the 
secondary structural features of a pseudosubstrate, termed 
"prototope" and may be responsible for maintaining the enzyme 
in the inactive form in the absence of allosteric activators 
such as phospholipid (House and Kemp (1987)). 
When the amino acid sequences of the different PKC 
types from different species were examined, two interesting 
points emerged. The first was that, when human and bovine gene 
products were compared, there was extensive sequence 
conservation ( 98%) within all regions of CL, f3 II and I""( proteins 
(Coussens et al. (1986)) and that a comparison ofp I sequences 
from human, rat, rabbit and bovine sources also showed 
. 
remarkable sequence homology (Kubo et al. (1987)). This 
interspecies conservation strongly suggests that any variable 
domains between the different types of PKC must play an 
important role in defining distinct functional specificities of 
the proteins rather than functioning as mere structural (or 
evolutionary) spacers. The second point, therefore, concerns 
the location of the regions of variability between the types of 
PKC in relation to their predicted function with the protein 
(see diagram 1.4). 
Alignment of bovine PKC Cl,/3 II and, sequences 
revealed an overall sequence homology in two major domains that 
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are separated by one large variable region (V3) (Coussens et 
a 1 . ( 19 8 6 ) ; Park er and U 11 r i ch ( 19 8 7 ) ) . Over a 11 , PK C ,,...( e X h i b i ts 
the highest degree of divergence within five significantly 
variable regions designated v1 to v5 . v1 an.d v2 are 
either side of the cysteine-rich c 1 region which is highly 
conserved in all three types of PKC. The proposed 
pseudosubstrate also lies within this c 1 region. The c 2 
region that follows v2 is 115 amino acids long and may 
contain a ca 2+-binding site distinct from the 'E-F hand' 
type. This zone is followed by the most highly variable region 
v3 . Just within the v3 region lies the sequence that Parker 
et al. (1986) originally described as a potential 
calmodulin-like ca2+ binding site. It is interesting, 
therefore, that this site is not conserved in either? or~. If 
this site is used to bind ca2+ in the cGform, the divergence 
may represent a functional distinction within the PKC family. 
Adjacent to this site is the largest region of 
extensive sequence divergence, which has hydrophilic 
characteristics in all three PKC sequences. It is likely to 
represent an exposed surface domain since it is sensitive to 
proteolytic attack and is proposed to be the 'hinge' region 
between the regulatory and catalytic domain (Coussens et al. 
(1986)). Beyond the v 3 region is a highly conserved region 
that includes a Gly x Gly xx Gly sequence for ATP binding and 
marks the beginning of the kinase domain. In PKC-A/, however, 
there is a minor insertion of five residues at the carboxyl end 
of this zone which constitutes v4 . Interestingly, a second 
Gly x Gly xx Gly consensus sequence for ATP binding sites is 
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found in all three PKC sequences at the end of the kinase 
domain, with lysine residues found an appropriate distance 
downstream in a.., andfi II only. Whether or not these sequences 
represent an additional ATP binding site requires further 
investigation. Another minor divergent structural feature is 
found at the carboxyl terminus (v5 ). The cc and; sequences 
are 2 and 11 residues longer respectively, than the aligned/9 II 
sequence. 
In a study, by Ohno et al. (1987), which compared 
the sequence fr om rabbit p I, /3 I I and ex. PKC, a similar 
conclusion concerning the location of the variable region was 
made. The only deviation was in the assessment of the catalytic 
domain, whereby, in the latter study, v4 was not present 
(because I was not examined) and the V 5 region ( termed D 4 
in that study) was extended back to include the last 50 to 55 
amino acids. This n4 zone may be important as it is the only 
area of difference between the/3 I and;B II gene products from 
human, rat and rabbit sources. It has been suggested (Ohno et 
al. (1987)) that n4 could be involved in the recognition of 
target proteins in a manner analogous to other systems, 
suggesting that different PKC types have different substrate 
specificities. However, there is as yet, no experimental 
evidence for this. 
Three distinct forms of PKC have been isolated from 
rat brain cytosol by hydroxylapatite column chromatography 
(Huang et al. (1986)), and, although all three types had many 
properties in common, including a kinase activity dependent on 
ca 2+ and phospholipid, they could be distinguished from one 
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another on the basis of either immunoreactivity or 
autophosphorylation sites. In addition, several studies 
concerning tissue distribution of m-RNA for PKCCX.,, j3 I,p II and 
1 have been performed (Brandt et al. (1987); Ohno et al. 
(1987)) and it has been clearly shown that different tissues do 
have different patterns of expression of the varius PKC forms. 
This information strongly suggests that the different types of 
PKC have different physiological roles within the cell. This 
would provide at least part of the explanation as to how the 
wide variety of hormones, neurotransmitters and growth factors 
can act through the one phosphoinositide signal transduction 
pathway and elicit such different responses. 
Less than two years ago it was assumed that PKC was 
a single entity. All the information that has been collected 
concerning the activation and subsequent role of this enzyme 
activity in generating a cellular response, has been 
interpreted in the light of this misconception. The fact that, 
until recently, there was no need to propose multiple forms of 
the enzyme to explain experimental data, suggests that the 
variations between the PKC isozymes may lead to subtle changes 
in the regulation of enzyme activity rather than overt changes 
in its character. It is hoped, therefore, that the following 
sections concerning the means and ramifications of the 
activation of PKC by DAG are generally valid and that future 
information gained from studying and distinguishingc<.,, J I, /3II 
andryPKC, serves only to qualify rather than re-appraise our 
current knowledge. 
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l.C.2.4.3 Biochemical and Physiological Activation of 
Protein Kinase C: 
Protein Kinase c, per se, is normally inactive, and 
in an unstimulated cell is found, in most cases, in the cytosol 
(Kikkawa and Nishizuka (1986)). However, upon cell stimulation, 
the enzyme apparently translocates to the membrane where i t s 
activity is modulated by membrane components (Takai et al. 
(1979); Bell (1986)). 
When assayed in a cell-free system, protein kinase c 
(PKC) activation depends totally on phospholipid and 
unphysiologically high levels of ca 2+ (Takai et al. (1979)). 
However, in the presence of diacyglycerol (DAG), the affinity 
of the enzyme for ca 2+ is greatly increased such that PKC can 
be fully active at physiological calcium concentrations (Takai 
et al. (1979a). It is generally considered that under such 
conditions the only phospholipid capable of activating PKC is 
phosphatidylserine, the affinity of the enzyme for which is 
also increased by DAG (Takai et al. (1979a)). However, recent 
evidence suggests that different substrates for the enzyme 
, 
generate different lipid requirements (Bazzi and Nelsestuen 
(1987)). various sonicated phospholipids have been reported to 
potentiate or inhibit phosphatidylserine-dependent activation 
(Kaibuchi et al. (1981)), but this has not been found when 
mixed micelles or defined lipid vesicles are used and under 
h . t 1 d. . t h . 1 . 1 2+ sue exper1men a con 1t1ons, a p ys10 og1ca ca 
concentrations, the activity of PKC shows close to absolute 
dependence on DAG (Hannun et al. (1985). 
various DAG are capable of activating the enzyme, 
(Boni and Rando (1985); Lapetina et al. (1985)) but in 
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physiological processes l,stearoyl-2-arachidonyl glycerol is 
the likely activator since most of the inositol lipids contain 
this DAG backbone (Holub et al. (1970)). Specificity tests have 
shown that the active DAG must be of the 1,2-sn configuration, 
suggesting that a highly specific lipid-protein interaction is 
needed for enzyme activation (Boni and Rando (1985); Ganong et 
al. (1986)). This also precludes a role for the DAG produced 
from triglycerides, by lipoprotein lipase or heparin-releasable 
hepatic lipase in activation of protein kinase c, as they have 
a 2,3-sn configuration (Morley and Kuksis (1972); Akesson et 
al. (1976). The 3-0H group and 1-2 carbonyls are both required, 
as is a long chain fatty acid, in at least one of the two 
positions with activity increasing from 3 to 11 carbons (Ganong 
et a 1 . ( 19 8 6 ) ; Hann u n et a 1 . ( 19 8 5 ) ) . 
Due to the highly co-operative nature of 
phosphatidylserine (PS) activation, four or more PS molecules 
are required per molecule of a enzyme (Hannun et al. (1985); 
Bell (1986)). Activation by DAG, however, is non-cooperative, 
requiring only a single molecule. Studies have shown that 
protein kinase c is fully activated by mixed micelles 
containing molar fractions of DAG (2.5%) and PS (8%) comparable 
to those in the plasma membrane during activation of 
phosphoinositide hydrolysis (Bell (1986)). 
Protein Kinase c can also be activated irreversibly 
by limited proteolysis, generating a 50.000Mr kinase known as 
protein kinase M which is both ca 2+- and phospholipid-
independent (Inoue et al. (1977); Kishimoto et al. (1983)). 
Such an activation has been shown to be mediated in vitro by a 
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ca 2+-dependent neutral proteinase present in cellular 
membrane fractions (Kishimoto .et al. (1983); Melloni et al. 
(1985); Mizuta et al. (1985)) and is thought to occur in vivo, 
resulting in the release of the constitutively active PKM into 
the cytosol, (and presumably leaving the hydrophobic regulatory 
unit within the membrane) (Melloni et al. (1985)). Enzyme 
activities attributable to PKM have been reported in the 
membrane and/or cytosol of keratinocytes (Chida et al. (1986)), 
platelets (Tapley and Murray (1985)) neutrophils (Melloni et 
al. (1985a)) and breast cancer cells (Fabbro et al. (1986)) 
treated with phorbol esters and in B lymphocytes treated with 
either phorbol ester and calcium ionophore or with the mitogen, 
SAC (Guy et al. (1986)). The physiological significance of this 
cleavage is still being debated (Murray et al. (1987); Buday et 
al. (1987)). However, there is growing evidence that the 
generation of PKM is not merely a means of degrading PKC (see 
Murray et al. (1987)). Furthermore, it is noteworthy that the 
greatest region of sequence variation, between the different 
forms of PKC, lies within the hinge region containing the 
predicted site of proteolytic attack (coussens et al. (1986)). 
It could be predicted that the different types of PKC have 
different capacities to be converted to the PKM form, some 
remaining predominantly within the membrane after activation, 
others moving to the membrane only to be cleaved. This idea is 
supported indirectly by studies, examining the phorbol ester-
mediated cleavage of PKC, which have shown that the time 
required for a 50% decrease in PKC activity in keratinocytes 
was one-sixth to one-seventh the time typical of BALB/3T3 or 
C3H/10Tl/2 cells (Chida et al. (1986)). 
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Taking this information together, models have been 
developed (Bell (1986) with Murray et al. (1987)) to explain 
what may be happening in vivo when protein kinase C is 
activated during phosphoinositide mediated signal transduction 
(see diagram 1.5). The first step involves translocation of the 
inactive cytosolic protein kinase C to the membrane. Studies 
using inside-out erythrocyte membranes (Wolf et al. (1985a)) 
h h th t t 2+ t t. . . 1 h aves own a, a Mg concen ra ions s1m1 ar tot ose 
inside the cell, a rise in the intracellular ca 2+ 
concentration, from a basal level (lSOnM) to that seen after 
stimulation (lj0tM), leads to rapid association of protein 
kinase c with the membrane. This association is promoted by 
DAG, probably by stabilization of the complex within the 
membrane. It is suggested that, initially, four molecules of PS 
form a structure on the surface of the membrane and bind ca 2+ 
through their carboxyl group (Bell (1986)). Protein kinase C 
binds to this complex of PS and ca 2+ in a 'primed' but 
inactive state. DAG then interacts with the complex at three 
points (one at ca2+ and two at protein kinase C) which may 
affect enzyme conformation thereby leading to activation 
(possibly by displacing the pseudosubstrate from the active 
site (House and Kemp (1987)) protein Kinase C might then be 
inactivated by dissociation of DAG from the complex after which 
it could remain in its primed state in the membrane until 
2+ [Ca ] . decreases. Alternatively, the membrane bound enzyme 
1 
may be cleaved by the neutral proteinase releasing the 
de-regulated protein kinase Minto the cytosol (Murray et al. 
(1987)). 
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l.C.2.4.4 Activators and Inhibitors of Protein Kinase C: 
In addition to the endogenously produced DAG, a 
number of other compounds have been shown to activate PKC, the 
most notable of which are the tumour promoting phorbol esters 
(Castagna et al. (1982); Yamanishi et al. (1983)). These tumour 
promoting phorbol esters which have been shown to activate PKC 
both in vivo and in vitro, have a molecular structure that is, 
in part, very similar to diacylglycerol and, like DAG, they 
dramatically increase the affinity of this enzyme for calcium, 
resulting in full activation at physiological ca 2+ 
concentrations (Yamanishi et al. (1983)). 
several lines of evidence suggest that protein 
kinase c is the prime target for the tumour promoting phorbol 
esters, acting as their so-called receptor (see Nishizuka 
(1984)). Kinetic analysis indicates that, roughly, one molecule 
of the phorbol ester can activate one molecule of protein 
kinase c (Kikkawa et al. (1983); Uratsuji et al. (1985)), 
probably via interaction at the DAG binding site. 
Because of the ability of both the permeant DAG such 
as l-oleoyl-2-acetylglycerol (OAG) and the tumour promoting 
phorbol esters to activate protein kinasa c in vivo, they have 
been used in many systems as experimental tools to examine the 
role of activated protein kinase c. However, several studies 
have suggested that the manner in which phorbol esters 
influence protein kinase C may not be identical to that of DAG 
or OAG, (Ashby et al. (1985); Bijleveld et al. (1988)) casting 
doubt on the unqualified suitability of these tumour promoters 
for cell biology experiments. This may be due, in part, to the 
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different rate of metabolism of the phorbol esters. DAG is 
present only transiently in membranes whereas the phorbol 
esters are metabolised very slowly and persist for longer 
periods within the membrane (Kikkawa and Nishizuka (1986)). The 
concentration of phorbol ester used is also an important 
consideration since at higher concentrations these agents can 
act as membrane perturbers or fusigens, influencing the cell 
directly rather than through protein kinase C (cited in Kikkawa 
and Nishizuka (1986)). However, other structurally unrelated 
tumour promoters such as mezerein, teleocidin and Aplysia toxin 
have also been shown to activate protein kinase C (Couturier et 
al. (1984); Fujiki et al. (1984) further supporting the key 
role for this enzyme in the regulation of cell growth. 
A number of endogenously produced fatty acids and 
their oxygenated products have also been shown to activate PKC 
in vitro including arachidonate, lipoxin A and the octa 
decadienoic acids, linoleic acid and linolelaidic acid (Seifert 
et al. (1987); Hansson et al. (1986)). Interestingly, it has 
been reported that the substrate specificity of PKC activated 
by lipoxin A is different from that of phosphatidylserine or 
phorbol ester (Hansson et al. (1986)). Moreover, short chain 
phosphatidylcholines, unlike their long chain counterparts are 
also capable of activating c-kinase (Walker and Sando (1988)). 
Many compounds have been found to inhibit protein 
kinase C activity but, unfortunately, none are specific for t he 
enzyme. The majority appear to act by disrupting membrane 
phospholipids (Kikkawa and Nishizuka (1986)). These include a 
number of the psychotic drugs such as chlorpromazine, local 
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anaesthetics (e.g. dibucaine), staurosporine, (Tamaoki et al. 
(1986)) triphenylethylenes, (O'Brian et al. (1986)) anti-
calmodulins, polyamines and polymixin B (reviewed in Hidaka and 
Hagiwara (1987)). These phospholipid interacting drugs usually 
inhibit calmodulin dependent protein kinases such as myosin 
light chain kinase. Some compounds, namely the isoquinoline-
sulfonamides, have been found which interact with the catalytic 
site of protein kinase c (Hidaka et al. (1984); Fujita et al. 
(1986)) but even H7, the most selective of these, also inhibits 
the activity of the cyclic nucleotide dependent protein kinases 
to some extent. 
Recently several endogenous inhibitors of protein 
kinase C have been reported which may prove to have both 
physiological and pharmacological significance. Two 
ca 2+-binding proteins, of molecular weight 17k Da and 12kDa, 
have been isolated from bovine brain cytosol, both of which 
have been shown to inhibit protein kinase c, in a manner which 
is due neither to interaction with substrates or co-factor nor 
to phosphatase activity (McDonald and Walsh (1986)). Both also 
display a certain degree of specificity in that they have no 
effect on calmodulin-dependent cyclic nucleotide 
phosphodiesterase or c-AMP-dependent protein kinase and, in the 
Case Of the 17kDa Ca 2+ b1'nd1'ng t · ff t · pro e1n, no e ec on myosin 
light chain kinase. A third 40 kDa, heat-stable inhibitor 
protein with a dimer configuration has also been isolated from 
bovine brain cytosol but its mode of action and specificity 
have not yet been reported (Hucho et al. (1987)). In addition, 
preliminary characterization of an endogenous protein kinase C 
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inhibitor has been reported 1n human neutrophils. It is 
primarily associated with neutrophil-specific grannuole 
membranes, is protease and heat sensitive and has neither 
protease nor phosphatase activity (Balazovich et al. (1986)). 
Alternatively, alkylacylglycerols, produced when choline 
phospholipids are degraded by phospholipase c, have also been 
shown to inhibit PKC in a concentration dependent manner. 
(Daniel et al. (1988)). 
l.C.2.4.5 catalytic Activity and Target Proteins of 
Protein Kinase C: 
Protein kinase c, like c-AMP-dependent protein 
kinase (PKA), phosphorylates proteins on serine and threonine, 
but not tyrosine residues in proteins. It uses ATP but not GTP 
as its phosphate donor (Kikkawa and Nishizuka (1986)). An 
extensive study using synthetic peptides (House et al. (1987)) 
has indicated, that unlike PKA, the phosphorylation recognition 
site used by PKC cannot be described by a simple amino acid 
sequence. A single basic residue, preferably arginine, on 
either side of the residue to be phosphorylated, is the primary 
determinant but additional basic residues and other structural 
features also influence the kinetics of peptide. 
phosphorylation. The substrate requirements for PKA are more 
restricted in that there is a specific preference for the 
arginine residue on the amino side of the phosphate acceptor 
(Krebs and Beavo (1979)). However, the overlap in site 
requirements of these kinases may justify the report that, in 
some instances, PKC and PKA, not only phosphorylate the same 
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proteins, but also the same residues (Kishimoto et al. (1985) )" , 
explaining why such seemingly divergent signal transduction 
pathways can have certain cellular responses in common. 
Nevertheless, comparative studies concerning the structural 
requirements of the two enzymes have indicated that, despite 
apparent similarities, the primary structural determinants for 
PKC and PKA are, in general, quite distinct. (Ferrari et al. 
(1985)) .-
PKc ' mediates its positive effects on cell growth by 
altering the activities of a variety of proteins through 
phosphorylation and perhaps by acting directly on the genome. 
In most tissues, conclusive information concerning its in vivo 
targets is not available. However, the enzyme has been shown to 
phosphorylate a wide range of proteins in vitro, many of which 
are phosphorylated in intact cells after treatment with tumour 
promoting phorbol esters or OAG (Kikkawa and Nishizuka (1986)). 
Although the physiological relevance of such phosphorylations 
is not always clear, many of the target proteins obviously have 
key roles in the growth response. 
Phosphorylation and subsequent activation of the 
Na+/H+ antiporter by PKC (Moolenaar et al. (1984a)) not 
only leads to an intracellular alkalinization, but also 
stimulates the Na+/K+ ATPase, explaining how activators of 
C-kinase activity have been shown to elicit many of the early 
ionic events associated with mitogenesis in quiescent 3T3 
fibroblasts (Vara et al. (1985)). The rise in intracellular 
free ca2+, generated by the Ins(l,4,5)P3 arm of the 
pathway, can also be modulated by PKC via the kinase's ability 
I 
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to phosphorylate phospholamban (Movsesian et al. (1984); Lagas t 
et al. (1984)). This results in an increase in the activity of 
the ca 2+ATPase in the sarcoplasmic (and presumably 
endoplasmic) reticulum, therefore replenishing the 
Ins(l,4,5)P 3 sensitive calcium stores. Moreover, the 
ubiquitous phosphorylation of ribosomal S6 protein in response 
to mitogenic stimulation can result from PKC activation (Parker 
et al. (1985)) and the alterations in the cytoskeleton, 
documented to occur during the proliferative response (Herman 
and Pledger (1985)), may, similarly, be explained, at least in 
part, by PKC mediated phosphorylation of such components as 
vinculin (Werth et al. ( 1983)). This is also true for the 
--
changes in glucose transport (Whetton et al. (1986); Witters et 
al. (1985)). 
In addition, PKC activators have been shown to alter 
the expression of a number of proteins by influencing their 
level of transcription. It has been shown that the 
tumour-promoting phorbol ester, phorbol 12-myristate, 
13-acetate (PMA), increases the transcription of genes for the 
IL-2 receptor, T3 and T cell antigen receptor in human T 
leukemic cell lines (Shackelford et al. (1987)) and induces t h e 
expression of the growth cycle-dependent gene, ornithine 
decarboxylase (O'Brien et al. (1976)). It also increases EGF 
receptor production in human breast carcinoma cells (Bjorge and 
Kudlow et al. (1987)) and the production of two secreted 
glycoproteins, mitogen regulated protein (MRP) and major 
excreted protein (MEP) in 3T3 fibroblasts, its ability to 
increase the production of these glycoproteins correlating with 
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its capacity to stimulate DNA synthesis (Fienup et al. (1986)). 
PKC activation also stimulates the production of IL-1 in 
peritoneal macrophages (Katakami et al. (1986)) but decreases 
the expression of glycophorin (Siebert and Fukuda (1985)) and 
phosphoenolpyruvate carboxykinase (Chu and Granner (1986)) in 
human leukemic K562 cells and rat hepatoma H4IIE cells, 
respectively. 
A study 1n NIH 3T3 cells, treated with PMA, has 
indicated that PKC activation can alter the expression of two 
classes of genes, those that do not require prior protein 
synthesis for transcription and those that do require the 
production of new proteins (Rabin et al. (1986)). In the latter 
case PKC is obviously not acting directly on the DNA. In the 
former case, however, it is not yet clear whether PKC actions 
are mediated by its ability to phosphorylate other enzymes such 
as RNA polymerase II (Chuang et al. (1987)) or are due to 
direct interaction of PKC with enhancer sequences within the 
genome. Those genes, belonging to the first group, include the 
cellular proto-oncogenes c-myc and c-fos which have been shown 
by many groups to be activated by PKC. (Kaibuchi et al. 
(1986)); Blackshear et al. (1987); Coughlin et al. (1985)). 
Genes, such as that for MEP, belong to the second class. 
Interestingly, it has been shown that elevations in 
2+ [ca ]i' produced by Ins(l,4,5)P 3 , can also induce c-myc 
transcription, independently of PKC activa t ion (Kaibuchi et al. 
(1986)) and that prolactin gene transcription is promoted by 
PKC activators in combination with an elevation in 
intracellular free ca 2+ concentration (Murdoch et al. (1985)). 
,, 
I 
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Other targets of PKC are identified daily, but it 1s 
clear from the nature of targets already known that PKC 
probably occupies a central role in cell proliferation. 
l.C.2.4.6 Down-Regulation and Negative Feedback: 
In addition to its positive role in signal 
transduction, PKC is also thought to be involved in the 
termination of second messenger production through negative 
feedback inhibition. It has been shown in many cell types, 
including fibroblasts (L'Allamain et al. (1986)), platelets 
(Watson and Lapetina (1985)), astrocytomas (Orellana et al. 
(1985)) and cultured smooth muscle cells (Brock et al. (1985)), 
that pre-incubation with tumour promoting phorbol esters 
inhibits agonist-induced stimulation of phosphoinositide 
hydrolysis and ca 2+ mobilization. That this effect is 
mediated by PKC is supported by the observation that inhibitors 
of the kinase prevent phorbol ester mediated inhibition 
(Tohmatsu et al. (1986)). The exact means by which this occurs, 
however, is not yet fully understood. In some cases, inhibition 
may be due to a decrease in agonist-receptor binding but, in 
others, modification of agonist binding is clearly not involved 
(Brock et al (1985)) and PKC is thought to act by directly 
influencing receptor-coupled phospholipase c activity. 
Accordingly, a recent report concerning formyl-rnethionyl-
leucyl-phenylalanine (FMLP) stimulation of PIP 2 hydrolysis in 
human leukemic cells, has suggested that PKC activation in 
intact cells impaired the coupling of both the receptor to the 
GTP-binding protein and of the GTP-binding protein to 
phospholipase C (Kikuchi et al. ( 1987)). 
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Protein Kinase Chas also been shown to have a 
negative effect on the second messengers produced by 
phosphoinositide hydrolysis. Its ability to phosphorylate the 
enzyme, inositol trisphosphate 5'-phosphomonoesterase (Connolly 
et al. (1986)), leads to an increase in phosphatase activity 
and therefore to the breakdown of Ins(l,4,5)P3 (and possibly 
rns(l,3,4,5)P 4 ). Furthermore, studies, concerning the 
association of PKC with the membrane, have indicated that the 
tight membrane-PKC complex, formed in the presence of phorbol 
esters, can be dissociated when ATP is added (Wolf et al. 
(1985a)). This ATP effect cannot be reproduced by other 
nucleotides, but requires Mgcl 2 and is accompanied by the 
phosphorylation of PKC itself, suggesting perhaps, that PKC 
autophosphorylation may regulate its own association with the 
membrane. Although it was not conclusively shown that the 
phosphorylation of PKC (as opposed to some other component) was 
the phosphorylation event which caused membrane dissociation, 
it is an interesting proposal, particularly since the different 
forms of PKC isolated from rat brain have been shown to have 
different autophosphorylation sites (Huang et al. (1986)). 
Evidence in other systems suggests that 
down-regulation mediated by PKC is not confined to its own 
receptors, but extends to growth factor receptors whose 
responses may not be mediated by phosphoinositide hydrolysis. 
For instance, PKC has been shown to phosphorylate the epidermal 
growth factor (EGF) receptor with a concomitant decrease in 
both its tyrosine kinase and growth factor binding activities 
( Downward et a 1 . ( 19 8 5 ) ; May et a 1 . ( 19 8 5 ) ) . Li k e w i s e , 
,, 
I 
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receptors for insulin and insulin-like growth factor are also 
phosphorylated by PKC, leading in the case of t h e i nsu lin 
receptor, at least, to a decrease in the receptor kinase 
activity (Bollag et al. (1986); Haring et al. (1986)). 
Somatostatin receptor binding in pancreatic acinar cell 
membranes (Matozaki et al. (1986)) is also inhibited b y t h e 
protein kinase c activators, OAG and PMA, which, likewise, act 
to reduce cell surface transferrin receptor numbers in human 
leukemic cell lines (Neckers et al. (1986); May et al. (1986 )) 
and leukotriene B4 receptor binding in neutrophils 
(O'Flaherty et al. (1986)). 
It should also be mentioned that there have been 
many reports of the so-called down-reg~lation of 
tumour-promoting phorbol ester binding sites in response t o 
prolonged treatment of cells with phorbol esters (Fabbro et a l. 
(1986); Gainer and Murray (1985)), suggesting that PKC is 
itself down-regulated by long term activation. However, t his 
statement should be qualified as there seems to be two d i s tinct 
phases to the decreases in both amount and activity of PKC . 
The initial down-regulation reported in mos t 
experiments occurs within 30 minutes of phorbol ester 
treatment. It may be due, initially, to a desensitization of 
the enzyme but is thought predominantly to occur by t h e a ctual 
loss of PKC from the membrane as the result of i t s p r oteolytic 
cleavage to the PKM form (Tapley and Murray (1985); Me llon i et 
al. (1985); Chida et al. (1986)). 
However, when cells are treated wi t h phorbo l esters 
for an extended period ( > 12 hr), PKC down-regulation cause d by 
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proteolytic cleavage is followed by a more permanent down-
modulation of the enzyme (Fabbro et al. (1986); Gainer and 
Murray (1985)). A study by Fabbro et al. (1986) indicated that 
treatment of human breast cancer cells for 72 hours with lOOnM 
PMA, resulted in the complete loss of PKC from the membrane 
within 2 hours, followed by a slower but total disappearance of 
the 60kDa and SOkDa (PKM) degradation products within 12 hours. 
No PKC of any type was detected for some time thereafter, and 
normal cellular levels of the enzyme were not apparent until at 
least five days after phorbol ester removal. The fact that the 
presence of phorbol esters did not lead to the continuous 
translocation and breakdown of PKC over the 72 hour exposure 
period, suggests that there may be some negative feedback 
system operating at the level of the genome whereby the finite 
cytosolic pool of PKC, once depleted, is no longer replenished. 
A recent study which examined this latter type of 
PKC down-modulation in neuronal cells (Mattingly et al. (1987)) 
has indicated that the extent of PKC depletion depends, not 
only on the time of phorbol ester treatment, but also the type 
(PMA vs PDBu~ and concentration of phorbol ester used, 
suggesting once again that different types of PKC have 
different susceptibilities to down-modulation mediated by 
phorbol ester. It is less likely, however, that this second 
phase of PKC down-modulation has any physiological 
significance, considering that the PKC-mediated negative 
feedback of phosphoinositide hydrolysis would prevent the 
rapidly metabolised DAG from remaining within the membrane for 
such an extended period. Nevertheless, the depletion of PKC, by 
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prolonged phorbol ester exposure, is useful experimentally as 
it has been employed to make nPKC-deficientw cells which can 
then be used to assess the importance of this enzyme in 
mediating the positive effects of agonist-receptor activation. 
l.C.2.4.7 Role of Protein Kinase C in Mediating Cell 
Growth: 
It is clear that an elevation in cytosolic free 
ca 2+ has a role in mediating the mitogenic signal, and the 
ability of rns(l,4,5)P 3 to raise [ca
2+Ji in a fashion 
that mimics the growth factor response, makes it a logical 
candidate as a second messenger (Berridge (1987)). This natural 
inference cannot, however, be made for the DAG/PKC arm of the 
pathway. Although increased protein phosphorylation is also an 
early event in mitogenesis, the identity of many of the target 
proteins is unknown. Even if it may be demonstrated that 
protein kinase c is capable of phosphorylating at least some of 
these proteins, the overlap of substrate specificity, between 
kinases, prevents an immediate assessment of the importance of 
PKC mediated phosphorylation in generating the growth signal. 
However, indirect but convincing evidence, that PKC 
is actively involved in the growth response, comes from many 
reports correlating the presence of an active, membrane-bound 
PKC with cell division and the ability of agents which activate 
PKC to stimulate cell growth. For example, in the study by 
Fabbro et al. (1986) mentioned earlier, in which human breast 
cancer cells were treated for extended periods with PMA, it was 
shown that the time at which no cellular PKC activity was 
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detected, coincided with the minimum PMA exposure time required 
for inhibition of growth. Accordingly, the resumption of cell 
cycling, after PMA removal, was accompanied by the 
re-appearance of PKC activity. Similarly, calcium deprivation 
has been shown to inhibit the proliferation of Balb/c 3T3 
fibroblasts with an accompanying loss of PKC from the 
particulate fraction. Re-addition of ca2+ to the medium 
resulted in a rise in membrane PKC activity which parallelled 
the increase in DNA synthesis (Donnelly Jr. et al. (1985)). 
In addition, investigations into the proliferation 
of confluent rat liver epithelial cells (Boynton et al. (1985)) 
indicated that serum-stimulated transition from G
0 
to G1 
and from G1 to s required high levels of extracellular 
calcium and was accompanied by an increase in 
membrane-associated PKC. Moreover, the requirement for calcium 
was lost when cells were treated with PMA, suggesting that PKC 
helps regulate the transition of these cells through the G1 
phase. 
Other evidence that PKC translocation to the 
membrane can accompany mitogenic stimulation comes from studies 
with B lymphocytes (Guy et al. (1986)) and T lymphocytes 
(Averdunk and Gilnther (1986)) and those using purified 
lymphokines with factor-dependent cell lines. In the latter 
reports it was not only shown that interleukin-2 (Farrar and 
Anderson (1985)) and interleukin-3 (Farrar et al. (1985)) could 
stimulate the rapid but transient association of PKC with the 
membrane, but also that the amount of membrane-associated 
C-kinase correlated with the amount of DNA synthesis. Likewise, 
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studies, using human and mouse (Adamo et al. (1986)) 
fibroblasts, have indicated that PKC activity and subcellular 
distribution undergo spontaneous changes in accordance with the 
proliferative state of the cell. 
l.C.2.4.8 Metabolism of Diacylglycerol: 
Diacylglycerol is normally not found free in the 
plasma membrane and, in general, appears only transiently, due 
to such events as receptor driven phosphoinositide hydrolysis 
(Lapetina et al. (1981)). Once formed, it is rapidly broken 
down by one of two major pathways. It may be either 
phosphorylated by 1,2-diacylglycerol kinase to form 
phosphatidic acid (PA) or cleaved by diacylglycerol lipase, 
releasing arachidonic acid (AA). (See Diagram 1.6.) 
Phosphatidic acid formation seems to be the dominant 
route under normal conditions (Lapetina et al. (1981)) and PA 
itself has been proposed as a bio-regulator due to its ability 
to gate ca 2+ across the plasma membrane (Putney et al. 
(1980); Gerrard et al. (1979); Brass and Laposata (1987)). Like 
DAG, it can be further metabolised in one of two ways. By 
combining with cytidine triphosphate (CTP) via 
CTP-phosphatidate: cytidyl transferase, it is converted to 
CMP-PA which can accept a free myo-inositol, forming the means 
by which DAG is re-cycled back to the phosphoinositides 
(Lapetina et al. (1973)). Alternatively it may be acted upon by 
a PA-specific phospholipase A2 , releasing arachidonic acid 
(Billah et al. (1981)). 
DAG can also be converted directly to arachidonic 
acid by a DAG lipase (Bell et al. (1979)). Although the fatty 
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Fig Ure "1 • 6 Metabolism of Diacylglycerol 
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acid . composition on the 2-position of the phosphoinositides i s 
usually AA, it can also be linoleate or oleate. However, during 
agonist stimulation, there appears to be a preferential 
degradation of molecules such that DAG always carries AA on the 
2-position (Bell et al. (1979)), prompting the suggestion that 
hydrolysis of PIP 2 may play an important role in controlling 
AA release (Berridge (1984)). Arachidonic acid is also 
considered as a bio-regulator and is the precursor of a wide 
variety of active metabolites including prostaglandins, 
leukotrienes and thromboxanes (reviewed in Needleman et al. 
(1986)). 
In addition, there appears to be a relationship in 
some systems between phosphoinositide hydrolysis and cyclic 
guanine monophosphate (c-GMP) formation via stimulation of 
guanylate cyclase (Michell (1975)). Although the means by which 
this occurs is not yet known, the fact that guanylate cyclase 
can be activated by a variety of fatty acids has led to the 
suggestion that this enzyme may be regulated by either AA or 
one of its metabolites (Peach (1981)). The calcium requirement 
for c-GMP formation could be met by changes in intracellular 
ca
2+ homeostasis modulated by the Ins(l,4,5)P 3 arm of the 
pathway. 
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l.C.2.5 Synergism Between the Two Arms of the 
Phosphoinositide Pathway and their Interaction with other 
Growth Signals in the Mitogenic Response 
One of the most intriguing aspects of the 
phosphoinositide signal transduction system is that both 
molecules generated by the hydrolysis of PIP 2 can be assigned 
a second messenger function (Berridge (1987)). The aqueous 
soluble Ins(l,4,5)P3 is proposed to act by increasing 
[ca 2+J. and DAG is thought to function by activating the 
1 
enzyme, protein kinase c. (Berridge (1984)). Although there is 
evidence to suggest that both an increase in [ca 2+J. 
1 
(Poggioli et al. (1986)) and the activation of PKC (Farese et 
al. (1985)) can be generated independently within cells, via 
mechanisms that do not involve phosphoinositide hydrolysis, it 
is also clear that when these signals are generated in 
combination they act synergisticly to mediate a biological 
response (Berridge (1987)). 
The interaction between the two arms of the pathway 
is demonstrated by the documented effects of [ca 2+J. on the 
1 
activity and subcellular distribution of PKC (Bell (1986)) and 
by the ability of PKC activation to not only modulate the 
generation (Bianca et al. (1986)) and catabolism (Connelly et 
al. (1986)) of Ins(l,4,5)P 3 but also to act upon calcium 
channels to directly modulate [ca 2+]. (Strong et al. 
1 -
(1987); Lagast et al. (1984)). Many examples of how these two 
systems act in concert to generate a biological response have 
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been reported (Kikkawa and Nishizuka (1986); Berr i dge (1 98 7)) 
but perhaps the clearest indication of the synergistic r ol e of 
these two signals in stimulating mitogenesis is given by th e 
finding that lymphocytes can be stimulated to initiate DNA 
synthesis by pharmacological agents which mimic the signals 
generated by phosphoinositide hydrolysis. Treatment of T 
lymphocytes with a combination of calcium ionophore (to r a ise 
[ca 2+] ). and phorbol 12-myristate 13-acetate (PMA) (to l 
activate PKC) leads to DNA synthesis whereas neither agent 
alone (administered in concentrations consistent with their 
ascribed action) could generate a fully mitogenic response 
(Truneh et al. (1985)). However, it has also been shown t ha t 
when T lymphocytes are depleted of macrophages t hey will no t 
re-initiate DNA synthesis in the presence of calcium ionophore 
and PMA without the additional presence of the co-mitogen, 
phytohaemagglutinin. (Kaibuchi et al. (1985)). This impl ies 
that although the phosphoinositide pathway may be actively 
involved in generating a mitogenic signal, it is not 
sufficient, by itself, to initiate DNA synthesis, a conclusion 
which is logical if one is to propose a multistep system in the 
regulation of cell growth (see next section). 
It has been found that when most known mitogenic 
agents are added singly to quiescent cells in serum-free medium 
they fail to stimulate cell division. However, when such agents 
are added in specific combinations they show striking s ynergism 
(Rosengurt and Mendoza (1985)). Therefore, by the co-ordinate 
examination of the molecular mechanisms by which t hese agents 
act, attempts are being made to determine the set of si gnals 
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necessary for cell division. (Rosengurt and Mendoza (1985); 
Metcalfe et al. ( 19 85)). 
A study in fibroblasts (Rosengurt and Mendoza 
(1985)) has indicated that the mitogenic agents for these cells 
can be divided into at least two groups based on the pattern of 
early signals they generate. The first group, exemplified by 
vasopressin, is catagorized by the ability to generate 
monovalent anion fluxes and to activate PKC. The second group 
containing prostaglandin E2 , failed to initiate any of the 
ion fluxes associated with mitogenesis (see Section l.B) but 
resulted in a prolonged increase inc-AMP. Combination of 
factors within a group did not result in DNA synthesis but 
combinations between groups can lead to a full mitogenic 
response. Moreover, the only agents which were found to 
stimulate DNA synthesis, when added alone, were 
platelet-derived growth factor (PDGF) and bombesin, both of 
which activate phosphoinositide hydrolysis and raise c-AMP 
levels. 
In addition, PDGF has been shown to stimulate the 
activation of the tyrosine protein ·kinase activity associated 
with its receptor (Ek and Heldin (1984)). Phosphorylation of 
proteins on tyrosine residues is also one of the early events 
associated with mitogenesis and, because a number of growth 
factor receptors, including those for PDGF, epidermal growth 
factor (EGF), and insulin have been shown to possess tyrosine 
kinase activity, it has been proposed that this may be an 
additional pathway for the transfer of mitogenic signals into 
the cell (reviewed in Hunter and cooper (1985)). None of these 
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three signals (phosphoinositide hydrolysis, elevation of c-AMP 
and activation of tyrosine kinase activity) are, however, 
essential for growth, as a maximal mitogenic response can be 
generated with any one of these signals missing. 
It is clear that these separate signals do not act 
independently but interact with one another to produce an 
overall mitogenic response. In some cases this leads to the 
potentiation of one of the signals. For example, although 
insulin does not generate PIP 2 hydrolysis on its own, it acts 
synergisticly with bombesin to enhance DNA synthesis and 
in o s i t o 1 p hosp ha t e for ma ti on ( He s 1 op et a 1 • ( 19 8 6 ) ) . I n 
addition, activation of PKC has been shown to increase the 
production of c-AMP via modula~ion of adenylate cyclase 
(Summers et al .. ( 1988)) and to phosphorylate, and apparently 
suppress, the function of the inhibitory GTP-binding protein 
N. coupled to adenylate cyclase (Katada et al. (1985)). l. 
- -
However, in other cases it appears that the signals are 
antagonistic. Protein Kinase C activation has been shown to 
decrease the affinity of EGF (Downard et al. (1985)) and 
insulin ( Bollag et al. ( 1986)) receptors for their agonists 
with a concomitant decrease in tyrosine kinase activity. 
Moreover, the c-AMP and phosphoinositide pathways are 
counteractive in some cells (see Kikkawa and Nishizuka (1986); 
Kaibuchi et al. (1984); Gainer and Murray (1986)). Even more 
confusing are the reports that both c-AMP generation (Katsaros 
et al. (1987)) and PKC activation (Issandou and Darbon (1988)) 
have been associated with the inhibition of cell proliferation 
in some systems. 
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Perhaps some of these apparent contradictions are 
due to differences in the duration of the stimulus required to 
produce the different responses. A key feature in the action of 
most mitogenic agents is that they have to occupy their 
receptors for hours before they stimulate increased DNA 
synthesis in the cell population (Rosengurt and Mendoza 
(1985)). A large transient increase in the cellular levels of 
c-AMP which is traditionally considered as the mea~s by which 
this molecule acts in signal transduction (Robison et al. 
(1971)), is not sufficient to act as a co-mitogenic stimulus in 
fibroblasts. Instead, c-AMP concentration must remain elevated 
for hours (Rozengurt (1982)). Likewise, a transient exposure of 
cells to vasopressin or phorbol esters is not sufficient to 
stimulate mitogenesis (Dicker and Rozengurt (1981)). Moreover, 
although short term activation of PKC leads to the 
down-modulation of EGF receptors, when quiescent cells are 
exposed for a number of hours to PMA or a synthetic DAG, these 
PKC activators act synergisticly with submitogenic levels of 
EGF to stimulate DNA synthesis (Davis et al. (1985)). This is 
not to suggest, however, that phosphoinositide hydrolysis is 
continuous in the presence of the appropriate agonists since it 
has been clearly documented that this signal transduction 
system is under negative feedback control (see Section 
l.C.2.4.5). Nevertheless, it is possible that phosphoinositide 
breakdown may oscillate in the presence of agonists. 
(Cuthbertson and Cobbold (1985); Berridge (1987)) and that 
sustained oscillations are required for the generation of the 
mitogenic response. 
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It 1s clear that stimulated phosphoinositide 
hydrolysis is associated with the actions of a number of 
mitogens including PDGF, bombesin, vasopressin 
phytohaemagglutinin and thrombin. (Berridge (1987a)). In 
addition, the second messengers, produced by this hydrolysis, 
are capable of mediating many of the early events which are 
responsible for ultimate cell division including increased 
[ca2+]., (Berridge (1984)), increased monovalent ion fluxes 1 
(Vara et al. (1985)) and increased protein phosphorylation 
(Kikkawa and Nishizuka (1986)). Moreover, PKC and · [ca 2+J. 
1 
have both been shown to stimulate the transcription of several 
genes, the expression of which correlates with the progression 
through the cell cycle (Rabin et al. (1986)). All this 
information suggests that the phosphoinositide pathway is one 
of the means by which the positive growth signals, delivered to 
the cell by growth factors, are converted to a mitogenic 
response. 
l.D CELLULAR GROWTH REGULATION 
The phosphoinositide pathway forms one of the means 
by which the information, delivered to th~ cell by growth 
factors, is converted into a positive growth signal inside the 
cell (reviewed in Berridge (1987a)). It has also been shown 
that the messages delivered by this pathway must be 
complemented by an additional positive signal before a cell is 
committed to divide (Kaibuchi et al. (1985); Rozengurt and 
Mendoza (1985)), indicating that cell proliferation is a 
multifaceted process which may be regulated by co-ordinate 
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presentation of the appropriate signals. However, it is now 
apparent that such regulation is not simply dependent on the 
presence or absence of growth inducers, but is a highly complex 
and dynamic process involving both positive and negative 
factors acting in concert to regulate cell growth. This 
concept, termed the Yin and Yang of growth control (Sager 
quoted in Marx (1986); Pardee (1987)), illustrates the balanced 
nature of normal cell growth and allows a conceptual 
understanding of how an imbalance of such factors can lead to 
alterations in growth regulation. 
Cells which have left the growth cycle and have 
become quiescent are in, what is termed, the G state (see 
0 
Section l.A "Cell cyclen - diagram 1.1). Factors, which 
determine whether the cell will remain in this state or undergo 
cell division, act at two main events, both of which have been 
proposed to be controlled by yes/no nswitches" (Pardee (1987)). 
The first involves the re-entry of the cell into the cell cycle 
and occurs at the transition from the G
0 
state to the G1 
phase of the cell cycle in a process known as competence 
(Pardee (1987)). A cell is made competent to divide by such 
factors as platelet derived growth factor (PDGF) (Stiles et al. 
(1979)). Approximately 12 hours later a second choice is made 
in the competent cells. Under the influence of other factors, 
such as epidermal growth factor (EGF) or insulin-like growth 
factor-1 (IGF-1), cells will either progress towards DNA 
synthesis or, alternatively, go back into quiescence. This 
second switching event is made at, what is termed, the 
restriction point about two hours before the onset of DNA 
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synthesis (Pardee et al. (1986)). After this, cells are no 
longer under the controlling influences of growth factors and 
it is presumed that once cells have replicated their DNA, they 
are committed to division since most cells 1n the animal are 
diploid when in G (Pardee (1987)). 
0 
The activation of these "switches" is dependent on 
the outcome of the interplay between the opposing positive and 
negative forces which regulate the cell cycle. conceptually, if 
a cell or its environment is manipulated so that the balance of 
such forces is permanently tipped to one side, then the switch 
becomes "stuck" in the one position and an element of growth 
control is lost. When both switches are "jammed" in the "on" 
position, the cell can readily transit the cell cycle without 
restriction. It is not clear, however, whether this change is 
sufficient to generate a tumour in vivo since there is growing 
evidence for the existence of additional negative growth 
signals, intrinsic to the cell genome, which may operate at 
positions other than the growth cycle switches to prevent un-
restricted cell division and ensure the programmed 
differentiation of the cell (Stanbridge (1985); Harris (1985)). 
Accordingly, both in vivo and in vitro evidence 
suggests that tumourigenesis is a multistage process (Foulds 
(1954); Land et al. (1983a)), the endpoint of which, for the 
purposes of this discussion, is the production of a cell which 
is capable of forming a tumour in a suitable animal host. The 
additional ability of such cells to spread throughout the body 
via a process known as metastasis is also a multistep process 
(reviewed in Poste and Fidler (1980); Ling et al. (1984)) not 
considered further. 
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cancers of every tissue type have now been found in 
man and many of these, as well as those developed 
experimentally in animal models, have been extensively studied 
both in vivo and in vitro in order to determine the molecular 
basis of growth regulation. Some of the factors, both positive 
and negative, which have been shown to influence cell growth 
will now be discussed with reference to their action in the 
production of tumourigenic cells. 
l.D.l POSITIVE FACTORS REGULATING CELL GROWTH: 
Cell proliferation is usually initiated by the 
binding of peptide growth factors to their cell surface 
receptors, resulting in the activation of intracellular second 
messenger systems (Rozengurt and Collins (1983)). Under normal 
circumstances, the magnitude and duration of the positive 
signal produced, is regulated by controlling either the number 
of agonist-receptor complexes formed or the ability of such 
complexes to generate second messengers. It is not surprising, 
therefore, that events which ·lead to a long term increase in 
either:-
(1) availability of growth factors, 
(2) the number of activated receptors, or 
(3) the generation of second messenger molecules, 
have all been shown to be capable of disrupting cellular growth 
control with a resultant change in growth state of the cell. 
Many of the so-called cancer genes or oncogenes have 
been shown to act in this fashion (Marshall (1986)). Oncogenes 
are the transforming genes carried by retroviruses (Duesberg 
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(1987)). Such viruses can produce tissue specific tumours upon 
infection of animal hosts and, therefore, the genetic material 
they carry has been widely studied in the hope of discovering 
the genetic basis of cancer (reviewed in Weinberg (1985); 
Bishop (1986); Marshall (1986)). More than 30 oncogenes have 
now been found and their protein products characterized into 
groups depending on their subcellular location, biochemical 
activity ·and proposed cellular functions (Marshall (1986); 
Weinberg (1985)). Examination of DNA sequence of the oncogenes 
indicates that many are hybrid genes that consist of truncated 
cellular genes (known as proto-oncogenes) recombined with 
regulatory, and often coding, elements from truncated 
retroviral genes. 
Although the function of all the cellular 
proto-oncogenes is not yet known, many have, been shown to code 
for proteins actively involved in the mitogenic response 
(Marshall (1986)). It should be noted, however, that the 
oncogenes are distinct from their cellular counterparts and the 
proposed oncogene concept, which states that proto-oncogenes 
are latent cancer genes which can be activated from within the 
cell to form virus-negative tumours (Weiss (1986)), is 
currently losing favour (Duesberg (1987); Klein and Klein 
(1986)). Moreover, although retroviral innoculation can lead to 
tumourigenesis in vivo, laboratory studies have indicated that 
transfection of normal primary cell cultures with a single 
activated oncogene, does not lead to the production of 
tumourigenic cells. (Land et al. (1983); Newbold and Overwell 
(1983)) These cells show altered growth characteristics but 
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transfection with at least one additional, complementary 
oncogene is necessary before such cells produce tumours. This 
is consistent with the proposal that tumourigenesis is a 
multi-step process and indicates, that since particular 
combinations of oncogenes are required for the production of a 
tumour, the nature, as well as the magnitude of the changes in 
cell function, are important. Interestingly, complementary 
oncogenes belong to different catagories acting either at the 
plasma membrane or within the nucleus (Weinberg (1985)), and 
may be associated with the key events occurring after the 
switch points during G1 . 
l.D.1.1 Increased Availability of Growth Factors and the 
Altered Growth State 
An example of oncogene activation, resulting in the 
over-production of growth factors, comes from work studying the 
transfection of cells with Simian sarcoma Virus (SSV) which 
carries the oncogene v-sis. The v-sis gene encodes a protein 
which is very similar or identical to that of platelet derived . 
growth factor (PDGF). (Waterfield et al. (1983); Doolittle et 
al. (1983)) Since SSV transfected fibroblasts are capable of 
responding to PDGF, the transfected cells can undergo what is 
termed "autocrine" stimulation of cell proliferation, becoming 
independent of exogenously supplied factor. However, although 
transfection of continuous cell lines such as NIH 3T3 cells, 
with either SSV or a special construct of cellular sis (c-sis) 
coupled to appropriate transcriptional and translational 
control elements, can lead to the production of tumourigenic 
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1 in e s ( c 1 ark e et a 1 . ( 19 8 4 ) ) , the tr ans f e c ti on of pr i mar y 
fibroblasts with SSV results in a cell that displays a 
transformed morphology but will not form tumours. 
Further examination of autocrine stimulation 
phenomenon has indicated that inappropriate expression of the 
basic fibroblast growth factor gene can also lead to autonomous 
cell proliferation with the permanent acquisition of the 
transformed phenotype (Neufeld et al. (1988)). In addition, a 
study by Lang et al. (1985) in which the gene for the 
haemopoietic growth factor, granulocyte-macrophage-colony 
stimulating factor (GM-CSF), was transfected into a factor-
dependent murine cell line (FDC-Pl) indicated that such cells 
synthesised and secreted GM-CSF, grew independently of 
exogenous GM-CSF and, unlike the parental line, formed tumours 
in the syngeneic mice. However, as with the case of ssv, 
transfection of normal haemopoietic cells with the gene 
construct, failed to make the cell tumourigenic. This suggests 
that autocrine stimulation of proliferation is not sufficient 
to make normal cells tumourigenic but that it does tip the 
balance of an already partially deregulated cell. 
l.D.1.2 Increased Number of Functional Receptors and the 
Altered Growth State 
A second way in which factors, which disrupt cell 
growth, may act, is by changing the number and function of cell 
surface growth factor receptors. Many of the known growth 
factor receptors, including those for PDGF, EGF, insulin-like 
growth factor (ILF-1) and monocyte growth factor (CSF-1), have 
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tyrosine kinase activity associated with their cytoplasmic 
face, the activity of which is regulated by agonist binding 
(Ramachandran and Ullrich (1987)). Such kinases are thought to 
generate second messages in an alternative or complementary 
manner to the phosphoinositide pathway. No less than 7 of the 
known oncogenes have such tyrosine kinase activity and it has 
been proposed that they may represent captured receptor genes. 
(Hunter and Cooper (1985)). Support for this comes from the 
finding that v-erb B, the oncogene carried by the avian 
erythroblastosis virus (AEV), has a sequence corresponding to a 
truncated EGF receptor (EGF-R) (Ullrich et al. (1984)). It 
contains stretches of the transmembrane and tyrosine kinase 
sequence of EGF-R but lacks the amino-terminal EGF binding 
domain and the extreme carboxyl terminal cytoplasmic domain. 
These deletions result in a viral oncogene product that 
expresses tyrosine protein kinase activity constitutively, 
independent of external regulation by EGF. In addition, it has 
been shown that c-fms, the cellular counterpart of v-fms, 
carried by the feline sarcoma virus (FSV), is the receptor for 
CSF-1 (Sherr et al. (1985)) and that the amino acid sequence 
for the insulin receptor has limited sequence homology to v-ros 
(cited in Ramachandran and Ullrich (1987)). 
In addition, an in vivo demonstration of the 
influence of receptor number on growth control is given in a 
study by Gill et al (1987), examining the relative growth rate 
of clonal human epidermoid carcinoma cells, A431, containing 
different amounts of EGF receptor gene amplification and 
protein expression. A direct correlation between the rate of 
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tumour growth and EGF-R concentration was found, supporting 
previous cell culture studies which quantitated the 
relationship between activated EGF receptors and cell 
proliferation. 
l.D.1.3 De-regulation of Second Messengers and the Altered 
Growth State 
A third stage at which the positive signals induced 
by growth factors can be manipulated, is at the level of the 
intracellular biochemical pathways activated by growth factor 
receptor binding. In the case of the tyrosine kinase mediated 
signal, the second messenger system is so tightly coupled to 
the receptor that both are on the same molecule (Ushiro and 
Cohen (1980)) and therefore a deregulation of the receptor also 
leads to the deregulation of the second messenger system. In 
the case of the phosphoinositide pathway, however, although 
phospholipase C is coupled to growth factor receptors via a GTP 
binding protein (Cockcroft (1986); Litosch and Fain (1986)), 
the association is not as tight, and the efficiency of the 
system can be modified without a change in the receptor 
molecule. By manipulating the components of the signal 
transduction system independently of the receptor, the actions 
of more than one growth factor can be affected. It is not 
surprising, therefore, that a number of steps in the 
phosphoinositide pathway are targeted by oncogenes (Michell 
(1984) (see diagram 1.7)) and have been shown to be deregulated 
in several chemically induced tumours (Rillema (1986); Kuboto 
et al. (1986)). 
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Figure 1. 7 
Oncogenes and the Phosphoinositide Pathway 
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It has been shown that transformation of a mink lung 
epithelial cell line with feline sarcoma viruses, carrying 
either v-fms or v-fes, results in significantly higher levels 
of guanine-nucleotide activated-PIP2-specific-phospholipase c 
(PLC) activity in the transformed cells leading to elevated 
steady state levels of inositol phosphates in these cells 
(Jackowski et al. (1986)). Moreover, PLC activity has also been 
reported to be elevated in DMBA-induced rat mammary tumours 
compared with their normal controls (Rillema (1986)). Likewise, 
confluent cultures of fibroblast and kidney cell lines 
transformed with three different activated ras genes show 
elevated ratios of DAG: PIP 2 indicating that the metabolism 
of PIP2 is increased in the transformed cells (Fleischman et 
al. (1986)). This is consistent with the reported similarity 
between the ras gene products and the -subunit of a GTP-
binding protein proposed to couple PLC to its receptor 
(McGrath, J.P. et al. (1984)). Transformation of cells with 
avian sarcoma virus, UR-2 (carrying v-ros), Rous sarcoma virus 
(carrying v-src) and transformation competent polyoma virus all 
lead to the increased 32P-labelling of the inositol lipids 
and it has been proposed that all three oncogene products have 
phosphatidylinositol (PI) kinase activity and in the case of 
v-src DAG kinase activity (Macara et al. (1984); Sugimoto et 
al. (1984); Kaplan et al. (1986)). This has, however, been 
disputed (Sugano and Hanafusa (1985); MacDonald et al. ( 1985)) 
and these oncogenes may act, instead, to influence the cellular 
kinases. SV40 transformed fibroblasts have elevated 
unstimulated levels of inositol phosphates (Villereal et al. 
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(1985)) and kidney tumour cells, displaying an abnormally 
increased expression of the proto-oncogene c-myc, showed a very 
marked enhancement of 32 P labelling in CDP-diacylglycerol. 
(Kubota et al. (1987). Moreover, the tumour promoting phorbol 
esters have been shown to activate the enzyme protein kinase c, 
both in vivo and in vitro as have a number of other tumour 
promoters such as teleocytin and Aplasia toxin (Nishizuka 
(1984)). 
In addition, it has been shown that second 
messengers generated by different pathways are capable of 
activating a common set of cellular genes whose expression 
appears necessary for the transit of the two switch points in 
the cell cycle mentioned earlier (Pardee (1987)). Several of 
these mitogenically regulated genes including c-myc, c-fos and 
c-ras have oncogene counterparts. 
l.D.2 NEGATIVE FACTORS REGULATING CELL GROWTH: 
As illustrated above, a sustained increase in the 
intensity of the positive signals which promote cell division, 
can lead to an alteration in growth state of a cell and thereby 
contribute to its progression to tumourigenicity. However, 
there is also evidence that a decrease in the level of negative 
growth signals can have the same effect (Marx (1986)). 
Conceptually, there are two ways in which such negative signals 
can act, either by inhibiting the actions of the positive 
signals or by actively directing the cell away from 
proliferation into a non-proliferative state (differentiation? ). 
Evidence that the first mechanism is operating is 
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demonstrated by such phenomena as receptor down-regulation and 
inactivation of key enzymes involved in signal transduction. 
These systems are often inbuilt into the normal cell division 
process as part of a negative feedback loop. For example, 
protein kinase C inhibits phospholipase C (Kikuchi et at. 
(1987)). 
Additional support for the existence of negative 
growth signals is given by the relatively recent discovery and 
characterization of a number of growth inhibitory substances, 
including transforming growth factor beta (TGFp) (Roberts et 
al. (1985)), beta-type interferon (IFft) (Mehmet et al. (1987)) 
and tumour necrosis factor (TNF), which have been shown to have 
antiproliferative effects in some cell types. Although these 
factors act from outside the cell, they, too, may be part of a 
negative feedback loop, since for example, PDGF has been shown 
to stimulate interferon production in fibroblasts (cited in 
Marx (1986)). The importance of such factors in regulating 
normal cell growth is illustrated in a study by Moses et al. 
(1985) examining the actions of TGFj on carcinoma cells. It has 
been shown that many carcinoma cell lines grew well in serum 
(containing inactive TGF/3) but are inhibited by active TGFJ , 
implying that the carcinoma cells have lost the capacity to 
activate TGFJ. Since most cells, including carcinoma cells, 
produce TGFp in an inactive form, this inability to generate a 
negative signal may have contributed to the tumourigenic 
phenotype. The way these agents work at the molecular level is 
not yet known. In general, they are not considered to act by 
inducing terminal differentiation although both TGF/3 and TNF 
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have been shown to promote differentiation in some cell types 
(Markovac and Goldstein (1988); Takeda et al. (1986)). 
--
Probably, the most conclusive support for the idea 
that negative signals operate to prevent uncontrolled 
proliferation in vivo, comes from the study of somatic cell 
hybrids derived from the fusion of normal diploid cells and 
tumourigenic cell lines (Stanbridge et al. (1982); Klinger 
(1980); Harris (1985)). It has been shown in human and rodent 
systems that when malignant cells, defined by their ability to 
form tumours in a compatible host, are fused with diploid cells 
of the same (Harris et al. (1969); Stanbridge (1976)) or 
different (Stoler and Bouck (1985)) species, the resultant 
hybrids are non-tumourigenic as long as they retain certain 
specific chromosomes from the diploid parent. When such 
chromosomes are lost from the hybrid, the segregant cells are 
again able to grow in vivo. Although this is seen in inter- as 
well as intra-specific hybrids, it is more clearly displayed in 
intra-specific hybrids, particularly of human origin, in which 
a higher degree of genetic stability is observed (Stanbridge et 
al. (1982)). The fact that the non-tumourigenic hybrids 
maintain their tumourigenic potential, which can be 
re-expressed by loss of specific chromosomes, indicates that 
the tumourigenic phenotype is being suppressed by some 
component, presumably carried, in an intact form, by the normal 
cell genome (Harris (1985)). In addition, it should be noted 
that the non-tumourigenic hybrids, like their tumourigenic 
segregants, usually behave as transformed cells 1n culture 
displaying abnormal growth characteristics such as lack of 
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contact inhibition, reduced growth factor requirements and 
anchorage independent growth (Stanbridge et al. (1982). This 
indicates that the transformed and tumourigenic phenotypes are 
under separate genetic control (Stanbridge et al. (1982)). 
The observation that re-expression of 
tumourigenicity is correlated with the loss of specific 
chromosomes, indicates that specific genetic elements (referred 
to as tumour suppressor genes (Stanbridge (1985) or 
antioncogenes (Knudson (1985)) are responsible for suppression 
of tumourigenicity. The identity of the individual chromosomes 
has been determined for a number of intra-(Stanbridge et al. 
(1981)) and inter-specific (Stoler and Bouck (1985)) hybrids 
and the gene(s) responsible for tumour suppression are 
currently being sought in order to determine how such elements 
operate at the molecular level. 
Investigations in a murine intra-specific hybrid 
system indicated that suppressor gene action may be overridden 
by the oncogene Ha-ras in that NIH3T3 fibroblasts transformed 
by Ha-ras, are no longer able to suppress tumour formation 
after fusion with the mouse melanoma derivative, PG19 (Harris 
(1985)). However, other groups, using different hybrid systems, 
have shown that suppression of tumourigenicity was observed 
even when the non-tumourigenic hybrids were expressing the ras 
gene protein (Benedict et al. (1984)), suggesting that, at 
least in some systems, repressor genes can override the actions 
of oncogenes. 
Alternatively, it has been proposed that suppressor 
genes may act by actively promoting the maintenance of a 
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differentiated phenotype rather than by directly inhibiting 
proliferation (Harris (1985); Stanbridge et al. (1983)). 
Support for this comes from histological examination of the 
NlH3T3 x PG19 hybrids innoculated into compatible hosts (Harris 
et al. (1985)). It was shown that the non-tumourigenic cells 
produced a collagenous extracellular matrix in vivo but that 
the original tumour cells and the tumourigenic segregants 
derived from the hybrids, grew and produced tumours devoid of 
an extracellular matrix. Harris (1985) proposed that cell 
multiplication in vivo ceased when the ability to produce an 
extracellular matrix was restored. Since the deposition of this 
matrix precedes the suppression of cell multiplication in the 
non-tumourigenic innoculates and the establishment of such a 
matrix is a manifestation of terminal differentiation in 
fibroblasts, it is reasonable to conclude that the cells 
stopped dividing in vivo because they underwent terminal 
differentiation (Harris (1985)). Furthermore, it has been shown 
by Peehl and Stanbridge (1982) that in HeLa x keratinocyte 
hybrids, cell multiplication in vivo is suppressed, or at least 
greatly reduced, in those hybrids in which squamous 
differentiation and keratinization take place. Interestingly, 
in the cases documented, the non-tumourigenic cells which, . 
undergo terminal differentiation in the animal host, display 
the phenotype of the normal parent cell irrespective of the 
origin of the malignant parental cell (Stanbridge (1985)). 
In addition, since differentiation is the process 
whereby a cell is committed to differentially express a subset 
of genes in its genome (resulting in a unique functional and 
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morphological phenotype) it is reasonable to assume that the 
intracellular factor(s) which direct the selection of such 
genes and/or the maintenance of that state, would be differen t 
for different cell types. Therefore, if suppressor genes are 
actively involved in the differentiation process, it would be 
predicted that tumours arising from different cell types would 
respond to distinct suppressor genes. 
In agreement with this, it has been shown that 
fusions between tumours of different tissue origin showed that 
carcinoma x carcinoma hybrids maintained their tumourigenicity, 
but that carcinoma x sarcoma and carcinoma x melanoma crosses 
produced hybrids which were non-tumourigenic, indicating gene 
complementation between some tumour types (Stanbridge et al. 
(1982)). Moveover, a number of human tumours excised from 
patients have been shown by cytogenetic analysis to have 
specific chromosomal re-arrangement or deletions characteristic 
of the malignancy (Knudson (i985)). For example, retinoblastoma, 
renal cell carcinoma and Wilms' tumour are associated with the 
loss of both allelles from chromosomes 13 (Murphree and 
Benedict (1984)),3 (Zbar et al. (1987)) and 11 (Koufos et al. 
(1984)) respectively. 
However, it should also be noted that a liver cancer 
(hepatoblastoma) and a muscle cell cancer (rhabdomyosarcoma) 
are also associated with deletion of the alleles on chromosome 
11 characterized by Wilms' tumour, indicating that at the 
tissue level, suppressor genes are not unique. Nevertheless, it 
has been stated by cavenee (cited in Marx (1986)) that all 
three tumours have the appearance of normal embryonic tissue, 
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maintaining the concept that the tumours are failing to 
differentiate in vivo. The involvement of a locus on chromosome 
11 is particularly interesting since it has been shown in the 
HeLa x fibroblast hybrids, that re-expression of 
tumourigenicity correlates with loss of chromosome 11 
(Srivatsan et al. (1986); Kaelbling and Klinger (1986)). 
Moreover, reintroduction of chromosome 11 is sufficient for the 
suppression of tumourigenicity in the hybrids (Saxon et al. 
(1986)). such corresponding findings give support to the 
contention that the actions of the tumour suppressor genes, 
observed to operate in the somatic cell hybrid systems, are 
also operating in diploid cells and that their loss from such 
cells actively contributes to the formation of a tumour in the 
animal. 
The control of normal cell proliferation, therefore, 
relies on the maintenance of a balance between positive and 
negative forces. It has been proposed that increases, in the 
frequency or intensity of positive signals, act to deregulate 
cell growth by manipulating one or both of the "switches" 
associated with the transition from G to s phase. However, 0 
results from somatic cell hybrid studies indicate that the 
maintenance of controlled proliferation in vivo, also requires 
the functioning of a third switch, perhaps located outside the 
cell cycle, which is associated with the progression to the 
differentiated phenotype. It has been shown that the 
transfection of normal cells with complementary oncogenes 
results in the production of tumourigenic lines (Land et al. 
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(1983)). If it is assumed that oncogenes act solely as positive 
signals modifying events at the G
0 
0 G1 and G1~ s 
switches, then it would have to also be assumed that an 
alternation in the ability of the cell to transit switch 3 and 
undergo differentiation is not necessary for the production of 
a tumour. However, it is possible and highly conceivable that, 
in addition to their ability to promote proliferation, at least 
some oncogenes act as anti-differentiation factors. For 
example, it has been shown that transfection of fibroblasts 
(Arbogast et al. (1977)) or epithelial cells (Falcone et al. 
(1985)) with the several different oncogenes prevents the 
expression of a differentiated phenotype. Moreover, the 
tumourigenic contribution of activated oncogenes can be 
considered to be differentiation-dependent (Klein and Klein 
(1986)) in that the transforming ability of an oncogene is 
dependent on the cell type and the stage of that cell in 
neoplastic progression. Whether these oncogenes are acting by 
actively blocking differentiation events or promoting the loss 
of genes necessary for differentiation remains to be determined. 
l.E SCOPE OF THESIS 
This thesis examined specific aspects of the 
phosphoinositide pathway in transformed, non-tumourigenic and 
transformed tumourigenic human somatic cell hybrids in order to 
assess the involvement of cell surface signal transduction 
events in maintaining the tumourigenic phenotype. 
Tumourigenicity, as such, can only be defined in an 
1n vivo context. There is no unequivocal way of knowing whether 
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cells in culture are tumourigenic without introducing them into 
an animal. conversely, whilst the cells remain within the 
animal, it is almost impossible to assess the intracellular 
biochemical changes that have taken place to make that cell 
tumourigenic. The advantage of the HeLa X fibroblast human 
somatic cell hybrid system, first developed by Stanbridge 
(1976), is that both non-tumourigenic and tumourigenic cell 
hybrids can be obtained from the one fused cell. Moreover, such 
cell lines, unlike many hybrid systems, are genetically and 
therefore, phenotypically stable for an extended period in 
culture (Stanbridge et al. (1982)). This allows the "in vitro" 
study of highly related cell lines which are known to differ in 
their growth behaviour in vivo. In addition, because both 
tumourigenic and non-tumourigenic cell hybrids display a 
transformed phenotype in culture, any biochemical differences 
noted between the two cell types are presumably associated with 
a defined stage of growth control involving the transition from 
a disrupted (transformed) to fully deregulated (tumourigenic) 
growth state. 
As seen from the previous section concerning the 
negative control of growth, the transition from the transformed 
to the tumourigenic state in this hybrid system correlates with 
the loss of tumour suppressor genes (Stanbridge 1985). These 
genes are conceptualized as transacting regulatory elements 
affecting the expression of unrelated genes (Stanbridge 1985) 
which are proposed to function by promoting cellular 
differentiation and growth arrest (Harris (1985); Stanbridge et 
al. (1983)). However, it has not yet been determined at the 
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molecular level, how these genes act or what effect their loss 
has on the expression of positive and negative growth signals 
within the cell. They may act solely to switch on 
differentiation genes, activation of which is sufficient in 
itself to inhibit proliferation. Alternatively, they may have a 
dual role, not only promoting differentiation but also 
impinging on the regulation of the growth cycle to down 
modulate the positive growth signals which occur during normal 
cell proliferation and which are enhanced or deregulated by 
activated oncogenes (Michell (1984)). This latter possibility 
is supported by the observation that the loss of suppressor 
genes in the human somatic cell hybrids is associated with the 
expression of a membrane-associated phosphoglycoprotein with 
protein kinase activity (Der and Stanbridge (1981)). 
A number of morphological and biochemical properties 
of these tumourigenic and non-tumourigenic hybrids have been 
examined in culture, with particular reference to the 
cytoskeleton and differentiation markers (Stanbridge et al. 
(1982), Gowing et al. (1984); and Tellam and Banyard (1986)). 
One of the most interesting findings in the context of positive 
growth signals concerns the report by Banyard and Tellam (1985) 
indicating that the tumourigenic somatic cell hybrids had 
significantly higher levels of intracellular free calcium 
[ca2+J. than their non-tumourigenic partners. Although 1 
' 
these differences are not large and the measurements represent 
an average for a cell population, evidence from many sources 
suggests that an elevation in [ca2+]. plays an important 1 
part in the triggering of mitogen-induced proliferation (Veigl 
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et al. (1984)) and that changes in [ca2+]. occur at various 
-- l 
stages throughout the growth cycle (Poenie et al. (1985)). 
Therefore, the elevated [ca 2+]. in the tumourigenic hybrids l 
may relate to a change in the growth responsiveness of the 
cell. There are, of course, many possible causes for this 
elevation, particularly since the regulation of intracellular 
calcium levels involves such a complex interplay of events 
(reviewed in carafoli (1987)). However, in normal cells, it is 
now considered that one of the main ways in which mitogens 
generate the rise in [ca2+J. is by activation of receptor l. 
driven phosphoinositide hydrolysis (Berridge et al. (1984); 
Ber r id g e ( 19 8 7 a ) ) . 
The phosphoinositide pathway was first proposed by 
Michell (1975) as the means by which calcium-mobilizing 
hormones acted and has since been shown to be the signal 
transduction pathway used by numerous hormones, 
neurotransmitters and growth factors (Berridge 1986)). Much 
information has been gained over the last ten years concerning 
the operation of this pathway and phosphoinositide metabolism 
has evolved into an exciting and rapidly growing area of 
research. Its role in the generation of positive growth signals 
has been well documented (reviewed Berridge et al. (1985); 
Berridge (1987a)) as has the manipulation of this pathway by 
chemical and viral agents which influence growth control 
(Section l.D.1.3), therefore making this a logical positive 
signal to examine in the transformed and tumourigenic hybrids. 
Several aspects of phosphoinositide metabolism were 
investigated, not only in the somatic cell hybrids but also in 
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the normal and tumourigenic parental lines, in order to assess 
at what stage in the tumourigenic process any changes may have 
occurred. In addition, an effector of the phosphoinositide 
second messenger system, protein kinase c, was also examined to 
assess whether this pathway may have been circumvented, if not 
deregulated in the tumourigenic hybrids. Protein kinase c, was 
chosen due to its multifaceted role in co-ordinating cell 
growth and differentiation (Kikkawa and Nishizuka (1986); 
Berridge (1987a)). 
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CHAPTER 2: 
GENERAL METHODS 
Definition and Maintenance of the Cell System 
The human somatic cell hybrids used in this study 
were derived from the fusion of the tumourigenic D98AH 2-clone 
of the human carcinoma line, HeLa, with normal human diploid 
fibroblasts. All hybrid lines were developed and generously 
provided for use in Dr Banyard's Laboratory by both Prof. E.J. 
Stanbridge (Dept. Microbiology, College of Medicine, University 
of California, Irvine, California, 92717) and Dr. H.P. Klinger 
(Dept. Genetics, and R.F. Kennedy centre, Albert Einstein 
College of Medicine, 1300 Morris Park Avenue, Bronx, New York, 
10461). Information concerning the method of fusion and further 
characterization of these cell lines are given in Stanbridge 
(1976); Stanbridge and Wilkinson (1978); Stanbridge and ceredig 
(1981); Klinger (1980). In each case, both the original 
non-tumourigenic cell hybrid and its tumourigenic segregant 
were provided such that cell lines could be analysed as pairs. 
All cell hybrids maintained in tissue culture 
displayed a transformed phenotype in that they exhibited an 
indefinite life span in vitro (immortalized), grew rapidly in 
the presence of low serum, and reached high population 
densities similar to those obtained by the D98AH2 cells 
(Stanbridge et al. (1982), personal observation). The hybrids 
grew as adherent colonies with a morphology intermediate 
between their fibroblastic and the epithelial HeLa parents. 
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cells representing the parental lines were also analysed, with 
the original D98AH 2 line being supplied by Prof. stanbridge. 
The human fibroblast cell line MRC-5 was obtained from Flow 
Laboratories (Scotland, U.K.) and the Al83 primary fibroblast 
cultures were established from amniocentesis samples supplied 
by Dr. Flower (Royal Children's Hospital Research Foundation, 
Victoria, Australia). A list of the cell lines used, and their 
growth behaviour both in vitro and in vivo are given in the 
following Table. 
TABLE 2A: Growth Characteristics of the culture Lines Used 
Cell Line Growth Behaviour 
in vitro in vivo 
39EC13 transformed non-tumourigenic 
ESH39 transformed tumourigenic 
SE transformed non-tumourigenic 
SL transformed tumourigenic 
Cn2B1Col1 transformed non-tumourigenc 
SA7mp transformed tumourigenic 
MRC-S or Al83 normal non-tumourigenic 
D98AH2 tr an sf or med tumourigenic 
39EC13, ESH39, SE, SL and D98AH 2 were supplied by Prof. E.J. 
Stanbridge; cn 2B1col 1 and SA7mp were from Dr H.P. Klinger. 
One of the advantages of this cell system is the 
genetic stability of the hybrids in culture (Stanbridge et al. 
(1982)). However, all cell lines were routinely tested for 
tumourigenicity by injection of sx10 6 cells subcutaneously 
into nude mice. cell lines which produced progressively growing 
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tumours within 2-3 weeks of innoculation were classified as 
tumourigenic. cells were also regularly tested for 
contamination by mycoplasma using the method of Chen (1977). 
All cells were maintained in Dulbecco's Modified 
Essential Medium (DMEM) [Gibco Laboratories, (U.S.A.)] 
supplemented with 2mM sodium pyruvate, 2mM L-glutamine and 
30mg/L penicillin G and containing either S% (v/v) fetal calf 
serum and S% (v/v) new born calf serum (for the 39EC13, ESH39, 
SE and SL cells) or 10% (v/v) fetal calf serum (for the 
cn 2B1col 1 , 5A7mp, D98AH 2 and fibroblast lines). The 
antibiotics neomycin ?ulphate (SOmg/L) and Streptomycin sulfate 
(50mg/L), used previously in this tissue culture system were 
omitted due to the reported inhibition of the phosphoinositide 
pathway by such compounds (Orsulakova et al. (1976; Downes and 
Michell (1981)). Cells were grown in plastic flasks and dishes 
of tissue culture quality at 37°C in a S% co2 (in air) 
humidified atmosphere. 
Because all cells are adherent, they were routinely 
trypsinized before subculture. Briefly, after the medium was 
removed, cells were washed with warm (37°C) physiologically 
buffered saline (PBS - see Appendix for formula) and then 
incubated for 7 minutes with 0.025% (w/v) trypsin in PBS+ 0.02% 
(w/v) ethylenediaminetetraacetic acid (EDTA) at 37°C. The 
trypsin was neutralized with an equal volume of medium and the 
cells collected by centrifugation at 2000g for 5 minutes. The 
cell pellet was suspended in serum supplemented medium and a 
proportion of the cells seeded into a new flask. When cell 
counts were performed 0.2% trypan blue was used to assess cell 
death. 
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Stocks of each cell line were stored in liquid 
nitrogen, the cells being frozen at l-2x10 6 cell/mL in serum 
supplemented medium containing 10% (v/v) Dimethylsulphoxide. 
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CHAPTER 3: 
EXAMINATION OF PHOSPHOINOSITIDE METABOLISM IN THE 
TRANSFORMED AND TUMOURIGENIC HeLa/FIBROBLAST 
SOMATIC CELL HYBRIDS: 
Investigation of possible deregulation of second messenger 
production. 
3.A INTRODUCTION 
Receptor driven phosphoinositide hydrolysis is 
clearly involved in the transduction of growth signals across 
the plasma membrane (for reviews see Berridge (1987a), 
Vicentini and Villereal (1986)). Because of this, many studies 
have examined the operation of the phosphoinositide pathway in 
cells whose growth regulation is altered, to determine whether 
an imbalance in this positive growth signal is associated with 
the generation of the tumourigenic phenotype. 
Probably the first correlation between 
tumourigenesis and the phosphoinositide pathway came from the 
observations that the tumour-promoting phorbol esters and 
several structurally unrelated tumour promoters exert many of 
their pleiotropic effects on cell growth through their ability 
to activate the enzyme, protein kinase c (Nishizuka (1984); 
Kikkawa and Nishizuka (1986)). However, as early as 1977, (the 
time at which protein kinase c was first being characterized 
(Inoue et al. (1977))) it was found that changes in 
phosphatidylinositol metabolism correlated with the growth 
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state of normal and Rous Sarcoma Virus-transformed Japanese 
quail cells (Diringer and Friis (1977)). Since then it has been 
shown that many of the viral oncogenes, including ras, ros, 
scr, fms, fes, sis and the transforming viral gene product 
polyoma middle T, are capable of influencing the metabolism of 
the phosphoinositides (see Section l.D.1.3) and that increased 
phosphoinositide turnover or alterations in the enzymes 
associated with phosphoinositide metabolism, are observed in 
several chemically transformed cell lines (Kuboto et al. 
(1986); Rillema (1986)). 
The majority of information, concerning the 
involvement of the phosphoinositide pathway in the loss of 
cellular growth control, concerns the investigation of 
phosphoinositide metabolism in established cell lines before 
and after transfection with DNA tumour viruses (eg Jackowski et 
al. ( 1986); Fleischman et al. ( 1986). A number of the oncogene 
and viral gene (polyoma middle T) products have been reported 
to have an associated phosphatidylinositol kinase activity in 
vitro (Kaplan et al. (1986); Whitman et al. (1986)) and it is 
probable that the observed changes in phosphoinositide 
metabolism, generated by activated oncogenes, are due to the 
direct action of these dominantly acting genetic elements upon 
the enzymes of the phosphoinositide pathway. It is assumed that 
these changes are associated with the production of a fully 
tumourigenic state although it is often not clearly defined at 
which stage in the transition from the normal to tumourigenic 
phenotype these changes are occurring. 
The aim of the present study was to examine the 
operation of the phosphoinositide pathway in the transformed 
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and tumourigenic HeLa x fibroblast human somatic cell hybrids 
on the premise that any noted changes in phosphoinositide 
metabolism would be associated with the events required for the 
maintenance, if not the generation, of the tumourigenic as 
opposed to the transformed state. Moreover, since the 
expression of the tumourigenic phenotype in the somatic cell 
hybrid system is associated with the loss of specific genetic 
elements, presumed to be carrying tumour suppressor genes 
(Stanbridge (1985)) a perceived change in the phosphoinositide 
pathway in these cells would not only give an insight into the 
functioning of these suppressor genes but also indicate that 
apparently divergent mechanisms for generating tumours in vivo 
(activation of oncogenes versus loss of suppressor genes) 
converge at the one biochemical pathway. 
Further incentive to seek a change in the 
phosphoinositide pathway in the tumourigenic somatic cell 
hybrids came from a report by Banyard and Tellam (1985) which 
indicated that intracellular free calcium concentrations in 
these cells were elevated compared with their transformed 
partners. Although there are many possible explanations for 
this rise, it was of interest to determine whether it could be 
attributed to an elevation in the steady state level of Ins 
(1,4,5)P 3 which has been shown to elevate [ca2+Ji during 
signal transduction by liberation of ca 2+ from internal 
stores (Berridge et al. ( 19 84)). 
In addition, several other changes associated with 
the assumption of the tumourigenic phenotype might be explained 
by an alteration in the phosphoinositide signal transduction 
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pathway. For example, the changes 1n the cytoskeleton that 
occur in the tumourigenic hybrids (Der et al. (1981); Gowing et 
al. (1984)) could be mediated, at least in part, not only by 
protein phosphorylations generated by protein kinase c (PKC) 
(Werth et al. (1983); Litchfield and Ball (1986)) but also, by 
changes in the reported interaction of -actinin with 
diacylglycerol (Burn et al. (1985)) and profilactin with 
phosphatidylinositol(4,5)- bisphosphate (PIP2 ) (Lassing and 
Lindberg (1985)). Likewise, the changes in glucose transport in 
tumourigenic hybrid lines (White et al. (1983)) may be mediated 
by the phosphorylation of the glucose transporter by PKC 
(Witters et al. (1985)). 
--
Phosphoinositide metabolism was examined in the 
transformed and tumourigenic human somatic cell hybrids and the 
cells representing their parents, by monitoring the 
incorporation of [ 3H]-inositol into the total inositol lipid 
pool in response to continuous serum stimulation. The relative 
size of the total exchangeable phosphoinositide pool was also 
determined and the levels of the inositol trisphosphate isomers 
compared in order to assess the functioning of the 
phosphoinositide pathway in the transformed and tumourigenic 
cells. 
3.B MATERIALS AND METHODS 
For maintenance and definition of cell system see 
Chapter 2. 
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3.B.l LABELLING MEDIUM FOR [ 3H]-INOSITOL INCORPORATION 
EXPERIMENTS: 
Because the provision of inositol in the medium is 
essential for the normal growth of some cells in tissue culture 
(Eagle et al. (1960)), it was important to ensure that the 
lowering of extracellular inositol concentrations, during 
labelling, did not compromise the growth of the somatic cell 
hybrids. Two hybrid cell lines (SE and SL) were grown in either 
DMEM or the commercially available inositol free medium, Basal 
Medium Eagles (Flow Laboratories, Scotland, UK) and their 
growth rates were compared. It was found that both cell lines 
grew equally well over a 72 hour period with or without 
inositol in the medium, suggesting that these cells either 
contain a large intracellular store of free inositol (as 
suggested by the decay experiments, see Section 3.C.l) or that 
they can synthesis it de novo from glucose (Eisenberg (1967)). 
When the amount of label incorporated into cellular 
membranes after 16 hours incubation was related to the 
concentration of myo-[2-3H] inositol (603 GBq/mmol; lmCi/mL: 
Amersham Int., Australia) in the medium, it was found that 
below a concentration of 18SkBq/mL (S)-lCi/mL), the level of 
incorporation was dependent on label concentration but that 
increasing the concentration above this level served little 
advantage. Therefore, a concentration of [ 3H]-inositol of 
18S-277.SkBq/mL (5-7.5/ U.Ci/mL) was routinely used. 
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3.B.2 DECAY EXPERIMENTS: 
The procedure used was continually modified during 
the course of these experiments (see results section 3.C.l). 
The final protocol was as follows:-
cells, plated at 1-5 x 10 5 cells/dish in 35mm diameter 
plastic petri dishes, were grown for 24 hours in supplemented 
DMEM before being washed with one mL phosphate buffered saline 
(PBS - see Appendix for composition) and radio-labelled for 24 
hours in Basal Medium Eagle (BME) containing 7.5),lCi/mL 
myo-[2- 3H] inositol (16.3 Ci/mmol; 603 GBq/mmol). After the 
labelling period, cells were washed twice with supplemented 
DMEM and then re-fed with 1 mL supplemented DMEM or processed 
as time zero. At appropriate times the medium was removed and 
cells washed twice with PBS then precipitated with 1 mL 
ice-cold 10% (w/v) trichloroacetic acid (TCA). Dishes were left 
on ice for 5 min, washed with a second mL of TCA then 1 mL 
H2o. These 3mL were combined and assayed for the presence of 
inositol trisphosphate (InsP3 ) as outlined below. 
The TCA precipitate, which contained the inositol 
lipids, was scraped into lmL H2o and the plate rinsed with a 
second mL H2o. A sample from the combined 2mL was taken for 
protein determination using the modified Lowry method (see 
3.B.9 of this section). l.5mL of the TCA precipitate were added 
to l.SmL chloroform, the solution vortexed and allowed to phase 
separate under gravity. The lower phase was collected and the 
upper phase washed with l.5mL chloroform. The lower phases were 
then combined and deacylated as in Downes and Michell (1981). 
Briefly, the 3mL chloroform extract was added to 0.6mL of 
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methanol and 0.6rnL of lN NaOH in methanol:H 2o (19:l(v:v)) 
(this solution was made by solubilizing NaOH in a2o before 
addition of methanol and was stored in a dark bottle). The 
mixture was vortexed 30 sec maximum speed, and left at room 
temperature for 20 min., after which 6.6mL of 
chloroform:methanol:H2o (10:6:6 (v/v/v)) were added, the 
solution vortexed and allowed to separate. The aqueous phase 
was then collected for separation on dowex ion exchange columns. 
The Dowex used for the separation of both the 
inositol phosphates and the deacylated lipids, was bought as 
the 200-400 mesh chloride form (Sigma Chemical co. USA) and was 
converted to the formate form by equilibrating the resin with 
20 volumes lM NaOH then 20 volumes lM formic acid. Originally, 
each column was converted separately and re-used but later the 
formate form was made in bulk and columns repacked between 
experiments to improve reproducibility. (Bio.Rad now market an 
exchange resin in the formate form which is also reported to 
give good separations (personal communication).) 
Tests of efficiency of the dowex resin packed as 1cm 
diam. x 1cm columns were performed by chromatographing standard 
InsP3 (from Sigma Chemical co. USA) or deacylated 
phosphatidylinosito1(4,5)bisphosphate (Sigma Chemical co. USA) 
and assaying the elution fractions for inorganic phosphate 
using the malachite green assay (see 3.B.9). To monitor the 
functionality of the columns during each experiment, a 
non-saturating concentration of ATP (O.S~lmol.) was loaded with 
each sample and the absorbance of the elutant measured at 260nM. 
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For the InsP 3 separation, 3mL of TCA extracts were 
extracted once with one volume of ether, to remove much of the 
TCA and then neutralized by addition of l.5mL of lM Hepes, 
pH7.0. The sample was loaded onto the column with ATP and 
batch wise eluted according to Lapetina et al. ( 1985): -
Step 
( i ) 
(ii ) 
(ii i ) 
(iv) 
( V) 
(Vi) 
Volume 
( rnL) 
2 X 6mL 
2 X 6mL 
2 X 6mL 
3 X 6mL 
3 X 4mL 
1 X 8mL 
Eluting 
Buffer 
H20 
5mM sodium tetraborate, 
60mM ammonium formate 
0.2M ammonium formate; 
O.lM formate 
0.4M ammonium formate; 
O.lM formate 
l.OM ammonium formate; 
O.lM formate 
1.5M ammonium formate; 
O.lM formate 
Species 
eluted 
inositol 
glycero-
phosphoinositol 
InsP 
InsP2 
InsP3 
I nsP 4? 
This last step (vi) was originally included to wash the 
columns. However, the radioactivity associated with this 
fraction is probably the, since discovered, inositol 
tetrakisphosphate, InsP 4 (Batty et al. (1985)). 
Fractions (v) and (vi) were freeze dried for 48 hours and then 
resolubilized in lmL a2o. Ten millilitres of an aqueous 
scintillant containing 66%(v/v) xylene, 33%(v/v) triton Xll4 
and 0.5%(w/v) 2,5 diphenyloxazole (PPO) were added and the 
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radioactivity assessed by liquid scintillation counting. 
Results were expressed per mg protein. 
For the deacylated lipid samples, the aqueous phase 
was made up to 4.SmL with H2o and O.SmL of 50mM disodium 
tetraborate was added such that the final concentration of 
disodium tetraborate was SmM. Samples were then loaded onto 
Dowex with ATP and eluted as in Downes and Michell (1981) as 
follows:-
Step Volume 
(mL) 
( i) 4 xs 
(ii) 3x6 
(iii) 4x5 
( i V) 3 XS 
Eluting buffer Species eluted 
SmM disodium tetraborate; everything 
0.18M ammonium formate 
0.3M ammonium formate; 
O.lM formate 
0.75M ammonium formate; 
O.lM formate 
1.2M ammonium formate; 
O.lM formate 
except glycero-
phosphoinositol(4) 
phosphate and 
glycerophospho-
inositol(4,5)-
bisphosphate 
glycerophosphoinositol 
-( 4) phosphate 
glycerophosphoinositol 
-(4,S)bisphosphate 
to clean the column. 
Fractions (iii) and (iv) were freeze dried and counted as above. 
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3.B.3 RE-APPRAISAL OF LABELLING MEDIUM: 
It was noted from the decay experiments that the 
extent of incorporation of [ 3H]-inositol into cellular 
membranes was very low with approximately 1% of externally 
added label being incorporated into 10 5 cells within 24 
hours. As reports had indicated that, in some cell types 
glucose competes with inositol for entry into the cell (Green 
and Lattimer (1982); Gillon and Hawthorne (1983)), the effect 
of glucose on inositol incorporation in the HeLa cell system 
was tested. Preliminary experiments with HeLa spinner cultures 
suggested that 5mM glucose in the medium did depress inositol 
incorporation, although the effect was not significant in the 
hybrids. Nevertheless, since cell growth (as assessed by 
doubling time) was unaffected, irrespective of carbon source 
(glucose versus fructose), in the four cell lines examined, a 
minimal essential medium free of inositol and glucose (MEM-G) 
was used for subsequent labelling experiments. (See Appendix 
for composition.) 
3.B.4 KINETICS OF INCORPORATION OF [3H]-INOSITOL INTO 
CELLULAR MEMBRANES: 
cell pairs were plated as replicates in 35mm 
diameter plastic petri dishes at 1 x 10 5 cells/dish in 
Supplemented DMEM. After 24-48 hours the medium was aspirated 
and the cells rinsed with 2mL of the supplemented labelling 
medium, MEM-G (composition given in Appendix). 
The dishes were then either (a) fed with 
supplemented MEM-G and used to obtain cell numbers at the 
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beginning and the end of the timecourse or (b) labelled with 
lmL of a stock solution of supplemented MEM-G containing 
185kBq/mL (5).LCi/mL) of [ 2- 3HJ-inositol (603 GBq/mmol). At 
various timepoints the medium was removed from duplicates an d 
the dishes washed with ice-cold PBS. One mL ice-cold 10% (w/v) 
trichloroacetic acid (TCA) was then added. After 5 minutes on 
ice, the plates were washed with another lmL 10% (w/v) TCA 
followed by lmL H2o. After removal of the H2o wash, the 
lipids were extracted from the TCA precipitate by addition o f 
0.8mL of chloroform:methanol:conc.HCl (100:200:2(v:v:v)). Th is 
lipid extract was transferred to plastic scintillation via ls 
and, after combination with a second 0.8mL chloroform:methano l : 
HCl rinse, lOmL of organic scintillation fluid (100% (v/v) 
xylene, 0.5% (w/v) PPO) were added for liquid scintillation 
counting. 
Therefore, the inositol containing phosphol i pids 
were defined as that proportion of radioactivity which was both 
precipitated by 10% TCA and subsequently extracted by 
chloroform:methanol: conc.HCl (100:200:2(v:v:v)). Th is assumes 
that all membrane phospholipids are precipitated by TCA an d 
recognises that those phosphoinositides covalently bound to 
protein may not be extracted from the precipitate. It has been 
documented that phosphatidylinositol acts as an anchorin g lipid 
for several cell surface proteins such as Thy-1 and 
acetylcholinesterase (Low et al. (1986); cross (1987 )) . 
However, since the orientation of t h e inosi t ol head group is 
facing outside the cell, these inositol lipids are unl ik e ly to 
be involved in the primary signal transduction event. 
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3.B.5 RELATIVE SIZE OF THE TOTAL EXCHANGEABLE INOSITOL 
LIPID STEADY STATE POOLS: 
These experiments were performed in the same way a s 
the kinetic studies except that six replicates/cell line were 
processed when the system had reached equilibrium, at 45-46 
hours. concurrent determinations of cell number were per f o rmed 
on five dishes. 
3.B.6 CELL SURFACE AREA MEASUREMENTS: 
After examining several indices of membrane sur f a ce 
area, the measurement of total membrane palmitate was 
considered the most suitable method for these studies. Cells 
were labelled for 45-46 hours to equilibrium with 3.7kBq/ mL 
(O.lj1Ci/mL) of [1- 14c]-palmitate l.85GBq/mmol; 50mCi/mmol ) 
(from New England Nuclear, USA) in lmL of supplemented MEM-G 
and then processed as in the inositol incorporation exper iments. 
3.B.7 THIN LAYER CHROMATOGRAPHY OF INOSITOL LIPIDS: 
Cells were grown on 35x9mm glass rectangula r 
coverslips in supplement DMEM and labelled for 48 hours in 
supplemented MEM-G containing 185kBq/mL (~Ci /mL) [2 - 3H]-myo 
inositol. After labelling, the slips were washed X 6 i n PBS at 
room temperature and the cellular lipids extracted i n a manner 
similar to that outlined by Billah and Lapetina (1982 ) and 
modified by Damian Myers (personal communication). Cel ls were 
incubated for 1 hour at room temperature in 4 mL of 
CHC13:MeOH:0.83M HCl (9:7:2(v:v:v)) under N2. The 
chloroform extract was transferred to a clean tube and 1 . 12 mL 
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of 2M KCL was added. The solutions were vortexed for 5 seconds 
at maximum speed and centrifuged at 5000 g for 5 min in a bench 
top centrifuge to facilitate phase separation. The lower phase 
was collected and the upper aqueous phase washed with 2.2mL of 
CHC1 2 :MeOH:0.83M HCl (9:7:2(v:v:v)). The lower phases were 
combined and after addition of~ 5;<.Ag of bovine brain 
phosphoinositides (Sigma Chemical co. USA) were dried down 
under N2 . Samples were resuspended in S~uL of CHcl 3 :MeOH: 
0.83N HCl (9:7:2(v:v:v)), 30~L of which were applied to a 
10x20 cm Silica 60F 254 thin layer chromatography plate 
(Merck; Germany) which had been previously soaked overnight in 
1% (w/v) potassium oxalate; 2mM ethylenediaminetetraacetic acid 
(EDTA) in MeOH:H2o (2:3(v:v)) and heat activated in a dry 
oven at 100° for 1 hour prior to use. Samples were then 
developed with authentic standards (phosphatidylinositol (PI); 
phosphatidylinositol(4)phosphate (PIP); phosphatidylinositol-
(4,5)bisphosphate (PIP 2 ) and phosphatidate - all from Sigma 
Chemical co. USA) in a paper lined chromatography tank using 
the solvent system CHC1 3 :Acetone:MeOH:acetic acid: H2o 
(40:15:13:12:8 (v:v:v:v:v)) as in Jolles, et al. (1981). The 
plates were air dried and the phospholipids visualized with 
iodine vapour. The appropriate spots were scraped from the 
plate into scintillation vials. After combination with O.SmL 
H2o and O.SmL MeOH, 10 mL of aqueous scintillant, 
(composition outlined previously) was added and radioactivity 
determined by liquid scintillation counting. 
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3.B.8 HIGH PERFORMANCE LIQUID CHROMATOGRAPH OF INOSITOL 
PHOSPHATES: 
Cells grown in 75cm2 tissue culture flasks were 
labelled for 72 hours in supplemented MEM-G containing 
185kBq/mL (S~CCi/mL) [2-3H]-myo inositol. At the end of the 
labelling period the medium was rapidly removed and the cells 
washed with lxSOmL normal saline (4°C). Cells were lysed with 
lOmL of ice-cold 10% (w/v) TCA and left on ice for 10 min. 
After removal of the TCA the flasks were washed with a further 
SmL of 10% (w/v) TCA and the combined TCA solutions were 
extracted x6 with ether (analytical grade not anaesthetic 
quality). The ether was removed by bubbling N2 through the 
solution and the samples were neutralized with lM Trizma Base. 
0.2mM mannitol was added and the samples freeze dried, after 
which they were stored at -20°C prior to use. cell number 
determinations were made from flasks grown in parallel in 
unlabelled MEM-G for the 72 hour period. 
Inositol phosphates were separated by anion exchange 
chromatography using a Partisil SAX column from Activon (USA) 
and a Waters high performance liquid chromatography (HPLC) 
system. The buffer system used was H2o (buffer A) and 1.7M 
NH 4 formate, pH 3.7 with orthophosphoric acid (buffer B) as 
in Batty et a 1 . ( 19 8 5 ) . Buff er s were f i 1 t ere d ( O . 4 5 p m po r e 
size; Millipore HV) and de-gassed and the column washed with 
buffer Bat the beginning of each chromatography session. 
Before loading the sample the column was equilibrated with 1% 
buffer B to minimize fluxes due to a change in pH at the onset 
of the gradient. Samples (500-80g;«L) which had been 
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resolubilized in H2o were loaded onto the column with lO~M 
ATP/ADP and AMP and eluted with a linear gradient of NH 4 
formate over 50 min. at lmL/min as outlined below. Elutions 
were monitored at 254nm and fractions collected every 30 second 
from minute 3 to 55 directly into scintillation vials. 
Time (min) Flow (mL/min) % A % B curve* 
0 1 99 1 6 
5 1 99 1 6 55 1 12 88 6 
60 1 12 88 6 
* (Designates a linear gradient on the Waters' system) 
Six mL of standard aqueous scintillant were added to 
fractions corresponding to minute 3-30 and the high performance 
commercially available scintillant, Aquasol (NEN-Du Pont, USA) 
was used for fractions 30.5-55 min. 500~1 of H2o was added 
to each vial to prevent clouding of the scintillant due to the 
presence of high salt. Radioactivity was assessed by liquid 
scintillation counting. 
3.B.9 PROTEIN AND INORGANIC PHOSPHATE DETERMINATIONS: 
Protein determinations of TCA precipitates of 
cellular material were performed using a modified Lowry Method 
as out 1 in e d or i gin a 11 y i n Lowry et a 1 . ( 19 51 ) . 
Briefly, TCA precipitates were collected by 
centrifugation at 10 OOOg, 15 min. and resuspended in lOO)AL 
lM NaOH. After addition of lmL of solution c (prepared just 
prior to use by the cornb_ination of 2 volumes of 1% (w/v) 
cu2so4 ; 1% (w/v) NaK tartrate with 100 volumes of 2% (w/v) 
Na 2co3 ), solutions were incubated at room temperature (RT) 
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for 10 min. 10),lL Folin-Ciocalteu reagent (BDH Chemicals Pty. 
Ltd. Aust.), diluted l:3(v:v) was added with thorough mixing 
and the solutions incubated for a further 30 min. at RT before 
measurement of spectrophotometric absorption at 750nm. Protein 
standards were concurrently prepared in the range 0-lO~g using 
lmg/mL bovine serum albumin (BSA fraction 5) (Armour 
Pharmaceutical Co. UK) in lM NaOH. 
Inorganic phosphate determinations of Dowex column 
elutions were performed according to the method of Stull and 
Buss (1977); Itaya and Ui (1966). Fifty microlitres (50/ llL) of 
column elutions were transferred to Pyrex tubes which had been 
washed (as was all glassware) in 6M HCl. Twenty-five 
microlitres (25.)-lL) of 10% (w/v) MgNo3 .6H2H in 95% (v/v) 
absolute ethanol was added and the samples ashed to liberate 
inorganic phosphate. This was performed in a fume hood and 
achieved by gentle hating, over a blue gas flame, until no 
further brown fumes had been emitted and the sample had formed 
a grey-white precipitate (note that black precipitates give 
spurious results). The precipitate was dissolved in 7501l.l.L 1.2M 
HCl and 250;UL malachite green solution added. This latter 
solution, made just prior .to use, contained 1 volume 10% (w/v) 
(NH 4 ) 6 Moo24 .4H2o in 4M HCl (molybdate dissolved in 
H2o prior to addition of acid) with 3 volumes 0.2% (w/v) 
malachite green (Sigma Chemical co., USA) and was filtered 
before use. Absorbance at 660nm was monitored immediately after 
addition of malachite green solution and readings were taken 
when absorbance had reached a plateau. Standard phosphate 
measurements in the 0-SOnmol range were concurrently performed 
with lmM KH2P04. 
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3.C RESULTS AND DISCUSSION 
3.C.l. DECAY EXPERIMENTS: 
Originally, it was planned to examine the metabolism 
of the phosphoinositides in the different cell types after long 
term labelling with [ 3H]-inositol by monitoring the 
serum-stimulated decay of phosphatidylinositol bisphosphate 
(PIP 2 ) from the membrane and the subsequent production of 
inositol trisphosphate(s) (InsP3 ) after transfer of the cells 
to unlabelled medium. 
Preliminary studies, in which the total inositol 
lipid pools were monitored (by measuring the trichloroacetic 
acid precipitable radioactivity at different timepoints), 
indicated that the size of the labelled phosphoinositide pool 
did not decay within the first 30 min of label removal and 
oscillated around a fixed value for the next four hours see 
figure 3.1. Addition of lOmM LiCl in to unlabelled medium to 
prevent re-synthesis of the phosphoinositides from the 
metabolized inositol phosphates did not alter the pattern of 
oscillations. It was assumed, therefore, that there was a large 
intracellular pool of free inositol (reported by others 
Jackowski et al. (1986) and so a single measurement was made 
after the removal of the radiolabelled medium but no further 
measurements were made until the cells had spent 1 hour in an 
unlabelled medium in an attempt to deplete the intracellular 
store of free inositol. 
When the decay of the individual phospholipid PIP 2 
was examined, oscillations were also found and despite numerous 
110 
experiments, no reliable measurement for membrane decay could 
be obtained (see figure 3.1). The pattern of oscillations 
varied between experiments, possibly due to the asynchrony of 
the cell population which would not be reproducible from one 
set of experiments to another. A number of controls were 
performed to assess the reproducibility of the experimental 
techniques but none could compensate for the fluctuations. The 
efficiency of the deacylation procedure was checked using 
standard PIP2 , the subsequent partitioning into the aqueous 
phase of which was monitored using inorganic phosphate 
determinations. The functionality of the Dowex columns was 
assessed by monitoring the elution of standard InsP 3 and 
deacylated PIP2 and during each experiment, by monitoring the 
elution of ATP. Neither of these factors were responsible for 
the oscillations. The lipid extraction procedure was also not 
the source of variation as the fluctuations between timepoints 
seen in the total chloroform extract, did not mirror those of 
the isolated PIP2 . It is possible, given the report by Gumber 
and Lowenstein (1986) indicating that, in a mixture of 
chloroform, methanol and H2o, phosphatidylinositol phosphate 
(PIP), PIP 2 and phosphatidic acid undergo non-enzymic 
phosphorylations in the presence of bivalent metal ions, that 
variations in the present study may have occurred between the 
extraction and deacylation steps. However, in order for this to 
explain the observed variations, it would also have to be 
assumed that this reaction was not uniform between timepoints. 
The observed oscillations in PIP 2 levels in the 
hybrids could be explained from a biological viewpoint by the 
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FIGURE 3.1 
DECAY OF THE PHOSPHOINOSITIDES 
A 
l(XX) 
0 -1---......----------T"----r----r--~----1 
0 100 400 
Time after label removal (min) 
B 
3(XX) --------------------. 
0 -+------------T"-----r-------1 
0 100 200 
Time after label removal (min) 
Results demonstrate the level of l3 HJ-inositol remaining 
in the total phosphoinositide pool (graph A) or as 
phosphatidylinositol bisphosphate (PIP 2 ) (graph B) after 
removal of the label.Results represent single separate 
experiments. 
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existence of multiple metabolic pools of PIP 2 which 
interchange slowly with other inositol containing lipids. A 
rapid interchange between the phosphoinosides mediated by 
phosphorylation-dephosphorylation reactions has been well 
documented (futile cycles see diag. 1.3). However, this 
interchange is rapid and is unlikely to be the cause of the 
fluctuations in the hybrid data. Instead, some additional long 
term exchange would need to be proposed, possibly involving the 
flipping of the parent molecule, phosphatidylinositol (PI), 
from the outer to the inner leaflet of the membrane, a 
phenomenon which has been shown to be mediated by specific 
tr an sf er pr o t e in s ( He 1 mk amp ( 19 8 5 ) ) . 
The results examining the production of InsP 3 over 
the same timecourse were also variable and in no case showed a 
decay (data not shown). In some experiments these values 
oscillated which, as assessed by the relative levels of the 
other inositol phosphates, was due to metabolism of InsP 3 . 
Whether this occurred invivo or after isolation was not 
determined. These measurements mean very little in terms of the 
dynamics of receptor driven production of InsP 3 , because the 
dowex columns do not allow a determination of the identity of 
the trisphosphate isomer present (Ins(l,4,5)P 3 or 
Ins(l,3,4)P3 ) (Burgess (1985)). Moreover, it is now apparent 
that the calcium mobilizing isomer Ins(l,4,5)P 3 is not only 
metabolized within a minute of its production but also that its 
formation may not be continuous, even in the constant presence 
of an agonist (Irvine et al. (1985), Burgess et al. (1985)). 
Therefore, the measurements being made during the hybrid study 
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more accurately represent the steady-state levels of rP 3 over 
that time period. The fact that the levels of radiolabelled 
IP3 changed very little over the 3 hours, suggested either 
that the pool of PIP 2 which is cleaved to produce IP 3 has 
approximately the same specific activity over that entire 
period, or that the metabolism of the inositol trisphosphate 
(Ins(l,3,4)P3 is very slow in the hybrids. The size of the 
steady state Ins(l,4,5)P3 pool in the different cell types is 
important and will be addressed in section 3.1.6. 
The observation that there was no notable decay of 
the PIP2 levels over the time period examined may indicate 
that the r~ceptor driven PIP 2 pool is small in comparison to 
the total PIP 2 pool. Alternatively the phosphoinositide 
pathway may not be involved in the maintenance of serum 
stimulated continuous cell growth in the somatic cell hybrids 
(in support of this see Tones et al. (1988)). It was apparent 
that the fluctuations in experimental data did not permit 
reliable interpretation of PIP 2 decay rate. To complement the 
data an associated study of the incorporation of [ 3H]-myo 
inositol into the total phosphoinositide pool was undertaken. 
3.C.2 KINETICS OF INCORPORATION OF [ 3H]-INOSITOL INTO 
CELLULAR MEMBRANES: 
The rate of incorporation of [ 3H]-inositol into 
the cell membranes of two cell hybrid pairs and the cell lines 
representing their parents were examined and composite graphs 
of their incorporation kinetics are depicted in figure · 3.2. 
A comparison of the parental cell lines was included as a 
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FIGURE 3.2 
KINETICS OF INCORPORATION OF INOSITOL 
INTO THE PHOSPHOINOSITIDES 
A: SE/SL >-- 8: 39E/ESH 
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The kinetics of incorporation of [ 1IJ-inositol into the total 
phosphoinositide pools of the non-tumourigenic ( D) and 
tumourigenic ( 0) cells were assessed over the time periods 
indicated. Panels A, B, and D pertain to hybrid pairs and 
panel C concerns the parental lines. Panels A, C and D depict 
results from a single typical experiment. Panel Bis a 
composite of two experiments. The bars denote the range of each 
point. If no bar is seen, its dimensions are exceeded by that of 
the point symbol. 
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potential means of assessing whether a failure to note a 
difference between the transformed and tumourigenic hybrids may 
be due to the alteration having already occurred during the 
transition from the normal to the transformed state. 
From figure 3.2, it can be seen that all the cell 
lines reached equilibrium by approximately 30 hrs. This 
timecourse seemed slow, particularly considering a report in 
freshly isolated hepatocytes ( Thomas et al. ( 19 84) ) and islets 
of Langerhans (Montague et al. (1985)) which indicated that the 
--
incorporation of 3H into inositol lipids had reached a 
plateau by 90 min. rt waa of concern that even in the 
continuous.- presence of s:erum, th e .. inositol head group of the 
phosphonos:itide-a wa.s no,t being readily metabolized in the 
tissue culture: 1.ines,.,_ However, since then it. has been confirmed 
by others; tha.t manif c·e:·lls in culture, includ ing pancrea tic 
islets (Bidern et. a-l •. (1987a)) and NIH 3TJ cells (Fleischman et 
--
a 1 . ( 19 8 6. ) ) al s:o. requi.r e ov e r 2 4 hour s lab e 11 in g with 
[ 3H]-inosito l to reach isotopic equilibrium. Since it has 
been established that the mitogenic stimulation of many of 
these cell Iine.s does involve PIP 2 breakdown, a plausible 
reason for the slow kinetics is that the receptor coupled 
phosphoinositide pool is small in comparison _ to that of the 
total phosphoinositides (eg creba et al. (1983)) and that the 
turnover of this minor receptor-coupled subclass of 
phosphoinositides is the primary means by which the headgroup 
of these lipids is exchanged. If this assumption, (that the 
receptor-coupled phosphoinositide pool is small and is solely 
responsible for phosphoinositide metabolism) is true then the 
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inferred rate of decay of the entire phosphoinositide pool in 
the presence of serum would reflect that of receptor-coupled 
PIP 2 . 
A comparison between the hybrid cells (panels A & B) 
of the kinetics of incorporation indicated that there was very 
little difference in the kinetics of incorporation between the 
transformed and tumourigenic cell lines. Moreover, a detailed 
study of the initial rates of incorporation in the 39EC13 and 
ESH39 pair (panel D) indicated that there was no difference at 
all between cell types. 
It could be inferred indirectly from this that the rate of 
decay of the phosphoinositides would also be very similar, an 
assumption which would be strengthened by conformation of the 
steady state pool sizes (see next section) . 
Examination of the kinetics of incorporat i on of the 
parental lines D98AH2 and MRC-5 (panel C) indicated, somewhat 
surprisingly, that the fibroblast line greatly exceeded the 
tumourigenic HeLa line in both the initial rate of inositol 
incorporation and the steady state membrane level. However, the 
factor by which both parameters differed was approximately the 
same, suggesting that if the values were normalised against 
some parameter other than cell number then the incorporation 
kinetics for these lines could also be superimposed, implying 
that the rate of breakdown in the normal and turnourigenic cells 
is also the same. It is recognized that in the case of the 
parental lines, the comparison is being made between cells of 
vastly different morphology and therefore any alterations in 
phosphoinositide metabolism generated by an alteration in 
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growth regulation may be obscured by differences in cell type. 
However, it has been reported that steady state levels of 
PIP2 and diacyglycerol were very similar in non-transformed 
cells originating from different tissues and species. 
( F 1 e i sch man et a 1 . ( 19 8 6 ) ) . 
It could be argued that the failure to note an 
appreciable difference in the metabolism of the 
phosph oinositide pool, in any of the cells examined, may be 
because the measurement of the total inositol lipid pool is too 
insensiti ve to reveal the types of specific changes in 
phosphoinositide metabolism, which are associated with its role 
in signal transduction. In defence of this, however, studies 
examining phosphoinositide metabolism in normal and transformed 
or tumourigenic eel.ls have reported substantial alteration in 
the levels· of phaspha tidyl inositol (PI) ( Kubota et al. ( 19 8 6) 
and by vir tue o,f the large contribution PI makes to the 
inositol containing lipids (Jackowski et al. (1986)) such 
changes would be detected in the present study of total 
phosphoinosi tides. In addition, more direct evidence that 
changes in the levels of the PIP 2 pool are reflected by total 
phosphoinositide measurements in the hybrids is given in 
section 3.C.6. 
3.C.3 RELATIVE SIZE OF THE TOTAL EXCHANGEABLE INOSITOL 
LIPID STEADY STATE POOLS: 
As a number of studies have examined the steady 
state levels of the phosphoinositides in transformed and 
un-transformed cells (Fleischman et al. (1986); Jackowski et 
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al. (1986)) it was considered appropriate to verify the 
relative size of such pools in the different somatic cell 
hybrids (see table 3.1). Six replicates were processed for each 
cell line after extensive labelling (45 hours). Statistical 
analysis of intra as well as inter experimental variation was 
obtained after consultation with Mr R. Cunningham (Statistics 
Department, Australian National University, Canberra, 2601, 
Australia). Because the ratio of membrane inositol 
content/10 5 cells of the non-tumourigenic to tumourigenic 
cells was examined, data was converted to logarithmic (log.) 
values before assessment, in order to approximate a normal 
distribution. All statistical analysis was performed on the 
log. transformed data, which is why, after conversion back to 
scalars, confidence limits were presented rather than standard 
error values. 
It was found that there was no significant 
difference between ·the pool size of the hybrid pairs SE and SL 
or 39EC13 and ESH39, indicating that, as a generalized 
phenomena, the assumption of the tumourigenic phenotype is not 
accompanied by an alteration in total phosphoinositide levels 
in the somatic cell hybrid system. However, there was a highly 
significant difference between the pool size of the 
cn 2B1col 1 and 5A7mp hybrids _and both fibroblast lines 
were significantly different from the D98AH 2 HeLa derivative. 
However, the kinetic studies with the D98AH 2 and MRC-5 lines 
(Fig 3.2) indicated that an increased incorporation rate in the 
fibroblasts was sufficient to explain the differences in total 
pool size. This elevated incorporation rate might have been due 
............ 
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TABLE 3.1 
RELATIVE STEADY STATE PHOSPHOINOSITIDE LEVELS PER CELL 
Cell pair 
SE/SL 
39EC13/ESH39 
A 183/D98AH2 
MRC-5/D98AH2 
Ratio of non-tumourigenic/tumourigenic 
steady state phosphoinositide pools 
A B C 
0.93 
1. 11 
1.14** 
1. 70* 
2. 50* 
(0.81 , 1 .07) 
(1 .00 , 1.23) 
(1 .09 , 1.21) 
(1 .55 , 1.87) 
(2.04 , 3.05) 
[5] 
[5] 
[3] 
[2] 
[2] 
Non-tumourigenic and tumourigenic cells were labelled for an 
extended eriod with [3H]-inositol (as in 3.8.5) and determinations 
of the steady state levels of total exhangable phosphoinositides per 
cell were made concurrently within a cell pair. Mean ratios of non-
tumourigenic to tumourigenic steady state pools are presented (column A) with 95°/o confidence intervals (column B) and number of 
experiments (column C). Statistical analysis was performed as 
outlined in Section 3.C.3. A two-sided Students t-test was used to 
assess significance *p<0.05, **p<0.01. 
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to an alteration in the activity of enzymes associated with the 
incorporation of the inositol head group but it might also have 
resulted from a physical dissimilarity between the cells. 
Because there is a perceptible size difference between the 
fibroblast and D98AH 2 cells f a measure of cell surface areas 
was made in order to assess whether disparity in the steady 
state pool sizes could be accounted for in this way. 
3.C.4. RELATIVE CELL SURFACE AREAS OF THE CELL PAIRS: 
Studies by Dr D. McKinnon (personal communication) 
using electron microscopy have indicated that the plasma 
membrane of the tumourigenic hybrids has many more microvilli 
than that of their transformed pairs, which would render 
misleading standard cell size measurements such as cell 
diameter. Therefore, what was required was a suitable index of 
membrane surface area which was both evenly distributed in the 
membrane and unlikely to be modified in its distribution by the 
assumpti o o f the tumourigenic phenotype. 
Palmitate was chosen as the parameter to be measured 
(see details in methods) since it is universally distributed in 
membranes and literature searches failed to find a correlation 
between an alteration in this molecule and tumourigenesis. 
Another advantage of this parameter was that it could be 
measured using an experimental protocol very similar to that 
used for the inositol lipids, therefore providing a suitable 
experimental control. 
Preliminary kinetic experiments were performed and 
it was found that membrane palmitate levels, like those of 
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inositol, had reached equilibrium by 30 hours (fig. 3.3). 
Originally, dual label experiments were performed in order to 
obtain a ratio of membrane inositol to palmitate from the one 
dish of cells. However, it was found that, due to the quenching 
effects of the extraction system, the 14c energy profile was 
shifted so far to the left that it completely eclipsed the 3H 
profile, making the distinction of the two isotopes impossible. 
Therefore, relative palmitate levels were determined in 
separate experiments which, as discussed later, may have some 
bearing on the interpretation of results. 
Relative palmitate values are given in table 3.2. 
The confidence intervals and statistical assessment associated 
with each measurement were obtained in the same way as those 
for the inositol val ues. It was found that all non-tumourigenic 
lines had, on average, more membrane area than their 
tumourigen i c partners but that, in the case of the 5E/5L pair, 
this difference was not ·significant. This finding was 
surprising considering that it was the tumourigenic cell lines 
which showed a greater number of membrane protrusions but it 
was also interesting in the context of the inositol data. 
Also tabulated are relative total cell protein 
values. These values were obtained by Dr Gowing and used as an 
index of cell size in her study on the actin content of the 
cell hybrids (Gowing et al. (1984)). They are presented here 
with her permission, to illustrate that the interpretation 
placed on the relative inositol values may vary, depending on 
the selection of the parameter by which they are adjusted. 
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FIGURE 3.3 
KINETICS OF INCORPORATION OF PALMITATE 
INTO CELLULAR MEMBRANES 
m 
o-a---- - ------------4 
0 10 ID 
Labelling time (hr) 
Results represent a typical experiment monitoring 
incorporation of [14 C]-palmitate into cellular membranes 
(as outlined in 3.B.6) in transformed (• ) and tumourigenic 
(, ) hybrids. Each point represents duplicate determinations. 
Cell pair 
SE/SL 
39EC13/ESH39 
A 183/D98AH2 
MRC-5/D98AH2 
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TABLE 3.2 
RELATIVE CELL SIZE MEASUREMENTS 
Ratio of non-tumourigenic/tumourigenic 
membrane palmitate total cell protein 
A 8 
1 . 1 6 (0.98 , 1.38) 
1. 3 2 * (1.07 , 1.64) 
1 m 88 * (1 .54 , 2.31) 
3 .. 18* (2.45 , 4.12) 
2. 74 * (2.02 , 3. 72) 
C 
[4] 
[5] 
[3] 
[2] 
[2] 
D 
1.00 
0.99 
0.82 
nd 
1.42 
Relative membrane surface areas for the non-tumourigenic and 
tumourigenic cell pairs were obtained in the present study by 
comparing the steady state levels of cellular palmitate (see 3.8.6). 
Ratios of the non-tumourigenic to tumourigenic cells are presented (column A) with 95°/o confidence intervals (column 8) and number of 
experiments (column C). Statistical analysis was performed as 
outlined in Section 3.C.3. A two-sided Students t-test was used to 
assess significance *p<0.05. Data for relative total cellular protein (column D) was obtained by Dr L Gowing. 
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3.C.5 RELATIVE PHOSPHOINOSITIDE STEADY STATE POOL SIZES 
CORRECTED FOR CELL SURFACE AREA: 
When the relative inositol values were corrected for 
membrane palmitate content, it was found. that the ratio of the 
inositol content per unit membrane of the non-tumourigenic to 
tumourigenic cells (table 3.3) was less than unity in each 
case. This would imply that there is an association between the 
assumption of the tumourigenic phenotype and an elevated level 
of inositol lipids per unit membrane. However, from confidence 
intervals obtained by taking the square root of the sum of the 
variance of the separate inositol and palmitate ratios, it was 
found that there is no significant difference in the inositol 
content per unit membrane either within the hybrid pair 
39EC13/ESH39 or between the parental lines MRC-5 and D98AH 2 . 
conversely, the value 1 is not strictly within the 95% 
confidence limit for the SE/SL pair even though neither the 
inositol nor palmitate ratios were found to differ 
significantly. 
However, for every cell pair, at least one 
experiment was performed whereby relative inositol and 
palmitate values were determined in parallel. Multiple 
replicates of both cell lines within a pair were plated and 
concurrently labelled with either inositol or palmitate for the 
45 hours. In these cases, the ratio of membrane inositol to 
palmitate content of the non-tumourigenic to tumourigenic cells 
was always less than one. This indicates, that the assumption 
of the tumourigenic phenotype may, indeed, be associated with 
elevated levels of inositol lipids per unit membrane and that 
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TABLE 3.3 
RELATIVE PHOSPHOINOSITIDE LEVELS PER UNIT MEMBRANE 
Cell pair 
SE/SL 
39EC13/ESH39 
A 183/098AH2 
M RC-5/D98AH2 
Ratio of non-tumourigenic/tumourigenic 
total phosphoinositides per membrane palmitate 
A B 
0.80 (0.64 , 0.99) 
Oa83 (0.66 , 1.06) 
0 . 61 (0.49 , 0.74) 
0. 91 (0.63 , 1.31) 
0.53 (0.41, 0.70) 
Determination of the relative phosphoinositide levels per unit 
membrane in the non-tumourigenic and tumourigenic cells (column 
A) was made by dividing the mean ratio for the phosphoinositides (Table 3.1) by that for relative membrane palmitate (Table 3.2). 95°/o 
confidence intervals (column B) were obtained as stated in 3.C.5. 
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the failure to show a statistical difference is attributable to 
some factor which varies between experiments, generating larger 
deviation in absolute values than the differences between the 
cell types. 
One factor which did differ between experiments was 
cell density. Although both cell lines within a pair were 
always assayed on the same day and plated at the same density, 
the total cell number per dish in experiments occurring on 
different days, varied slightly due to differences in plating 
efficiency and the time in culture before adding radio label. 
Wnen the amount of radio label incorporated into 10 5 cells by 
45 hours was monitored at different cell densities, it was 
found that both the membrane inositol and palmitate levels 
decreased as cell densi t y increased (see Fig. 3.4). This 
phenomenon was seen for both the transformed and tumourigenic 
lines and did not differ between cell types. Because both 
inositol and palmitate values were affected, it was unlikely 
that the effect was related to the role of the inositol lipids 
in mitogenic signal transduction but was more likely due to 
some nutritional or spatial constraint. 
It should be noted that there 1s no strong 
statistical evidence for the proposal that tumourigenesis is 
associated with an elevated level of inositol lipids per unit 
membrane. In fact, if membrane inositol content was corrected 
for total cellular protein instead of membrane palmitate, then 
the association would completely disappear. However, the idea 
is intriguing, particularly if it is to be postulated that a 
change in phosphoinositide metabolism occurs during the 
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FIGURE 3.4 
EFFECT OF CELL DENSITY ON INOSITOL AND 
PALMITATE INCORPORATION INTO CELLULAR 
MEMBRANES 
20 
10 
0 ~----------.~---------.----j 
0. 0 0 0. 2 0 0. 4 0 0. 60 0. 8 0 
Cell density (105 cells/cm2) -
Results represent typical experiments indicating how 
the steady state levels of [3 H]-inositol ( • ) and 
[1 4 C]-palmitate ( t:1 ), incorporated into cellular 
membranes varies as a function of cell density. Each 
point was obtained from duplicate determinations , 
the range of which are denoted by bars. 
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transition from the transformed to the tumourigenic, phenotype 
and suggests that the nature of the change at this level of 
growth control is more subtle than a simple overproduction of 
an initiating mitogenic signal. 
Perhaps, instead of a continuous overproduction of 
second messengers, the rate of phosphoinositide metabolism in 
tumourigenic cells is altered as a function of differing levels 
of growth factor stimulation, such that, even when external 
growth stimuli are absent or at suboptimal levels, the 
magnitude of phosphoinositide turnover is identical to that of 
a maximally stimulated cell. The experimental protocol had not 
addressed this point since all experiments were performed in 
the presence of sufficient growth factors, supplied as serum, 
to produce a maximal mitogenic response. It could be proposed, 
however, that an elevated level of phosphoinositides per unit 
membrane in the tumourigenic line would allow greater 
opportunity for receptor-transducer coupling and, therefore, 
the potential to be more responsive to external growth signals. 
This is an important point since tumourigenicity is defined in 
an in vivo context where the actual level of growth stimulation 
from minute to minute is, as yet, unknown. 
This idea was investigated by examining the growth 
of the cell hybrid pair 39EC13/ESH39 in medium containing 
different concentrations of serum (see figure 3.5). However, 
there was no serum concentration below which the growth of the 
transformed cell line was inhibited compared with its 
tumourigenic partner and this approach was not pursued further. 
Obviously such studies were preliminary and investigations 
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FIGURE 3.5 
EFFECTS OF SERUM CONCENTRATION ON CELL GROWTH 
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Comparison of the rates of growth of the 
tumourigenic ( } and non-tumourigenic ( .... .... .... .... ) hybrid 
pair, 39EC13 / ESH39 in medium containing different 
concentrations of serum, as indicated. Each point represents 
the average of two measurements, the range of values 
being denoted by bars. Comparative growth studies 
were also performed at serum concentrations (v/v) of 0.2°/o, 
O.So/o, 0.75°/o and 1.3°/o with similar results. 
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involving the systematic variation of purified growth factors 
may demonstrate a level of external growth stimulation at which 
the mitogenic response of the tumourigenic cells is superior. 
However, the interpretation of the relevance of such findings 
to tumourigenic expression in vivo would be complex, and from 
the preliminary experiments performed with whole serum, it was 
concluded that, if the perceived increase in phosphoinositide 
levels per unit membrane in the tumourigenic cells was real, it 
did not provide a selective advantage in terms of the serum 
stimulated mitogenic response in such cells. 
3.C.6. THE RELATIONSHIP BETWEEN TOTAL PHOSPHOINOSITIDE 
LEVELS AND THOSE PHOSPHOINOSITIDES ASSOCIATED WITH SIGNAL 
TRANSDUCTION: 
In order to verify the relevance of the data 
concerning the total inositol lipid pool to that proportion of 
phosphoinositides involved in signal transduction, it was 
decided to examine the active participants in receptor-driven 
phosphoinositide hydrolysis. Steady state levels of the 
individual inositol lipids were determined in the hybrids after 
separation by thin layer chromatography. It was found that the 
ratio of PI to PIP2 from 5 separate experiments was 4.2+0.76 
and 5.3+1.3 (mean+ standard error) for the transformed and 
tumourigenic cell types respectively. These values were not 
significantly different (P > 0.4), indicating that the relative 
kinetics and pool size behaviour of the PIP2 pool mirrors 
that of the total phosphoinositide pool. However, several 
studies in erythrocytes (Muller et al. (1986)) and platelets 
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(Vickers et al. (1986)) have indicated that there are multiple 
metabolic pools of PIP 2 , not all of which are likely to be 
involved in signal transduction (a finding supported by the 
decay experiments in the hybrids). Therefore, it was decided to 
complement the steady-state lipid data with an examination of 
the inositol phosphates. 
After labelling the hybrid pairs with [ 3H] 
inositol for an extended period (72 hours) in serum 
supplemented medium, the cells were lysed and their 
aqueous-soluble inositol phosphates extracted for separation by 
high performance liquid chromatography (HPLC). A typical 
profile is given in Figure 3.6. The calcium-mobilizing inositol 
trisphosphate isomer, inositol{l,4,5)trisphosphate 
(Ins{l,4,5)P3 ), was identified as that radioactive peak which 
co-chromatographed with a tritiated authentic Ins{l,4,5)P3 
standard. Inositol{l 1 3,4)trisphosphate {Ins{l,3,4)P3 ) eluted 
just prior to this within half a minute of the standard 
adenosine triphosphate (ATP) {as reported, (Lew et al. 1986). 
Although complete baseline resolution of these 
isomers has been reported previously (Irvine et al. (1985); Lew 
et al. (1986); Burgess et al. (1985)), such resolution was not 
achieved in the present study despite numerous modifications to 
the gradient system. Identification of the other peaks is 
tentative as authentic standards for inositol bisphosphate 
{InsP 2 ) and inositol monophosphate (InsP) were not 
chromatographed. Free inositol was chromatographed and eluted 
in the void volume at the position corresponding to the large 
initial peak. Peaks two and three though possibly 
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FIGURE 3.6 
SEPARATION AND QUANTITATION OF THE INOSITOL PHOSPHATES 
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Steady state levels of inositol phosphates in the transformed 
(Tr) and tumourigenic (Tu) cell hybrids were determined after 
separation by HPLC, as outlined in 3.B.8. A typical column 
profile is presented, as are results for the levels of the two 
isomers of inositol trisphosphate. Comparison of the levels of 
these isomers between the transformed and tumourigenic 
hybrids, using the two-sided Students t-test indicated that 
differences between lines were not significant. 
--
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glyceroinositol phosphates, are assumed to be InsP 1 and 
InsP 2 on the basis of their elution positions in relation to 
adenosine monophosphate (AMP) and adenosine diphosphate (ADP) 
(Irvine et al. (1985)). 
The inositol trisphosphates (InsP 3 ) form a minor 
part of the total cellular inositol phosphates. (A finding also 
observed in o the r c e 11 sys t ems ( Be st et a 1 . ( 19 8 7 ) ; Hansen et 
al. (1986)), which is consistent with the ability of these 
compounds to be biologically active at low concentrations. It 
is difficult, however, to assess the functioning of the 
phosphoinositide pathway in the serum stimulated hybrids from 
these values alone. This is because in the hybrid study, 
comparisons were made between different types of equally 
stimulated cells, as opposed to single cell populations after 
different levels of stimulation. Appropriate negative controls 
were not readily available due to the inability of the hybrids 
to be growth arrested. Quiescent fibroblasts were considered an 
unsuitable control due to the observed size difference 
(affecting total phosphoinositide pools) between cells. 
Moreover, the presence of the inositol trisphosphate isomers 
does not, in itself, signify that receptor mediated 
phosphoinositide hydrolysis is occurring. Both Ins(l,4,5)P3 
and Ins(l,3,4)P3 have been detected in a number of cells 
prior to stimulation, the levels of which substantially 
increase upon the addition of an agonist. 
current information concerning the agonist-
stimulated production of inositol phosphates indicates severa l 
points about the metabolisms of Ins(l,4,5)P3 and 
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Ins(l,3,4)P 3 which must be considered when interpreting the 
steady state data. The first is that Ins(l,4,5)P 3 is produced 
immediately in response to agonist stimulation but then drops, 
in the majority of reports, within 60 seconds to new steady 
state levels, even in the constant presence of an agonist 
(Burgess et al. (1985)). The extent of the decline varies with 
the cel1 type and the tissue examined (Irvine et al. (1985); 
Burgess et al. (1985): Biden et al. (1987); Hansen et al. 
(1986)) with levels in some cells returning almost to baseline 
(Irvine et al. (1985); Burgess et al. (1985)). This is possibly 
due, not only to the rapid metabolism of Ins(l,4,5)P3 (see 
Majeras et al. (1988)) but also to the reported negative 
feedback loop .involving the inhibition of phospholipase c by 
protein kinase C (Kikuchi et al. ( 1987)). Consequently, in the 
continuous presence of an ,agonist, InsP 3 levels are 
presumably cycling (see Cuthbertson and Cobbold (1985); 
Berridge (1987)). If this is so, the absolute levels of 
InsP 3 , at a given time, are dependent on the temporal 
position of the measurement within the cycle., and therefore 
the values obtained for the population of asynchronously 
proliferating hybrids represent an average of the extremes of 
InsP3 fluctuation. This would explain low levels of InsP 3 
without the need to suggest that the phosphoinositide pathway 
does not function in these cells during serum-stimulated 
proliferation. 
Secondly, some statement about the metabolism of the 
InsP 3 in the hybrids can be made by equating the relative 
levels of the trisphosphate isomers. From agonist stimulated 
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systems it appears that Ins(l,3,4)P3 is formed from 
Ins(l,4,5)P 3 via Ins(l,3,4,5)P4 (Batty et al. (1985)) (see 
Introduction diagram 1.3). It rises within the cell 5 seconds 
after agonist stimulation and in most cells remains elevated 
for some minutes. The relative levels of the isomers in 
stimulated cells varies with the time after stimulation and 
also with the cell type and agonist (Biden et al. (1987); 
Burgess et al. (1985)). However, all evidence indicates that 
the metabolism of Ins(l,4,5)P3 to Ins(l,3,4,5)P 4 is rapid, 
occurring within 10 seconds (Burgess et al. (1985); Biden et 
al. (1987)). It was noted in the hybrid study that there was a 
consistent delay of 90 seconds between removal of the labelling 
medium and TCA precipitation of the cells, a duration which is 
hypothetically sufficient to deplete cells of agonist generated 
Ins(l,4,5)P3 . This is unlikely, however, as it assumes that 
receptor-mediated generation of Ins(l,4,5)P3 ceases 
immediately upon removal of the medium, requiring 
agonist-receptor dissociation to be instantaneous. Moreover, it 
would predict (if, as in other cell types, Ins(l,4,5)P3 was 
metabolized via ·InsP 4 ) that the Ins(l,3,4)P3 isomer would 
predominate over Ins(l,4,S)P3 . Instead, the hybrids displayed 
very similar levels of the isomers in 10 separate 
determinations. Alternatively, the hybrids may metabolize, 
Ins(l,4,5)P3 directly to Ins P2 and not via InsP 4 . This 
possibility is likely since radioactivity eluting at a position 
consistent with InsP 4 was very low or absent in most 
chromatograms. In addition, the peak of radioactivity 
consistent with IP 2 was large. Due to its elution position in 
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relation to ADP it is likely to be the Ins(l,4)P 2 isomer and 
therefore not produced from Ins(l,3,4)P3 . 
A third possibility, which again must be mentioned, 
is that the isomers are at comparable levels because they are 
equivalent to the basal levels detected in other cells, their 
generation being dissociated from signal transduction. 
Experiments were performed to compare InsP 3 levels 
in the transformed and tumourigenic hybrids and results from 
three separate experiments are given in Table 3.4. It could be 
argued that, if anything, the levels of both isomers are 
slightly elevated in the transformed cells. However, these 
differences are minor . Moreover, values were derived from the 
area under the chroma tograms which, as can be seen from the 
magnitude of the values, represent very few radioactive counts 
above background. More experiments will be needed in order to 
establish whether any noted changes lie within the range of the 
experimental error. However, since the InsP 3 levels in the 
different cell types are very similar, it is unlikely that the 
possible metabolism of the InsP 3 during isolation, influences 
the interpretation of relative InsP 3 levels (unless rates of 
metabolism are coordinately altered in the different cell 
types) and it is clear, from the current results, that the 
elevated levels of [ca2+J. reported in the tumourigenic l 
cells (Banyard and Tellam (1985)) are not due to elevated 
steady state levels of Ins(l,4,5)P 3 in these cells. 
3.D RAMIFICATION OF RESULTS 
The results reveal that, during continuous serum 
stimulation, there is no difference in the metabolism of the 
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phosphoinositides between the transformed and tumourigenic HeLa 
X fibroblast human somatic cell hybrids, indicating that, as a 
generalized phenomenon, the maintenance of the tumourigenic 
phenotype does not require an alteration in phosphoinositide 
metabolism. 
This is in contrast to a number of studies examining 
similar parameters to those investigated in the present study. 
such studies have reported an alteration 1n either . PIP 2 :PI 
ratios (Fleischman et al. (1986)), steady state levels of 
InsP3 (Jackowski et al. (1986)) or the metabolism of PI 
(Diringer and Friis (1977), Kubota et al. (1986)) in 
association with viral or chemical transformation. The most 
likely reason for the conflict in findings is due to the 
varying nature of the cell systems usedo 
The human somatic cell hybrid model is an internally 
controlled system in that tumourigenic cells can be generated 
from the non-tumourigenic hybrids without the additional 
treatment of cells with carcinogens or foreign genetic 
material. Their phenotype is stable and their tumourigenicity 
in vivo was checked regularly throughout the course of this 
study. Therefore, phosphoinositide metabolism was assessed in 
the tumourigenic hybrids and their equplly transformed but 
non-tumourigenic partners without the additional complications 
generated by viral infection or non-specific chemical 
carcinogens. Moreover, as tumourigenesis is considered to be a 
multistage process, it 1s possible that the transformed and 
tumourigenic hybrids may be at different relative sub-stages in 
the progression to the tumourigenic process from the cells in 
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the viral and chemical transformation studies. It may be that 
an alteration in the phosphoinositide pathway did occur at an 
initial stage 1n the transition from normal to the fully 
tumourigenic phenotype in the HeLa parent but, if this was the 
case, the present study suggests that the maintenance of the 
altered phenotype does not require continuous repetition of the 
initiating event. 
It should also be noted, however, that there is very 
little difference in the in vitro growth characteristics in 
terms of growth-factor requirements and doubling times between 
the hybrids (Stanbridge et al. (1982), figure 3.4). Although 
there are clear distinctions between the transformed and 
tumourigenic hybrids in vitro (including alterations in the 
cytoskeleton (Der et al. (1981), Gowing et al. (1984)), glucose 
transport (White et al . (1983)) and intracellular free calcium 
(Banyard and Tellam (1985)) which are presumed to relate to 
differences in tumourigenic expression, it may be that the 
effects of the proposed tumour suppressor genes (Stanbridge 
(1985)) upon cell growth are not fully expressed under in vitro 
conditions and that differences in the phosphoinositide 
pathways between the two cell types would be manifested in the 
whole animal where a greater variety of external stimuli may 
arrive at the cell receptors. It is interesting, therefore, 
that the only consistent difference in phosphoinositide 
metabolism within the hybrid pairs was that the levels of 
phosphinosites per unit membrane were elevated in the 
tumourigenic lines, suggesting that they may have greater 
potential for signal transduction under certain growth 
stimulation conditions. 
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Another possibility is that the phosphoinositide 
pathway in the hybrid cells, is altered at a level beyond the 
inital signal transduction event. If the maintenance of the 
tumourigenic state in all cell systems requires a change 1n a 
specific cellular pathway, then, since tumourigenesis in the 
somatic cell hybrids is associated with the loss of genetic 
material rather than the gain of some foreign gene product 
(which may act directly on the pathway), the hybrid cells would 
have to alter the expression of their own proteins to mimic 
that change. From the examination of phosphoinositide 
metabolism in the hybrids, it appears that the enzymes 
associated with the metabolism of PIP 2 and InsP 3 are not 
altered. However, intracellular calcium levels have been 
reported to be altered in the cells (Banyard and Tellum 
(1985)), an effect which may be due to an alteration in 
membrane-located ion channels. It is possibly significant in 
this context that a number of proteins associated with the 
2+ movement of ca across membranes can be altered by the 
activation of protein kinase c (Lagast et al. (1984); Strong et 
al. (1987)), an enzyme which is activated by a metabolite of 
phosphoinositide breakdown. 
PKC has been proposed to have a general regulatory 
role in a number of cell processes (Berridge (1987)), including 
both proliferation and differentiation. As it has been proposed 
that the tumourigenic hybrids do not stop growing in vivo 
because they fail to differentiate (Stanbridge et al. (1983); 
Harris (1985)), it is logical to examine several aspects of the 
enzyme, protein kinase c, in the somatic cell hybrids. This 
work is described in the next chapter. 
CHAPTER 4: 
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PROTEIN KINASE C CONTENT, ACTIVITY AND SUBCELLULAR 
DISTRIBUTION IN THE TRANSFORMED AND TUMOURIGENIC 
CELL HYBRIDS: Investigation of Possible 
De-regulation at the Level of the third Messenger 
4.A INTRODUCTION 
There is no clear association between the assumption 
of the tumourigenic phenotype and an alteration in 
phosphoinositide metabolism in the human somatic cell hybrids 
(see Chapter 3). This does not, however, discount the 
possibility that the phosphoinositide pathway may be disrupted 
in the tumourigenic cells at a level beyond that of the initial 
signal transduction event. 
One of the most intriguing features of the 
phosphoinositide pathway is that two separate second messengers 
are produced from 
(1987)). The rise 
the one signal transduction event (Berridge 
in intracellular free calcium ([ca 2+].) 
. l 
generated by inositol(l,4,S)trisphosphate and the activation of 
protein kinase C (PKC) by 1,2-sn diacylglycerol (DAG) have been 
shown not only to modulate one another but also to act 
synergisticly to generate the growth response (see Introduction 
l.C.2.5). However, it is also apparent that the two functional 
arms of the pathway can operate independently of each other t o 
influence cellular growth. Just as agents, such as glucagon 
which stimulate cyclic adenosine 3'5'-monophosphate (c-AMP) 
production, but not phosphoinositide hydrolysis, can raise 
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[ca 2+Ji (Poggioli et al. (1986)), so, too, can DAG levels 
be elevated without an accompanying change in phosphoinositide 
metabolism. Both insulin and the tumour-promoting phorbol 
ester, phorbol 12-myristate 13-acetate (PMA) have been shown to 
increase DAG · levels in myocytes (Farese et al. (1985)) and 
fibroblasts (Takuwa et al. (1987)) respectively, without an 
increase in inositol phosphates. This is most likely achieved 
' by an increased turnover of other phospholipids such as 
phosphatidylcholine and inhibition of DAG kinase (Takuwa et al. 
(1987)). Given the reported elevation in [ca2+J. in the 1 
tumourigenic hybrids, it is conceivable that, if the activity 
of PKC in these cells was also modified, then such cells could 
generate their own aberrant growth signals without the need for 
a disruption in phosphoinositide metabolism. 
Protein kinase c, the effector molecule for the 
second messenger, DAG, is a ca 2+- and phospholipid-dependent 
protein kinase which, when activated, has been shown to mediate 
a wide variety of cellular responses (Kikkawa and Nishizuka 
(1986)). There are several logical reasons to predict a role 
for the alteration in the activity of this enzyme at some stage 
in the tumourigenic process. 
Firstly, there is the association between the mode 
of action of a number of structurally unrelated tumour 
promoters and PKC (Kikkawa and Nishizuka (1986); Nishizuka 
(1984)). Tumour promoters are molecules that are not 
carcinogenic themselves although they are able to increase the 
incidence of tumours in animals pre-treated with carcinogenic 
agents. This suggests that they act by promoting the transition 
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from a de-stabilized (initiated or transformed) to a fully 
tumourigenic growth state. Some of the most effective tumour 
promoters are the tumour promoting phorbol esters, such as PMA 
which are thought to act predominantly through their ability to 
bind to and modulate the activity of PKC (Nishizuka (1984)). 
Secondly, an alteration in membrane fluidity and 
lipid composition is one of the most common features of 
tumourigenic cells (e.g. Itaya et al. (1976)). Given the 
phospholipid dependency of PKC (Kaibuchi et al. (1981)), this 
membrane disruption may serve to modify enzyme activity even in 
the absence of altered DAG levels. Moreover, the elevated 
[ca 2+J. in the tumourigenic hybrids (Banyard and Tellam i 
(1985)) is likely, in itself, to alter the activity of many 
cellular enzymes, including PKC. It is difficult, however, to 
assess the extent to which this elevation in [ca 2+]. would 
i 
affect PKC, given that the calcium measurements represent 
average cytoplasmic calcium concentrations for a population of 
cells. Nevertheless, even small changes in calcium 
concentration can affect PKC regulation, since translocation to 
the membrane increases most sharply between lOOnM and 500nM 
free calcium (Wolf et al. (1985)). 
I 
Further support for the concept that a change in PKC 
activity occurs in association with the expression of 
tumourigenicity can be drawn from the correlation of reported 
differences between the transformed and tumourigenic hybrids 
with known actions of PKC. A number of phenotypic differences 
between the transformed and tumourigenic hybrids have been 
noted, including changes in cytoskeletal organization (Der et 
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al. (1981); Gowing et al. (1984)), fibronectin and collagen 
cell surface distribution (Stanbridge et al. (1982)), glucose 
transport (White et al. (1983)), hormone secretion (Stanbridge 
et al. (1982)) and [ca2+J. (Banyard and Tellam (1985)). 
-- 1 
It is noteworthy that PKC phosphorylates several of 
the cytoskeletal binding proteins, including vinculin (Werth et 
al. (1983)) and talin (Litchfield et al. (1986)), which are 
responsible for organization of the cytoskeleton within the 
cell. Moreover, treatment of cells with PMA results in 
cytoskeletal re-or9anization similar to that generated 
(transiently) by the mitogen, platelet derived growth factor 
(PDGF) (Herman and Pledger (1985); Herman et al. (1986)) and to 
that displayed by the tumourigenic cells (Gowing et al. 
(1984)). In addition, given the co-ordinate alteration in the 
tumourigenic cells of the two major extracellular matrix 
components, fibronectin and collagen (Stanbridge et al. 
(1982)), it is pertinent that long-term treatment ( > 6 hr.) of 
human fibroblasts with PMA increases the secretion of basement 
membrane (type IV) collagen-degrading metalloproteinase (Salo 
et al. (1985)). PKC has also been shown to phosphorylate the 
glucose transporter both in vivo and in vitro (Witters et al. 
(1985)) and regulates the expression of a number of genes 
including c-fos, the expression of which is elevated in the 
tumourigenic D98AH 2 parent (O'Hara et al. (1986)). 
Due to the key role played by PKC in co-ordinating 
the growth response in normal cells (Berridge (1987; 1987a)) 
coupled with the circumstantial evidence that a PKC-like 
activity may be de-regulated in the tumourigenic lines, it was 
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decided to investigate several aspects of this enzyme in the 
somatic cell hybrid system. Because mitogenic stimulation and 
cellular growth state (quiescence versus logarithmic growth) 
have been associated, in a number of systems, with the 
translocation of cytosolic PKC to the membrane (see Section 
l.C.2.4.6), it was decided to monitor levels of PKC activity in 
cytosolic and membrane fractions from the hybrid cells and the 
parental lines. In addition, phorbol diester binding studies 
were performed with intact cells, as an independent measure of 
the molecular levels of PKC in the different cell types. 
4.B MATERIALS AND METHODS 
4.B.l ISOLATION OF PROTEIN KINASE C: 
Cell pairs were grown to confluency in large 
175cm2 tissue culture flasks in appropriately supplemented 
DMEM (see Chapter 2: General Methods). At the time of 
isolation, the medium was removed and the cells washed with 
2xlOOmL of ice-cold normal saline. Cells were then scraped into 
lOmL of ice-cold extraction buffer containing: 
20mM Tris/HCl 
0.25M sucrose 
pH 7.4-7.5 
lmM dithiothreitol (DTT) 
lO~g/mL leupeptin 
lOO~(M phenylmethylsulfonyl fluoride (PMSF) I 
(DTT, leupeptin and PMSF were stored at -20°C as stock 
solutions: lM DTT in H2o, lOmg/mL leupeptin in H2o and lOmM 
PMSF in ethanol, and added just prior to use.) 
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A small sample of the collected cells was taken for 
determination of cell number and the remainder was sonicated on 
ice for 2xl0 seconds, on setting 5 of a sonicator (Ultrasonics 
Inc.; Model W-220F). A known volume of this cell homogenate was 
then centrifuged at 4°C for 1 hour at 100 OOOg in a 50Ti rotor 
using a Beckman ultracentrifuge (model L3-50 or L8-70). The 
resultant supernatant was considered to be the cytosolic 
fraction. The pellet was resuspended in a buffer containing: 
20mM Tris/HCl 
0.25M Sucrose 
0 .SmM EDTA 
O.SmM EGTA 
pH 7.4-7.5 
0.05% (v/v) triton XlOO 
lmM DDT 
lO~g/mL leupeptin 
lOo/'M PMSF 
and tumbled at 4°C for 45 minutes before being centrifuged for 
1 hour, 4°C, at 100000g. The supernatant from this 
centrifugation was considered to contain the membrane bound PKC 
(referred to as the membrane fraction). 
Protein kinase c was partially purified from 
cytosolic · and membrane fractions by DEAE anion exchange column 
chromatography performed at 4°C in a manner similar to that 
outlined previously (Miloszewska et al. (1986)). Glass columns 
20cm x 1cm diameter (from Bio.Rad, USA) were packed with 
approximately lOmL of DE 52 cellulose (from Whatman Ltd., U.K.) 
and pre-equilibrated with at least 400mL of column buffer 
c6mprising 20mM Tris/HCl pH 7.4-7.5, 0.5mM 
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ethylene-diaminetetraacetic acid (EDTA), O.SmM ethylene glycol 
bis ~-aminoethylether) - N,N,N',N'- tetraacetic acid (EGTA). 
Pre-equilibration was found to be essential for the successful 
elution of PKC. Immediately before loading the sample, lSmL of 
column buffer containing freshly added lmM DTT, 10)-l-g/mL 
leupeptin and 100;-,<-M PMSF was passed through the column and, 
after the sample had been loaded, another lSmL of the same 
buffer was used to wash the column free of unbound protein. 
Confirmation that all unbound protein had been eluted was 
obtained by monitoring elution absorbance at 280nm. Protein 
kinase C was then eluted with a 40mL continuous gradient of 
0-0.4M NaCl in column buffer. Again, protease inhibitors and 
protein stabilizers ( 10/" g/mL leupeptin, sqµ M PMSF and lmM 
DTT) were included in this step. Fractions were collected every 
3 minutes (~ 2mL/fraction) and assayed for PKC activity as 
outlined below. At all stages during the procedure, cellular 
preparations were maintained at 4°C. 
4.B.2 DETERMINATION OF PROTEIN KINASE C ACTIVITY: 
PKC activity in the column fractions and the samples 
from which they were derived was assayed in a manner s~milar to 
those outlined previously (House et al. (1987)). The substrate 
used, termed GS(l-12) was developed and generously provided by 
Dr. Kemp (Department of Medicine, The University of Melbourne, 
Victoria, Australia). GS (1-12) is a 12 amino acid peptide 
analogue of glycogen synthase (sequence Pro-Leu-Ser-Arg-Thre-
Leu-Ser-Val-Ala-Ala-Lys-Lys). The advantage of using such an 
enzyme-specific, high affinity substrate (House et al (1987)), 
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is that the phosphorylating activity monitored in the absence 
of phosphatidylserine is likely to be attributable to protein 
kinase M; (PKM is that kinase produced after the phospholipid 
and calcium binding regulatory domain of PKC has been removed 
(Inoue et al (1977)). 
PKC activity was assessed by determining the amount 
of 32 P incorporated into the substrate, GS(l-12), over a 15 
minutes period in the presence or absence of phosphatidylserine 
(PS). All column fractions were assayed within 24 hours of 
separation. The [?"- 32 P]-ATP used as the phosphate donor (New 
England Nuclear, USA through DuPont, USA) was supplied at high 
specific activity (111 TBq/rnmol; 3000 Ci/mmol) but was diluted 
before use in lO~M ATP in lOmM Tris/HCl, pH 7.4 to give 
~ 250 000 CPM/reaction tube. (All ATP was stored at -20°C). PS 
was stored in chloroform: methanol (95:5 (v:v)) at -20°C. 
50~Ug lots were dried down under nitrogen before use and 
re-solubilized in 20~L of chloroform: methanol (1:1 (v:v)). 
One mL of lOmM Tris/HCl pH 7.4 was added and the solution 
sonicated 2xl0 seconds on setting 5 of the sonicator to produce 
a milky micellar solution. The substrate was solubilized in 
H2o. A 10 x stock of reaction buffer containing lOOmM 
Tris/HCl pH 7.4, lOOmM Mgcl 2 , 7.5mM cacl 2 was stored at 
room temperature. 
Assays were carried out in polycarbonate plastic 
tubes in a final volume of 70~<L. 
The reaction mixture containing: 
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7~L 10 x reaction buffer 
+ 7~L 500 g/mL PS 
FINAL CONCENTRATION 
0.75mM cacl 2 , lOmM MgCl2 
10 or 17 µ L H20 
S~L lmg/mL substrate 
~ L lOOflM [ 32p ]-ATP 
12mM Tris/HCl* 
SOrg/mL 
7lµg/mL 
lOpM 
(* after addition of column fractions, final cone. 
Tris, O.SmM cacl 2 , 9.75mM Mgc1 2 ) 
22mM 
was pre-warmed at 30°C for 10 minutes before addition of 3~L 
of sample. The solution was then vortexed and incubated for 15 
minutes at 30°C. The reaction was stopped by spotting SS~L of 
reaction mixture onto a 2.5cm x 2.5cm square of P81 cellulose 
phosphate paper (Whatman Ltd., U.K.), allowing approximately 10 
seconds for the solution to soak into the paper and then 
dropping the paper into a wire mesh basket inserted into a 
beaker containing 75mM orthophosphoric acid. When all fractions 
from a column run had been processed, the papers were soaked 
for a further 10 min in the orthophosphorate, washed for 5 
minutes in fresh acid and then rinsed for 2 minutes in absolute 
ethanol before being dried under a hair dryer. The papers were 
then counted for radiolabelled peptide after addition of 
scintillation fluid (67% (v/v) xylene, 33% (v/v) triton Xll4, 
0.5% (w/v PPO) by standard liquid scintillation counting. 
4.B.3 PHORBOL ESTER BINDING STUDIES: 
Phorbol ester binding was performed using 
[20(n)- 3H]-Phorbol-12,13-dibutyrate, specific activity 729 
GBq/mmol (19.7Ci/mmol) (from Amersham Int. Aust.). Non-specific 
binding was judged as that level of binding occurring in the 
presence of S~g/mL (9.9~M) unlabelled phorbol-12,13-dibutyrate 
("PDBU) (Sigma Chemical co., USA). 
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Cell pairs were plated at either o.sx10 5 or 
1.ox10 5 cells per dish in 35mm diameter plastic petri dishes 
and grown for 24-48 hours in appropriately supplemented DMEM. 
At the time of labelling, the medium was removed and O.SmL of 
the same medium, supplemented with an appropriate concentration 
of [ 3H]-PDBu, with or without unlabelled PDBu., was added. 
The dishes were then returned to the 37°C incubator for 30 
minutes. 
After this time, the medium was rapidly removed and 
the dishes washed with 3X lmL of ice-cold phosphate buffered 
saline (PBS) (see Appendix for formula). The dishes were then 
stored on ice prior to trypsinization (as 1n Chapter 2: General 
Methods). 4 millilitres of the O.SmL cell suspension was 
transferred to liquid scintillation vials for determination of 
radioactivity. cell numbers were determined from parallel 
dishes. 
For Scatchard analysis, binding was determined at O, 
2, 5, 10, 20, 35, 50, 75 and lOOnM [ 3H]-PDBu. Single point 
determinations were made in quadruplicate at SOnM [ 3H]-PDBu. 
Specific binding was calculated from the formula 
B specific = B without 
cold PDBU 
- 18 with 
Lcold PDBu 
where B - bound (CPM) and F = free (CPM). 
X F without PDB~l 
F with PDBU j 
The implicit assumption of this formula, that non-specific 
binding is a linear function of concentration, was confirmed 
during the course of the study, see figure 4.4. 
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4.C RESULTS AND DISCUSSION 
4.C.l PROTEIN KINASE C ACTIVITY IN THE CYTOSOL AND 
MEMBRANE OF TUMOURIGENIC AND NON-TUMOURIGENIC CELLS: 
4.C.1.1 PKC Activity Profiles Generated from DE 52 
Chromatography of Cytosolic and Membrane Fractions 
cytosolic and membrane-bound PKC activities (defined 
as that kinase activity capable of phosphorylating a specific 
peptide substrate in a phosphatidylserine (PS) dependent 
manner) were determined in column fractions from salt eluates 
of DE 52. several pairs of cells were examined and typical 
activity profiles, for a somatic cell hybrid pair 
(39EC13/ESH39), are given in figure 4.1. From these profiles 
several conclusions can be drawn. 
The first, is that there is no difference in either 
the cytoplasmic or membrane activity profiles between the 
tumourigenic and non-tumourigenic cell types, suggesting that, 
if the tumourigenic lines do contain an aberrant form of PKC, 
the alteration does not influence its behaviour on anion 
exchange chromatography. This does not, however, exclude the 
possibility that the different cell types express different 
levels of the transcriptionally distinct forms of PKC [C(,,~I, 
fl I I an d ,,-,, ( C ou s sens et a 1 . ( 19 8 6 ) ] since th e di ff er en t i so z ym e s 
of C-kinase are not distinguished by DE 52 chromatography 
(Huang et al. ( 19 8 6) ) . 
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FIGURE 4.1 
PROTEIN KINASE C ACTIVITY PROFILES FOR THE 
MEMBRANE AND CYTOSOLIC FRACTIONS FROM A CELL 
HYBRID PAIR 
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Protein kinase C activity profiles for cytosolic and 
membrane extracts from the cell hybrid pair 39EC13 / 
ESH39 obtained after fractionation on DE 52 ion 
exchange resin, as outlined in methods section 4.8 
Enzyme activity was assessed in the presence (39EC13 
• ;ESH39 • ) or absence (39EC13 c ;ESH39 A ) of 
phosphatidylserine . Note scale difference between 
ordinates of cytosol and membrane profiles. 
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A second point is that there is a difference in the 
chromatographic behaviour of PKC activity between the membrane 
and cytosol of all cell types, with the peak cytosolic enzyme 
activity eluting at a lower salt concentration (0.05-0.12 M 
NaCl), than that of the membrane associated enzyme, (0.1-0.2 M 
NaCl). PKC, from other sources, has been reported to elute at 
salt concentrations below O .lM (Cochet et al. (1986); 
Christiansen et al. (1986)) corresponding to the activity found 
in the cytosol in this study. It may be that the activity in 
the membrane fraction is due to some other, unrelated kinase, 
although this is unlikely due to the specific nature of the 
syn the tic peptide substrate used ( House et al. ( 198 7) ) . It was 
noted, however, that a substantial proportion of the latter 
half of the membrane activity peak is PS independent, 
suggesting that the PKC-like activity may be attributable to 
the degraded form of the enzyme, known as protein kinase M 
(PKM) (Inoue et al. (1971); Kishimoto et al. (1983)). This 
kinase is _ produced by the proteolytic cleavage of the PS and 
ca2+ binding regulatory domain from PKC and has, in fact, 
been reported to elute at a higher salt concentration than PKC 
(Tapley and Murray (1985); Melloni et al. (1986); Buday et al. 
(1987); Romhanyi et al. (1985)), further supporting the notion 
that some of the membraneous activity is that of PKM. There 
are, also, two PS dependent peaks of PKC activity in the 
membrane fraction. The first minor peak co-elutes with the 
cytosolic peak and may be due to cytosolic contamination of the 
membrane pellet. The fact that the second peak begins eluting 
at slightly higher salt concentrations than the cytosolic 
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enzyme is most likely due to its interaction with some 
solubilized membrane components, leading to either a 
conformational change in the enzyme or the binding of 
additional charged groups. However, the possibility that the 
PKC which associates with the membrane, is distinct from the 
majority of that in the cytosolic pool, cannot be excluded. 
The third point concerns the observation that, in 
terms of proportions of activity in the subcellular fractions, 
the membrane fraction contained a much higher proportion of its 
total enzyme activity as the alleged PKM. This is surprising, 
since it has been reported (Melloni et al. (1986), Mizuta et 
al. (1985)) and it is logical to assume, given the presence of 
cytoplasmic substrates for PKC activity (White et al. (1984)), 
that cleavage of PKC at the membrane would result in the 
release of the catalytic domain into the cytosol, presumably 
leaving the calcium and phospholipid binding domain in the 
plane of the membrane. However, PKM activity has also been 
reported in the membrane fraction by others ( Tapley and Murray 
(1985); Buday et al. (1987)). The fact that it remains 
associated with the membrane may indicate that, despite the 
presence of protease inhibitors, the PKM was generated after 
isolation and that the cytosol failed to show similar 
proportions of PKM due, simply, to the predominantly 
membraneous location of the appropriate cleavage enzyme 
(Melloni et al. (1986), Buday et al. (1987)). An alternative, 
less likely, explanation is that the catalytic domain forms a 
sufficiently strong association with the membrane to remain 
membrane-bound during isolation, suggesting that the catalytic 
domain also contains a membrane binding site. 
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Finally, the non-tumourigenic and tumourigenic cell 
types have differing amounts of PKC activity in both cytosoli c 
and membrane extracts. Originally, it was planned to make 
multiple activity determinations on the un-chromatographed 
subcellular fractions but this was not possible as the 
cytosolic fractions exhibited no apparent PKC activity prior to 
fractionation on DE 52 cellulose, a finding discussed in more 
detail in section 4.C.2. Instead, the amounts of PKC and PKM in 
the subcellular extracts were determined by measuring the areas 
under the peaks of the elution profiles. These are presented in 
Table 4.lA and 4.lB. 
4.C.1.2 Quantitation of Protein Kinase c and Protein Kinase M 
Activity in the Membrane and cytosol of the Tumourigenic and 
Non-Tumourigenic Lines 
Table 4.lA lists absolute activity values for each 
cell line from individual experiments. The magnitude of these 
activities was in agreement with those reported previously for 
human and mouse fibroblasts (Adamo et al. (1986)), and the 
trends in subcellular distribution and relative amounts of 
enzyme activity in the different cell types (given in Table 
4.lB) were, with one exception, maintained between experiments. 
The exception concerned the subcellular distribution of PKC in 
a single experiment with SE cells. Otherwise, the amount of PKC 
activity, in each cell line, was substantially higher in the 
cytosol than in the membrane. In the case of the single SE 
experiment, cytoplasmic levels were comparatively reduced 
whereas membrane levels were significently higher than in other 
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TABLE 4.1 A 
PROTEIN KINASE C ACTIVITY IN THE MEMBRANE AND CYTOSOL 
Protein kinase C activity (pmol/min/1 os cells) 
Cell type 
Cytosol membrane 
PKC PKM PKC PKM 
SE 32.8 1.8 6.0 4.2 
22.6 3.7 43.9 7.4 
SL 17 .0 1.4 4.7 3.3 
nd nd 13.4 5.0 
39EC13 55.0 5.4 13.9 9.8 
nd nd 8.5 7.6 
ESH39 27.5 3.4 3.9 1 .6 
nd nd 1 .6 0.9 
Cn2B1 Col1 9.9 1.2 5.0 2.7 
26.1 3.0 nd nd 
5A7mp 32.8 4.9 1.9 1.6 
42.9 3.5 nd nd 
MRC-5 36.1 nd nd 
95.5 8.0 18.3 4.5 
D98AH2 12.2 1.5 nd nd 
12.2 2.0 2.4 1.7 
Protein kinase C(PKC) and protein kinase M (PKM) activity values 
for the membrane and cytosolic fractions of the different cell 
types were determined by summating the activity found in 
individual column fractions obtained from DE 52 anion exchange 
chromatography ,as outlined in 4.8.1. PKC activity was calculated 
as that level of phosphatidylserine(PS)-dependent kinase activity 
above that observed in the absence of PS. PKM was calculated as 
that PS-independent activity occuring above background. Non-
tumourigenic and tumourigenic cells within a pair were always 
assayed together (nd=activity not determined) 
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TABLE 4.1 8 
RELATIVE PROTEIN KINASE C ACTIVITY IN NON-TUMOURIGENIC AND 
TUMOURIGENIC CELLS. 
Relative protein kinase C activity 
Cell type 
~Q n-tu mQ u rigeo iQLtu mQu rig en iQ 
cytosol/membrane cytosol membrane 
SE 1. 0 
1. 9 2.3 
SL 2.3 
39EC13 2.5 
2.0 5.0 
ESH39 5.6 
Cn281 Col1 1 .4 
0.5 2.2 
5A7mp 10.8 
MRC-5 4.5 
5.4 5.6 
098AH2 3.4 
Values represent relative enzyme activities after pooling protein 
kinase C (PKC) and protein kinase M (PKM) activities. A comparison 
between membrane and cytosolic pools was only made from those 
values obtained within the one experiment. Relative non-
tumourigenic and tumourigenic values were derived from all 
relevant data. 
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cells studied. This may indicate that a translocation of enzyme 
from the cytosol to the membrane had taken place, suggesting 
that the membrane and cytosolic pools are freely 
interchangeable. However, it is possible that this result is 
anomalous due to an experimental artifact, such as resealing of 
membrane fragments after sonication, resulting in the 
entrapment of cytoplasmic activities within membrane vesicles. 
Alternatively, as the extraction buffer did not contain 
chelators, the presence of contaminating calcium may have 
resulted in the association of PKC with the membrane. 
The observation that, in the majority of cases, the 
size of the cytosolic pool exceeded that of the 
membrane-associated pool was surprising, considering the number 
of reports indicating that proliferating cells contained 
relatively higher levels of C-kinase in their particulate 
fractions (Adamo et al. (1986); Averdunk and GUnther (1986); 
Farrar and Anderson (1985)). A report by Adamo et al. (1986), 
examining a number of cell lines, indicated that, in 
proliferating cells, 60-80% of activity was found associated 
with the membrane, a situation which was reversed in confluent 
quiescent cultures. Although the hybrid cells in the present 
study were grown to high density, all cell lines were 
considered to be actively growing at the time of assay. One 
notable difference between this and the Adamo study, however, 
was that, in the latter case, subcellular fractions were not 
further fractionated prior to assay which may have influenced 
the interpretation of cytosolic PKC levels (see next section). 
An alternative report by Donnelly et al. (1985) examining PKC 
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distribution in fibroblasts grown in normal or low calcium 
medium, indicated, in agreement with the hybrid study, that 
after fractionation on DE 52 cellulose, cells growing in normal 
medium contained 90% of their PKC activity within the cytosol. 
Lowering extracellular calcium acted to growth arrest the cells 
and reduce the levels of membrane associated PKC even further. 
One drawback of that study, however, was that cells were 
disrupted in the presence of EGTA which may also hav~ 
influenced relative cytosolic PKC levels (see next section). 
Another consistent trend, discussed earlier, was 
that although the amount of PKM in the cytosolic and membrane 
fractions was similar, the proportion of PKM activity was, in 
general, 3 to 4 fold higher in the membrane fraction. As this 
may have been due to "post- isolational" degradation, PKC and 
PKM values were combined before relative values for subcellular 
distribution and pool sizes for the different cell types were 
determined. 
4.C.1.3 Relative Protein Kinase c Activities in the 
Transformed and Tumourigenic Hybrids and Parental Lines 
When activity levels in the different cell types 
were compared, an important trend emerged. It was found that 
the levels of membrane-associated PKC activity were 
consistently less in the tumourigenic cells compared with their 
non-tumourigenic partners. This is particularly important 
since, as PKC activity under in vivo conditions is dependent on 
both DAG and phospholipid, (Kishimoto et al. (1980), it is 
expected that it is the membrane-associated enzyme which 
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mediates the biological response. The fact th at cytoplasmi c PKC 
activity levels were also decreased in 3 tumourigenic cel l 
lines, suggests that the observed decrease in membrane levels 
in the tumourigenic cells is due to a decrease in total 
cellular PKC activity, not just a change in the levels of one 
or more regulatory factors responsible for mediating the 
translocation of the enzyme to the membrane. However, since the 
relative total cellular PKC activities are lower than t he 
relative membrane activities, the tumourigenic cells may al s o 
have alterations in the regulatory mechanisms associated wi th 
the translocation of the enzyme to the membrane. Intracel lul a r 
free ca 2+ is an unlikely candidate as [ca 2+]. is reported l 
to be elevated in the tumourigenic hybrids. Therefore, DAG 
levels may be decreased in the tumourigenic cells. 
Alternatively, however, it may be that the tumourigenic hybrids 
have reduced levels of one of the isozymes of PKC which 
preferentially associates with the membrane, thereby expl a i n in g 
why relative membrane levels do not reflect total cellular 
levels. 
There are several possible reasons for this obse rved 
decrease in total enzyme -activity in the tumourigenic c e lls. It 
may be due to a decreased rate of synthesis or an increase in 
the degradation of the enzyme. Since degradation is t hought to 
occur primarily at the membrane (Melloni et al. (1985 ) t his 
would be another explanation for the disparity between r e lative 
total and membrane-associated activities. Alternativel y , the 
different cell types may have comparable levels of t he enz yme 
but the rate at which the PKC molecules from the t umour ige nic 
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cells phosphorylate the synthetic substrate may be reduced, 
due, perhaps, to a change in the primary sequence of the 
enzyme. A third possibility is that the tumourigenic lines have 
higher levels of phosphatase activity rather than lower levels 
of C-kinase activity. This is an unlikely explanation, however, 
since relative PKC activities were assessed after fractionation 
on DE 52. In order for phosphatase levels to influence the 
interpretation of kinase activities, they would have to 
co-elute with PKC. In addition, since in three cell lines the 
cytosolic PKC levels were also reduced, it would have to be 
predicted that, either the one phosphatase co-distributes 
between cytosolic and membrane locations, or that more than one 
phosphatase was elevated. 
In summary, using salt gradient elution from DE 52 
anion exchange resin, there was no apparent difference in the 
chromatographic behaviour of PKC and PKM activities between the 
normal, transformed and tumourigenic cell lines. However, the 
tumourigenic cells had consistently less membrane-associated 
PKC activity than their nontumourigenic counterparts. Since 
this difference was observed in every hybrid pair examined, it 
is inferred that a decrease in PKC activity is associated with 
the transition from the transformed to the tumourigenic 
phenotype. Given the well documented involvement of PKC in 
mitogenesis (see Berridge (1987); Kikawa and Nishisuka (1986)) 
and the tumour promoting actions of the phorbol esters, coupled 
with several of the phenotypic changes associated wi~h the 
assumption of the tumourigenic state, it was predicted that any 
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change in PKC activity associated with tumourigenesis would 
involve an increase rather than decrease in PKC activity. 
However, PKC has also been documented to have a role in the 
inhibition or regulation, as well as the generation, of cell 
proliferation. Its function in this capacity will be discussed 
in conjunction with the findings from the phorbol ester binding 
data in section 4.C.4. 
4.C.2 THE EFFECTS OF DIVALENT METAL CHELATORS ON THE 
SUBCELLULAR DISTRIBUTION OF PROTEIN KINASE C: 
Initially, when the system was being developed, 
cells were isolated and disrupted in a Tris buffer containing 
the chelators, EDTA and EGTA (O.SmM of each), on the premise 
that the majority of investigators, including several examining 
the subcellular distribution of the enzyme, added such 
chelators (usually 2-SmM) to isolation buffers (Christiansen et 
al. (1986)). However, when cellular extracts were assayed prior 
to separation by DE 52 chromatography, it was routinely found, 
in contrast to the situation in the absence of chelators, that 
although activity was detected in the cell homogenate and 
cytosolic fraction, no apparent PKC activity was present in the 
membrane extracts. This was surprising considering the reported 
association of PKC with the membrane in actively dividing cells 
(Adamo et al. (1986); Farrar and Anderson (1985); Farrar et al. 
(1985)). Therefore, the possibility that the absence of 
membrane associated C-kinase activity was an experimental 
artifact, was investigated. The majority of activity in the 
cell homogenate was found in the cytosol, indicating that the 
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absence of membrane activity was more likely to be due to 
displacement, rather than inhibition or inactivation of the 
enzyme. This was difficult to fully assess quantitatively, 
however, particularly if the membraneous activity was small, 
because the homogenate activity was independent of exogenously 
added PS and the different cellular fractions contained 
different levels of endogenous substrate. 
A possible source of inhibition of membrane 
associated PKC activity was the 0.1% (v/v) triton XlOO 
detergent used in the extraction of the enzyme from the cell 
pellet. It had previously been reported that triton did inhibit 
the enzyme in other systems (e.g. Donnelly et al. (1985)) and 
so the effects of varying the concentration of the detergent 
was examined. It was found that triton concentrations above 
0.05% (v/v) did indeed inhibit PKC activity from cell 
homogenates in a dose dependent manner (data not shown) but 
that, even when detergent levels were lowered to 0.05% (v/v), 
no membrane associated PKC activity was found. (Experiments 
performed on membrane fractions isolated in the absence of 
chelators indicated that 0.05% (v/v) triton was sufficient to 
liberate the majority of PKC activity from the membrane pellet.) 
An alternative explanation, which was examined at 
the same time, was that PKC was being dissociated from the 
membrane during isolation by the action of divalent metal 
cation chelators. Such an occurrence was possible, given the 
reported ability of ca 2+ to mediate the translocation of PKC 
to the membrane in an inside out erythrocyte ghost model and 
the ability of chelators to reverse this situation, provided 
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that stabilizers, such as the tumour promoting phorbol esters, 
are not present (Wolf et al. (1985; 1985a)). It was found that, 
when cells were isolated in the absence of chelators, a 
substantial amount of PKC activity was found in the 
unfractionated membrane extract but that there was no 
detectable phosphatidylserine-dependent activity in the 
cytosol. This situation is completely opposite to that seen 
when either 0.5mM or 5mM EDTA and EGTA are present in the 
isolation buffer. The possibility, that the absence of PKC 
activity in the cytosol was due to inhibition of the enzyme by 
an excess of divalent cations, was dismissed by the re-addition 
of chelators before assay. 
Therefore, on initial inspection, it could be 
assumed that in vivo, in actively dividing cells, nearly all 
the PKC activity is associated, albeit loosely, with cellular 
membranes, with the proviso that the total absence of chelators 
has not artificially promoted the membrane association of PKC. 
This conclusion was, however, found to be invalid when activity 
determinations were made on subcellular fractions after partial 
purification by DE 52 chromatography (see figure 4.2). It was 
found that, after fractionation, the cytosolic extracts from 
cells isolated in the absence of chelators had levels of PKC 
activity comparable to that in the cytosol of cells isolated in 
the presence of 5.0mM EDTA and 5.0mM EGTA. The only difference 
in the profiles was that the EDTA/EGTA cytosol contained an 
additional shoulder of activity, eluting at a slightly higher 
salt concentration, which corresponded to the activity peak in 
the membrane profile from cells isolated without chelators. 
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FIGURE4.2 
EFFECT OF CHEIATORS ON SUBCETJ,UIAR 
DISTRIBUTION OF PROTEIN KINASE C ACTIVITY 
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Protein kinase C activity profiles for cytosolic and 
membrane extracts from the cell hybrid, 39EC13 extracted 
in buffers with c~,A) or without (• ,c) EDTA/EGTA and 
assayed in the presence ( I, i) or absence (c, a) of 
phosphatidylserine. Note scale difference between 
ordinates of cytosolic and membrane profiles. Authenticity 
of shoulder on the cytosolic peak obtained after extraction 
with EDTA/EGTA was verified by several experiments. 
......... 
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Interestingly, in this particular profile, the shoulder did not 
contain the same proportion of PKM as the corresponding 
membrane associated peak. This is more likely to be because the 
protease responsible for its formation had been denatured 
rather than because the cleavage enzyme remained associated 
with the membrane, since, in other experiments, PKM activity 
co-eluting with this shoulder, has been noted. 
The fact that, even after being shunted from the 
membrane, the PKC activity, that is usually associated with the 
membrane, chromatographs at slightly higher salt 
concentrations, may indicate that the membrane associated pool 
is either permanently modified by membrane interaction or that 
the bulk of the cytosolic pool and the membrane associated pool 
are not interchangeable. As can be seen, there was no PKC or 
PKM activity found in the membrane extract from cells disrupted 
with EDTA and EGTA, even after fractionation. 
A possible explanation for the apparent lack of PKC 
activity in the unfractionated cytosol from cells disrupted 1n 
the absence of chelators, is that the cells contain an 
endogenous inhibitor of C-kinase, whose activity is expressed 
in the cytosol under such experimental conditions. In order to 
test this possibility, a proportion of unfractionated cytosol 
was added back to the most active supernatant fraction, and PKC 
activity re-assessed. When compared to a control, to which the 
same quantity of extraction buffer had been added, the 
unfractionated cytosol (10JLL/70;UL reaction mixture) depressed 
PKC activity by approximately 50%. 
If the observed operation of this inhibitor depends 
solely on its location in relation to PKC rather than on the 
......... 
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regulation of its activity, then it would have to be predicted 
that, in the presence of chelators, the inhibitor moves to the 
membrane, since the cytosolic activity of cells treated in this 
manner shows no apparent inhibition. There is no positive 
evidence for this membrane-associated inhibition since under 
such experimental conditions, PKC leaves the membrane and 
therefore, moves away from its inhibitor. (This proposal could 
I 
be tested, however, by examining the effects of adding back a 
proportion of the membrane extract, from cells extracted with 
chelators, to active. cytosolic fractions). An alternative, 
perhaps more likely, explanation is that the activity of the 
inhibitor(s) is dependent on calcium or other divalent cations, 
explaining why cytosolic fractions from cells isolated in the 
presence of chelators are free from such inhibition. This is in 
agreement with work by McDonald and Walsh (1986), in rat brain 
cytosol, which indicated the presence of 12kDa and 17kda 
ca
2
+-binding proteins that inhibited PKC activity and which 
were proposed as potential regulators of C-kinase activity, at 
least in brain, at eievated [ca 2+]. levels. A complete l 
characterization of the nature of the inhibitory activity in 
the hybrids, to determine whether it represents a counteractive 
phosphatase or a specific inhibitor of PKC, will be a 
worthwhile future investigation. 
4.C.3 PHORBOL DIESTER BINDING TO INTACT CELLS: 
4.C.3.1 Characteristics of Phorbol Diester Binding 
In order to determine whether the perceived decrease 
in PKC activity in the tumourigenic cell lines was due to a 
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reduction in the amount of enzyme present, the levels of 
cellular PKC were quantitated by monitoring tritiated phorbol 
diester binding in intact cells. 
[ 3HJ-phorbol 12,13-dibutyrate (PDBu) was used 
because, although it is less potent than PMA as a tumour 
promoter, it is chemically more polar and so can be more 
readily removed from the cell, resulting in lower levels of 
non-specific binding (Blumberg et al. (1984)). It has been well 
documented that the biologically active phorbol esters, 
including PDBu, promote the translocation of PKC to the 
membrane (Kraft et al. (1983); Skoglund et al. (1985); Gainer 
and Murray (1985)) and, thereby, may influence its 
down-regulation by proteolytic cleavage (Melloni et al. (1985); 
Tapley and Murray (1985)). However, it was found that when 
39EC13 hybrid cells were exposed to 30nM [ 3H]PDBu at 37°C, 
the level of phorbol ester which was specifically bound, 
changed very little between 7 and 68 minutes, indicating that 
the interaction of phorbol ester with its cellular receptor(s) 
is rapid and that the apparent rate of down-regulation of PKC 
in these cells is slow. It could be argued, that the reason for 
the absence of an observed drop in [ 3H]-PDBu binding over the 
one hour period, is because the majority of specific 
[ 3H]-PDBu binding sites do not correspond to PKC. However 
this is unlikely as all evidence points to PKC being the major 
PDBu binding site (Nishizuka (1984)). 
In addition, a number of experiments monitoring the 
1n vitro [ 3H]-PDBu binding to subcellular extracts and DE 52 
column fractions were performed with the hybrids, using a 
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modified version of the binding assay outlined in (Homma et al. 
(1986)). Quantative results for these investigations are not 
presented and were difficult to interpret because of extremely 
low levels of apparent specific binding in these dilute samples 
against a variable background, which was tentatively attributed 
to the glass fibre filters used in the assay. (It should be 
noted that the binding studies are made with 3H label which 
has a much lower specific activity than that of 32 P label 
used in the activity assays. It should also be noted that 
binding is a one-to-one event with each molecule of PKC, 
whereas each enzyme molecule may phosphorylate several peptide 
substrates in the course of an assay.) Nevertheless, when 
column fractions from cytosolic extracts were analysed in order 
to assess their ability to bind PDBu, it was found that a 
significant and reproducible peak of specific [ 3H]-PDBu 
binding co-chromatographed with PKC activity. No additional 
peak was present. Although this does not negate the possibility 
that a PDBu-binding protein eluted prior to application of the 
salt gradient, it does indicate that PDBu binds to PKC and that 
PKC is the major negatively charged component capable of 
binding PDBu in the cytosolic extracts. 
The number and affinity of PDBu binding sites in the 
different cell types were examined by determining the levels of 
specific binding at different concentrations of [ 3H]-PDBu. 
Binding curves and subsequent Scatchard analysis for the hybrid 
pair, cn 2B1col1/SA7mp, are presented in figure 4.3. As 
can be seen from the Scatchard plots (specific bound/[free] vs 
specific bound), the points do not fall on a single line but 
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FIGURE 4.3 BINDING OF PHORBOL 12,13-DIBUTYRATE TO 
INTACT CELLS: SCATCHARD ANALYSIS AND BINDING CURVES 
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Figures representing the characteristics of specific binding 
of phorbol 12,13-dibutyrate (PDBu) to the intact transformed ( m) 
and tumourigenic ( •) hybrid pair, Cn 2B1 Coh /SA 7mp. Specific 
binding was calculated as outlined in 3.B.3. 
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FIGURE 4.4 
RELATIONSHIP BETWEEN THE CONCENTRATION 
OF FREE PHORBOL 12, 13-DIBUTYRATE AND ITS 
NON-SPECIFIC BINDING TO INTACT CELLS 
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Data represent a typical experiment indicating 
the relation between the level or non-specific 
binding of phorbol 12, 13-dibutyrate (PD Bu) to 
intact cells and the concentration of unbound 
PDBu (R=0.99) - see Section 4.8.3 
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are better described by a curve, from which tangents have been 
drawn. (This was true for all cell pairs examined although it 
was less obvious 1n the 39EC13 cell line which could, perhaps, 
have been described by a linear relation). This type of plot 
indicates that there is heterogeneity in PDBu binding to the 
cells, a finding which has also been reported in a number of 
other cell systems using intact cells (Dunn et al. (1985); 
Greenebaum et al. (1983); Horowitz et al. (1981)) or 
subcellular fractions (Dunn and Blumberg (1983)). It is 
possible that the curved data is generated by an experimental 
artifact, particularly since some studies using PDBu, report 
the presence of a single binding site (Solanki and Slaga 
(1981); Chida et al. (1986); Jaken et al. (1981)). However, a 
study by Dunn et al. (1985) which also observed heterogeneous 
binding of PDBu to intact keratinocytes, found, using the same 
experimental protocol, that calcium resistant cell lines 
possessed a single binding site, arguing that heterogeneity was 
biological rather than experimental. If this heterogeneity is 
real, it could be generated in a number of ways. It may 
indicate 2 or more unrelated binding sites indicating that PKC 
is not, in fact, the only specific cellular receptor for PDBu. 
Alternatively, the data could represent a continuum of 
different affinity states of the one receptor. A study by 
Blumberg et al. (1984), has indicated that variation in 
phospholipid composition or DAG content of the lipid 
environment surrounding PKC, alters the affinity of the 
enzyme's binding to PDBu. Therefore, different pools of PKC, 
varying in size and membrane location, could conceivably 
..... 
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generate a plot similar to that obtained. A third possibility 
concerns the different isozyrnes of PKC. Characterization of 
their PDBu binding have not yet been reported. If they differ 
then the heterogeneity could be generated by distinct, but 
related sites. 
Although, given the current information, it is not 
possible to distinguish between these possibilities, results 
will be discussed in terms of high.and low affinity binding 
sites based on the dissociation constants for PDBu calculated 
from Scatchard analysis (See Table 4.2). 
A dissociation constant (kd) is the inverse of an 
association constant (ka) and, therefore, has an inverse 
relationship to binding affinity. It is calculated as the 
negative inverse of the slope of the tangent from the Scatchard 
plot. The kd values for the high affinity site range from 2.6 
to 15.3nM. This is in agreement with other reports including 
those in which only a single PDBu binding site was observed 
(see Nishizuka (1984)). In addition, studies with purified PKC 
indicated that PDBu bound with a kd of 8nM (Kikkawa et al. 
(1983)), indicating that the high affinity site is likely to 
correspond to PKC. Values for the low affinity sites are less 
accurate as they are generally obtained from fewer points on 
the curve. The number of sites associated with this type of 
binding greatly exceed (at least 3-fold) those of the high 
affinity sites. 
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TABLE 4.2 
PHORBOL DIESTER BINDING TO INTACT CELLS 
PDBu binding 
Cell type 
high affinity low affinity 
kd(nM) n(sites/cell) kd(nM) n(sites/cell) 
5E 3.2 2.0x1 as 66.7 9.0x1QS 
5L 2.6 1 .3x1 as 50.0 6.9x1 as 
39EC13 15.3 4.3x1 as 100.0 15.3x1 as 
ESH39 12.5 2. 7x1 as 33.3 7.2x1QS 
Cn2B1 Col1 12.5 3.9x1 as 200.0 16.3x1 as 
5A7mp 11 .8 2.2x1 as 200.0 7 .5x1 as 
MRC-5 6.7 5.4x1 as 100.0 16.3x1 as 
D98AH2 4.2 1 .6x1 as 66.7 8.4x1 as 
Scatchard analysis of the binding of PDBu to intact cells was 
consistent with the presence of more than one affinity binding site (designated high and low). From Scatchard plots (see Figure 4.3) the 
dissociation constants (kd) and the number of binding sites per cell 
(n) were obtained for each class of binding site in the non-
tu mourigenic and tumourigenic cells. Values presented are for 
individual experiments (cell pairs were assayed concurrently). 
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4.C.3.2 The Relative Number of Higher Affinity Binding Sites 
in the Transformed and Tumourigenic Hybrids and Parental Lines 
When the number of high affinity sites for the 
different cell types were compared, it was found that, in each 
case, the non-tumourigenic cell lines have more sites per cell 
than their tumourigenic partners. All values are in general 
agreement with those reported previously in other cell types 
(Dunn et al. (1985)). In order to further examine the relative 
binding of PDBu by the different cell types, multiple 
determinations were made at a single PDBu concentration (SOnM). 
Relative values are given in Table 4.3 accompanied 
by values for relative numbers of binding sites, obtained from 
Scatchard analysis (over the full range of concentrations) and 
relative activity values calculated in section 4.B.l. The 
values obtained with the single point binding agreed well with 
the Scatchard figures, with the exception of the MRC-5/D98AH 2 
pair. This was due to marked variations in the MRC-5 values, 
also noted in the activity data (table 4.lA), which may be 
related to the age of the fibroblasts. The D98AH2 HeLa 
derivatives were the most consistent of all lines examined in 
both activity and phorbol diester binding measurements. 
4.C.3.3 comparison of Relative Protein Kinase C Activity and 
Phorbol Diester Binding 
As seen from Table 4.3, the relative levels of high 
affinity binding sites are in closer agreement with the total 
relative PKC activities than with those activities obtained for 
membrane-associated PKC. The only exception is the 
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TABLE 4.3 
RELATIVE PHORBOL DIESTER BINDING AND PROTIEN KINASE C 
ACTIVITY LEVELS IN THE NON-TUMOURIGENIC AND TUMOURIGENIC 
. CELLS 
Relative non-tu mou rigenic/tumou rig en ic 
Cell pair PDBu 
binding 
A 
SE/SL 1.38 
39EC13/ESH39 1.66 
MRC-5/D98AH2 9.20 
high affinity 
PDBu binding 
8 
1.51 
1.60 
1. 77 
3.38 
protein kinase C activity 
total membrane 
C D 
1.69 
2.3 
0.45 
6.9 
2.3 
5.0 
2.2 
5.6 
Relative non-tumourigenic to tumourigenic levels of PDBu binding 
to intact cells at a single PDBu concentration (50 nM) are given in 
column A. Such ratios represent a composite of four determinations 
of specific binding · for each cell line. When non-tumourigenic and 
tumourigenic cells were compared, all sets were found to be 
significantly different (p<0.01) as judged by the Students t-test. 
Also presented are relative numbers of high affinity binding sites 
obtained from Scatchard analysis (column 8) and relative protein 
kinase C activity values (column C and D). 
......... 
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cn2 B1 col 1/SA7mp pair which differed from other activity 
measurements, in that the cytoplasmic activity of the 
tumourigenic 5A7mp line exceeded that of its transformed 
partner. 
The extent to which phorbol diesters promote the 
translocation of PKC to the membrane has not been documented in 
the somatic cell hybrids. However, it has been reported that 
phorbol esters have an absolute requirement for PS and ca2 + 
in order to bind PKC (Tanaka et al. (1986)) and, therefore, it 
is inferred that the enzyme molecules which bind [ 3H]-PDBu 
must have some interaction with the membrane. A comparison of 
the relative activities and relative binding data, suggest that 
the majority of PKC is translocated to the membrane by PDBu, 
although the relative number of PDBu-binding sites per cell 
are, in most cases, lower than the relative total activity 
values. This may be because, in addition to reduced amounts of 
PKC, the activity per molecule may also be reduced in the 
tumourigenic cells. 
Alternatively, there may be a limit to the 
availability of suitable membrane binding sites and therefore 
the measureable differences in the higher affinity PDBu binding 
sites are limited by differences in membrane area. This idea is 
supported by the observation that the relative PDBu binding 
sites more closely reflect relative membrane palmitate levels, 
calculated in chapter 3 (table 3.2) than the total activity 
valves. This is not to suggest however, that relative 
PDBu-binding should be corrected for relative membrane area 
since, given the predominantly cytoplasmic location of PKC 
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activity in the hybrids, such a relationship would be false. 
(When relative high affinity PDBu binding sites/cell are 
corrected for the more suitable parameter of total cellular 
protein, the differences noted on a cellular basis are 
maintained.) A third, as yet untested possibility is that the 
different isozyrnes bind PDBu with different affinities such 
that the different forms · do not contribute proportionally to 
total high affinity binding. Therefore, if the differences in 
PKC activity in the tumourigenic and non-tumourigenic cells is 
generated by a selective decrease in an isozyrne which does not 
interact strongly with PDBu, then activity differences would 
not be reflected by the PDBu-binding studies. 
If it is assumed that the affinity PDBu binding site 
represents total cellular PKC and that PDBu and PKC bind in a 
1:1 stoichiometry (Nishizuka (1984)) then, by relating the 
activity data (pmol substrate phosphorylated/ min/10 6 cells) 
to the number of PKC molecules per cell, it is possible to 
determine a value for PKC activity/ molecule of enzyme. In the 
case of MRC-5 (the normal fibroblast line), this value is 
-10 2.34xl0 pmol/min/ molecule. House et al. (1987) have 
reported velocity values for purified rat brain PKC of 
1-2/"lmol/min/mg protein using synthetic substrates, including 
GS(l-12) which was used in the present study. Assuming a 
molecular weight for PKC of 76 000 da (Parker et al. (1986)) 
these velocities correspond to values of l.26-2.52xlO-lO 
pmol/min/molecule, further supporting the contention that the 
high affinity phorbol diester binding sites in this study 
correspond to PKC. 
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4.D RAMIFICATION OF RESULTS: 
Both in vitro PKC activity studies and phorbol ester 
binding studies indicate that the tumourigenic cells have 
reduced levels of PKC per cell and that this difference, in 
terms of activity, is accentuated at the membrane, presumably 
the point at which external controlling stimuli impinge on the 
cell (Kikkawa and Nishizuka (1986)). When assessing the 
significance of this finding, it is important to consider 
whether the observed change is merely a non-specific 
consequence of the assumption of the tumourigenic state and, 
more importantly, what role it has in maintaining the 
tumourigenic phenotype. 
Within the milieu of intact cells, it is conceivable 
that any differences in activity, between the transformed and 
tumourigenic lines, could be attributed to a more generalized 
change within the cell; such as an alteration in the properties 
of the membrane. such an alteration could generate a number of 
generalised effects, including a change in PKC activity without 
any alteration in the PKC molecule,~ se. However, in the 
present study, PKC activity was assessed using an in vitro 
assay where the enzyme from both cell types was examined under 
the same conditions. In addition, the amount of PKC per cell, 
as judged by PDBu binding, was reduced in the tumourigenic 
lines, suggesting that the perceived decrease in enzyme 
activity is due, at least in part, to a change in the level of 
the enzyme itself, further implying that the change in PKC 
activity is not just a consequence of some other primary 
alteration. 
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It is important, therefore, to consider what 
ramifications a reduction in this enzyme may have on cell 
growth. PKC activation, in relation to cellular growth, is most 
often associated with the generation of a mitogenic signal 
(Berridge (1987a)). However, as more information concerning the 
function of PKC is being collected, it is becoming clear that 
the role of this enzyme in cellular proliferation is highly 
complex, with activators of PKC often mediating apparently 
opposing actions, depending on the duration of stimulation 
(Davis et al. (1985)), the cell type examined (Forsbeck et al. 
(1985)) and the growth state of the cell (Mccaffrey and Rosner 
(1987)). For example, short term exposure of A431 carcinoma 
cells to PMA or the synthetic DAG, sn-1,2-dioctanoylglycerol 
(Dic 8 ) causes inhibition of high affinity binding of 
epidermal growth factor (EGF) to its receptor with a subsequent 
decrease in the receptor kinase activity. However, when 
quiescent fibroblasts are exposed for a number of hours to PMA 
or Dic8 , these PKC operators operate synergisticly with 
submitogenic levels of EGF to stimulate DNA synthesis (Davis et 
al. (1985)). 
Perhaps some of the observed paradoxes can be 
explained by the finding that the long term treatment of cells 
with tumour promoting phorbol esters, leads to the depletion of 
total cellular PKC (Fabbro et al. (1986); Gainer and Murray 
(1985) and see Borner et al. (1988)) rather than its 
constitutive activation. Nevertheless, there is still no 
unifying role for PKC in the mediation of cell growth. For 
example, it has been indicated that, in some cell types, PMA 
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induced inhibition of cell growth is due to a decrease in 
cellular PKC (Gescher and Reed (1985)), whereas in others, it 
appears that growth inhibition is associated with the 
activation of this enzyme and that down-regulation of PKC plays 
no part in the growth inhibition (Issandou and Darbon (1988)). 
Another example of the conflicting actions of PKC 
concerns its role in differentiation. Although PKC activation 
has been shown to inhibit cell differentiation initiated by 
hormones and other a gen ts ( Shinohara et al. ( 19 85)), it has 
also been shown to induce differentiation in several cell 
systems (Homma et al. (1986)). This is interesting in the 
context of this study, particularly if differentiation is 
considered to be an alternative, if not opposing process, to 
proliferation (see general introduction: section l.D.2). A 
study (Balazovich et al. (1987)), investigating the activity 
and cellular distribution of PKC during dimethylsulfoxide 
(DMSO) or hypoxanthine induced differentiation of murine 
erythroleukemia cells has indicated that, after addition of 
. 
inducers, PKC undergoes a rapid and prolonged association with 
the membrane, accompanied by a gradual decline in total PKC 
activity over the ensuing 5 days. Moreover, exposure of HL-60 
cells to the differentiation inducers, DMSO or retinQic acid, 
caused at least a two-fold increase in all 3 isozymes of PKC 
(cx.,;8 and'?') in the HL-60 cells (Makowske et al. (1988)). This 
increase in C-kinase activity was seen in both membrane and 
cytosolic pools with approximately 10% of total PKC activity 
being membrane associated in both control and differentiating 
cells. 
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The findings with the somatic cell hybrids cannot, 
however, be directly related to the changes seen in either the 
differentiation studies or those concerning proliferation since 
both of these latter cases are examining a dynamic situation 
where PKC activity and distribution are being monitored during 
the transition from one growth state to another. In the somatic 
cell hybrids no equivalent transition is occurring during the 
current study. Therefore, variations in PKC between the hybrids 
are conceivably associated with the maintenance rather than 
generation of the cells' unique growth characteristics, in 
vivo. 
It may be that the decreased level of PKC in the 
membrane of tumourigenic lines represents the decreased ability 
of these cells to coordinately regulate incoming mitogenic 
growth signals, delivered by peptides such as EGF (see 
introduction l.C.2.4.5). Another possibility is that the 
reduced pool size in the tumourigenic cells may mean that the 
membrane pool cannot be sufficiently enlarged in the presence 
of appropriate inducers to mediate the types of 
anti-proliferative signals, associated with differentiation, 
which are necessary to halt continuous cell growth. The answer 
to these questions awaits not only a clearer understanding of 
how PKC regulates cell growth, but also, a more specific 
determination of the nature of the differences in PKC activity 
in the tumourigenic cells. 
The recent discovery of the different isozyrnic forms 
of PKC may help clarify the apparently divergent biological 
actions of PKC and may also help delineate the nature of the 
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change in PKC activity in the tumourigenic cells. It could be 
speculated that the decrease in PKC activity in the 
tumourigenic cells is due to an imbalance or absence of one of 
the subtypes of PKC, rather than a reduction in the overall 
activity of the enzyme. It would be of great interest, 
therefore, to measure the levels of both mRNA and translation 
products of the three known isozymes of PKC in the normal, 
transformed and tumourigenic cells. This would serve, not only 
to uncover any differential isozymic expression in the 
different cell types, but also to indicate whether the observed 
decrease in PKC levels are due to decreased synthesis of 
message, i.e. change in regulation of PKC genes, or increased 
degradation of the enzyme, i.e. modulation of other proteins 
which act on PKC itself. The human ex_, ;B and I PKC genes have 
been mapped onto chromosomes 17, 16 and 19 respectively 
(Coussens et al. (1986)), none of which correspond to those 
chromosomes whose loss from the somatic cell hybrids results in 
the reversion from a transformed to a tumourigenic state. 
However, it is conceivable that the expression of C-kinase 
genes is under the control of the tumour suppressor genes (see 
introduction l.D.2) whose presence within the cell is necessary 
to suppress the tumourigenic phenotype. In this context it 
would be of interest to examine PKC activity in those 
tumourigenic hybrids that had reverted back to a 
non-tumourigenic state after the re-introduction of chromosome 
11 (Saxon et al. (1986)) to examine whether a decrease in PKC 
activity had a causal relationship with the tumourgenic 
phenotype and not merely a consequential association. A more 
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direct way to test this, particularly if it eventuates that the 
tumourigenic cells do have decreased levels of one of the 
isozymes of PKC, would be to introduce PKC genes, coupled to 
appropriate promotors, into the tumourigenic hybrids and 
re-test for tumourigenicity in vivo. Alternatively it would be 
of interest to examine the effect, on tumour development in 
nude mice, of localized administration of activators or 
inhibitors of PKC activity at, or after, the time of 
introduction of the non-tumourigenic and tumourigenic hybrids 
to the animal host. 
Preliminary attempts have been made to assess the 
impact of a change in PKC activity on expression of the 
tumourigenic phenotype in vitro, by examining the level of 
cytoskeletal organization before and after treatment of cells 
with activators and inhibitors of PKC. Results indicate that 
after 30 minutes exposure to PMA, the tumourigenic hybrid, SL, 
showed some improvement in its cytoskeletal organization but 
that the changes were not substantial. 
More work needs to be done in characterizing the 
changes in PKC associated with · the expression of the 
tumourigenic phenotype in the human somatic cell hybrids. A 
role for PKC in mediating an altered growth state has been 
inferred by the ability of phorbol esters to activate 
(Nishizuka (1984)) and possibly down-modulate (Fabbro et al. 
(1987)) this enzyme, and by the ability of oncogenes to raise 
the steady state levels of DAG (Fleischman et al. (1986)). The 
findings described in this chapter provide further direct 
experimental support for a role for PKC in tumourigenesis and 
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additionally have indicated other avenues for future 
investigations, including the characterization of the PKC 
inhibitory activity within the cytoplasm of the hybrids, and 
the subcellular distribution of PKC in intact cells in response 
to changes in extracellular [ca 2+]. 
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CHAPTER 5: 
CONCLUSIONS 
The aim of this investigation was to examine the 
operation of the phosphoinositide signal transduction pathway 
in the HeLa X fibroblast human somatic cell hybrid system in 
order to assess whether this pathway has been deregulated in 
association with the transition from the transformed to the 
fully tumourigenic growth state. 
The binding of a number of growth factors to their 
receptors has been shown to stimulate phosphoinositide 
metabolism, with the cleavage of the lipid 
phosphatidylinositol(4,5)bisphosphate, resulting in the 
production of the proposed second messengers, 
inositol(l,4,S)trisphosphate and diacylglycerol (Berridge 
(1987a)). An alteration in the functioning of this pathway has 
been reported in association with -the assumption of a 
transformed or tumourigenic phenotype in several cell systems 
(see section l.D). 
By examining the incorporation of inositol into the 
total phosphoinositide pool, and by com~aring the relative 
rates of incorporation with the steady state pool sizes in the 
transformed and tumourigenic cell hybrids, it was inferred that 
there was no difference in the turnover of phosphoinositides 
between the different cell types under maximal growth 
stimulation (10% serum). A comparison of the parental lines 
gave similar results in terms of the turnover of the 
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phosphoinositides. However, it was noted that the HeLa and 
fibroblast cells differed, not only in their growth 
characteristics, but also in their morphology which was 
reflected in the size of their total exchangeable 
phosphoinosidite pools. This prompted the re-examination of the 
relative phosphoinositide pools after correcting for 
differences in cell surface area. 
When the phosphoinositide levels within the normal, 
transformed and tumourigenic cells were expressed per unit 
membrane rather than per cell, it was found that the 
tumourigenic cells had higher levels of phosphoinositides/unit 
membrane than did their non-tumourigenic counterparts. Although 
this deviance was not significant in every case, it was 
interesting, since, a higher level of phosphoinositides per 
unit membrane may give the tumourigenic cells a growth 
advantage. If it could be shown that the additional 
phosphoinositides were coupled to receptor complexes that are 
in excess of their phosphosphoinositide effector in the 
non-tumourigenic cells then the tumourigenic hybrids would be 
able to generate higher levels of intracellular mitogenic 
signals for a given concentration of external agonist than 
their non-tumourigenic partners. However, a comparison of the 
ability of the different cell hybrids to divide in different 
serum concentrations, failed to indicate a difference in the 
growth responsiveness in the cell types. Moreover, when cell 
hybrid pairs were grown under maximal growth stimulation 
conditions (10% (v/v) serum) a comparison of the steady state 
levels of inositol (1,4,S)trisphosphate, indicated that there 
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was no difference in the levels of this molecule between the 
hybrids. Therefore it was concluded that, in tissue culture, 
there was no functional difference in the operation of the 
phosphoinositide pathway between the transformed and 
tumourigenic cells. 
The absence of a significant difference in the rates 
of turnover of the phosphoinositides, between any of the cell 
types, may signify that this pathway is functioning normally in 
the hybrids. conversely, it may indicate that it is not 
functioning at all to mediate serum stimulated proliferation in 
the actively dividing cells. This latter possibility should not 
be dismissed, given the recent report that there is no 
appreciable change in phosphoinositide metabolism during the 
progression through the cell cycle of Chinese hamster ovary 
cells, stimulated to divide with serum ( Tones et al. ( 1988)). 
However, although the transformed and tumourigenic 
hybrids have different growth characteristics in vivo, they 
have very similar growth properties in vitro. (Standbridge et 
al. (1982)). In addition, it is not until the hybrids have 
spent several days within the animal host that the full 
expression of the tumourigenic potential becomes obvious 
(Stanbridge and ceredig (1981)). This indicates that the 
activation or function of the suppressor genes, proposed to be 
lost in association with the assumption of the tumourigenic 
phenotype, (Stanbridge (1985)) is not instantaneous in vivo and 
that its complete operation in vitro is not possible (as 
assessed by the inability of the non-tumourigenic hybrids to be 
growth arrested in G or to display the differentiated 0 
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phenotype of the normal parent). Therefore, although the 
present study does not support the suggestion that an altered 
turnover in phosphoinositides is a key difference associated 
with tumourigenicity, the possibility cannot be eliminated that 
minor alterations in phosphoinositide me~abolism, detected in 
this study, are amplified by the distinct environment occurring 
in vivo. 
One difference between the transformed and 
tumourigenic hybrids, which was observed in tissue culture, 
concerned the levels of protein kinase C within the cells. It 
was found that both the in vitro kinase activity, and the high 
affinity phorbol diester binding in intact cells, was reduced 
in the tumourigenic hybrids, suggesting that the actual amounts 
of this enzyme are lower in such cells. This indicates that the 
change in protein kinase C activity occurred independently of 
phosphoinositide hydrolysis but that it may affect the outcome 
of the activation of this pathway. It could be argued that the 
decreased levels of protein kinase c would lead to a reduction 
in the availability of positive growth mediators in the 
tumourigenic lines. However, protein kinase Chas equally been 
shown to mediate many negative effects of growth including, not 
only inhibition of its own activator-generating system (Kikuchi 
et a 1 . ( 19 8 7 ) ) , bu t a 1 so the i nh i b i ti on o f o the r gr ow th s i g n a 1 s 
(Bollag et al. (1986)) and in some cells, the induction of 
differentiation (Makowske et al. (1988)). 
Before making a full assessment of the importance of 
these findings to the assumption of the tumourigenic state, it 
will be necessary to assess the magnitude of the difference in 
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intracellular protein kinase C activity in the intact hybrids, 
and highly desirable to determine the proportionate expression 
of the different known isozymes of C-kinase within the 
transformed and tumourigenic cells. Even with this information, 
it could be argued that the observed decrease inc-kinase 
levels is a non-specific consequence of tumourigenesis which 
plays no part in the progression or the maintenance of the 
tumourigenic state. However, it could equally well be proposed 
that PKC plays a central role in the regulation of cell growth, 
and that a reduction in the levels of this enzyme actively 
contributes to the tumourigenic phenotype. This could no doubt 
be tested directly using the tools of molecular biology, as 
outlined in chapter 4. Intellectually, this idea is supported 
from the current information concerning the transforming 
oncogenes. Oncogene products have been shown to mimic the 
function of growth factors (sis), growth factor receptors 
(erb-B), and GTP-binding proteins (ras). They can enhance 
phosphoinositide turnover (ros, src, ras, fms, fes) and are 
highly related to the cellular genes which are switched on by 
second messengers (myc, fos). In fact, they appear to have 
mimicked every stage in the generation of positive mitogenic 
signals. Yet none of the known oncogenes have sequence homology 
to protein kinase c (Parker et al. (1986)). This would make 
sense if the primary role of this kinase is the regulation 
rather than the promotion of growth. 
It is proposed, therefore, that the observed 
decrease in protein kinase c levels in the tumourigenic somatic 
cell hybrids, compared with their transformed partners, 
..... 
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actively contributes to the tumourigenic growth state and t h a t 
at least one protein kinase C gene is a target for the tumour 
suppressor gene(s) whose presence within the cell is necessary 
for controlled growth within the animal. It remains to be seen 
whether the additional protein kinase c activity in 
non-tumourigenic cells helps control growth by promoting 
differentiation or modulating proliferation. Whatever the 
outcome, the findings will further the understanding of the 
role of protein kinase c in cell surface signal transduction. 
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APPENDIX 
COMPOSITION OF MEDIA 
(a) Phosphate Buffered Saline (PBS) 
137 mM 
7 mM 
3.5 mM 
NaCl 
Na2HP04.2H20 
Na H2P04.2H20 
(b) Minimal Essential Medium without glucose (MEM-G) 
116 mM 
l.36mM 
5.4 mM 
1.0 mM 
26.2mM 
1.0 mM 
NaCl 
CaCl2 
KCl 
MgS04.7H20 
NaHC03 
NaH2P04.2H20 
AA 
AEV 
AMP,ADP,ATP 
c-AMP 
cDNA 
c-GMP 
clns(1 :2)P 
CMP,CDP,CTP 
DAG 
DEAE-cellulose 
DiCs 
DMSO 
DNA 
DTT 
EGF 
ER 
EDTA 
EGTA 
FMLP 
FSV 
Go,G1 ,G2 
gly 
GMP,GDP,GTP 
Gp, Gs, Gi 
GTP y-S 
HPLC 
IF~ 
IL F-1 
lnsP, lnsP2,lnsP3 
lnsP4, lnsPs, lnsPs 
[ion]i 
[ion]o 
mRNA 
OAG 
PDBu 
PDGF 
pHi 
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ABBREVIATIONS 
arachidonic acid 
avian erythroblastosis 
adenosine mono-, di-, and triphosphate 
adenosine 3' ,5'-cyclic mono phosphate 
complementary DNA 
guanosine 3' ,5'-cyclic mono phosphate 
inositol cyclic monophosphate 
cytidine mono-, di-, and triphosphate 
diacylglycerol (sn-1 ,2 configuration unless 
otherwise stipulated) 
diethylaminoethyl cellulose 
sn-1 ,2-dioctanoylglycerol (synthetic DAG) 
dimethylsulfoxide 
deoxyribonucleic acid 
dithiothreitol 
epidermal growth factor 
endoplasmic reticulum 
ethylenediaminetetraacetic acid 
ethylene glycol bis(~-aminoethylether)-
N, N, N', N'-tetraacetic acid 
formyl-meth io nyl-leucyl-ph enylalan i ne 
feline sarcoma virus 
stages or temporal gaps in the cell cycle 
glycine 
guanosine mono-,di- and triphosphate 
GTP-binding proteins (also Np, N5 , Ni) 
non-hydrolysible analogue of GTP 
high performance liquid chromatatography 
interferon type beta 
insulin-like growth factor 
inositol mono-, bis-, tris-, tetrakis-, 
pentakis-, and hexakisphosphate, 
respectively. Numbers in parenthesis 
denote regiochemistry 
free intracellular molar concentration of 
ion denoted 
free extracellular molar concentration of 
ion denoted 
messenger ribonucleic acid 
1-oleoyl-2-acetylglycerol (synthetic DAG) 
phorbol 12, 13-dibutyrate 
platelet-derived growth factor 
intracellular pH 
Pl, PIP, PIP2 
PKA 
PKC 
PKM 
PLC 
PMA 
PMSF 
PPO 
PS 
TCA 
TGF~ 
TNF 
v-fes, v-fms, v-ros, 
v-ras, v-src,v-myc, 
v-fos, v-erb B 
c-fes, v-fms etc 
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phosphatidylinositol, phosphatidylinos itol 
mono-, and bisphosphate. Numbers in 
pa re nth es is denote reg i oc hem i stry. 
protein kinase A viz c-AM P-dependent 
protein kinase 
protein kinase C 
protein kinase M 
phospholipase C 
phorbol 12-myristate 13-acetate 
phenylmethylsulfonyl fluoride 
2,5-diphenyloxazole 
p hosp ha tidy Iseri n e 
trichloroacetic acid 
transforming growth factor beta 
tumour necrosis factor 
oncogenes 
proto-oncogene 
